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The most common heart arrhythmia atrial fibrillation (AF) is concurrently one of the least 
understood and most difficult arrhythmia to cure. AF affects about 33.5 million people 
worldwide and is not confined to any age limit.1 However, incidence of AF does increase 
rapidly with age. For persons of 40 years and older, risk of developing AF during their life 
is 25%.2 Pharmacological treatment often has intolerable side effects or recurrences of 
AF occur despite drug therapy. Invasive treatment is more successful than conservative 
therapies, nonetheless, even invasive therapy still frequently fails. This chapter introduces 
AF including current knowledge of its etiology, prognosis and treatment options and 
discusses the challenges restricting optimal treatment.
Atrial fibrillation: a chaotic heart rhythm with short- and long-term 
consequences
During a normal heart rhythm, electrical activation of the heart starts in the sinus node 
located in the right atrium. From the sinus node, electricity propagates in a relatively fixed 
expansive pattern through the myocardium of both atria. The rate of sinus rhythm ranges 
between 60 per minute in rest to 200 per minute during exercise. During AF, electricity 
propagates through the atria in a very chaotic manner with an atrial activation frequency 
between 300-400 times per minute. Atrial rate is filtered between the atria and the ven-
tricles at the AV-node, but ventricular rate can still reach up to 200 per minute during AF. 
The high atrial frequency and chaotic electrical conduction results in a higher resting heart 
rate and an irregular heart rhythm. Symptoms patients can experience during AF include 
fast and/or irregular palpitations, dizziness, fatigue, shortness of breath (on exertion), 
sweating and/or chest pain. These symptoms may hinder normal daily activities or sleep 
significantly. Some patients do not have any symptoms of AF and AF is diagnosed coinci-
dentally, so-called silent AF. Hemodynamic compromise during AF rarely occurs, in most 
such cases another severe underlying heart disease is present, and therefore short-term 
prognosis is very good. However, long-term negative consequences of AF include heart 
failure due to rapid heart rates and the risk of cerebral vascular accidents due to blood 
stasis mainly in the left atrial appendage forming blood clots that can travel to the brain.3, 4 
Patients with additional risk factors for stroke such as age ≥65 years, previous stroke, heart 
failure, peripheral vascular disease, diabetes or hypertension are therefore required to 
use oral anticoagulants.5, 6 For symptomatic patients, initially a rhythm control strategy is 
usually chosen aimed at maintaining sinus rhythm. On the one hand, by antiarrhythmic 
drug therapy combined with medicine controlling heart rate during an AF episode and 
on the other hand by electrical cardioversions restoring sinus rhythm in case medication 
fails. Unfortunately, medications have hindering side effects in 10-30% of the patients 
such as nausea, stomach ache, dizziness or fategue.7 In addition, AF episodes recur in 65% 
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of patients while on medication and in 68% within 1 year after cardioversion.7, 8 Since 20 
years, there are also invasive treatments available that aim to terminate and prevent AF 
by freezing or burning parts of atrial tissue which then become electrically inactive (abla-
tion). After one year, 36% of patients have a recurrence which is a significant improvement 
over other therapies, but failure rate increases to 47% after 3-years.9 Multiple ablation 
procedures for AF improve outcomes and finally result in 20% failure9, this means ablation 
therapy still fails in many patients.
Expression, progression and risk factors of atrial fibrillation
The success of therapies and symptomatic burden of AF depends on the clinical expres-
sion profile of AF. AF has a wide spectrum of clinical expressions from an occasional short 
self-limiting episode with years in between to permanent AF. AF expression has been 
defined in 3 clinical profiles according to the duration of AF10:
1. Paroxysmal AF: AF that terminates spontaneously or with intervention within 7 days of 
onset
2. Persistent AF: continuous AF that sustains beyond 7 days
3. Long-standing persistent AF: continuous AF longer than 12 months duration
Especially the difference between paroxysmal and persistent AF is of clinical significance 
as success rates of therapies decrease in patients with persistent atrial fibrillation. Abla-
tion therapy for example is 13% less successful in patients with persistent AF than in 
patients with paroxysmal AF.5 Patient with paroxysmal AF can also progress to persistent 
AF. Of patients that initially present with paroxysmal AF 8-15% progresses to persistent 
AF in the first year and 25% after 5 years.11 Symptoms of AF can be so indistinct or absent 
in total that diagnosis may be delayed and patients present with persistent AF at time of 
diagnosis.
Multiple risk factors for AF have been identified.12, 13 Some risk factors for AF are modifiable; 
those include smoking, alcohol consumption, hypertension, diabetes and a sedentary life-
style. Although too much endurance exercise (>1500-2000 hours of high intensity/ lifetime) 
also has an increased risk of development of AF in men.14-16 In short, a healthy lifestyle 
without excessive endurance training decreases the risk of AF. Other non-modifiable risk 
factors include advancing age and genetically determined risk factors. Men are 1.5 times 
more likely to develop AF than women. Caucasian people also have an increased risk 
over people of African, Asian or Hispanic descent.13, 17 Furthermore, other structural heart 
diseases increase the risk of AF. Many structural heart diseases, whether congenital or 
valvular heart disease or cardiomyopathies, directly or indirectly cause structural changes 




Electrical and structural remodeling in atrial fibrillation
The progressive course of AF is not only caused by increasing tissue remodeling of ongoing 
underlying heart diseases or other comorbidities, but presence of AF itself triggers struc-
tural and functional changes of atrial tissue.20, 21 When a cardiac cell is electrically activated 
called depolarization, different ion channels at the borders of the cell open consecutively 
which cause a flux of electrically charged ions in and out of the cell and the release of 
calcium that leads to muscle contraction. The ion flux on the outside and inside of the 
cell (through intercellular connections named gap junctions) depolarizes neighboring 
cells as well. High depolarization rates of cardiac cells during AF result in intracellular cal-
cium overload and induce stress at the level of the endoplasmic reticulum (important for 
protein synthesis and distribution within the cell).21, 22 Multiple structural changes within 
the cell occur in response such as down regulation of ion channels and gap junctions, 
dysfunctional protein synthesis and distribution, and cell enlargement ultimately lead 
to changes and dysfunction of electrical conduction (electrical remodeling). These func-
tional changes in the electrical conduction and excitation include shortening of the action 
potential duration, delayed depolarizations, intercellular disconnection and symphatic 
discharges influencing ion channels.21 The longer AF is present the more structural and 
functional changes are observed.23, 24 The electrical changes have been shown to recover in 
time but the more time AF was present the longer it takes for cells to recover.24-27 Structural 
remodeling due to AF may even be (partly) irreversible.26 Electrical conduction patterns 
that follow remodeling and sustain AF are still mainly unknown and may in fact differ be-
tween patients and may even change in time within a patient due to ongoing remodeling.
Mechanisms of atrial fibrillation
In 1998 it was discovered that paroxysmal AF is mostly triggered by spontaneous electrical 
activity originating from the pulmonary veins.28 Therefore, isolating the pulmonary veins 
from the remaining atrial tissue successfully cures AF in a high number of patients with 
paroxysmal AF and is now the corner stone of AF ablation therapy. However, in persistent 
AF other underlying mechanisms seem to take over.29, 30 In the past, different hypotheses 
about the electrophysiological mechanisms underlying persistent AF have been pro-
posed. These theories can be divided into two main categories: 1) self-sustaining multiple 
wavelets and 2) (focal) drivers with fibrillatory conduction.31-33 The multiple-wavelets 
theory consists of a constant presence of multiple wavelets finding different pathways 
with non-refractory (excitable) tissue and endlessly continue circulating through the atria. 
The other theory is that a specific area in the atria excites at such a high rate causing fibril-
latory conduction in the remainder of the atria. Fibrillatory conduction is discontinuous 
conduction of waves due to an activation rate near the refractory period (time in which a 
cell is recovered and can be reactivated) resulting in wave breaks when encountering tis-
sue that is still unexcitable. The heterogeneity of fibrillatory conduction and thus the state 
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of recovery in atrial tissue is based on concepts of anisotropy (conduction speed differs 
between longitudinal and transversal excitation direction of cardiac cells) and structural 
discontinuities slowing conduction. Drivers have been proposed to present various phe-
nomena: (multiple) site(s) of micro- or macro-re-entry, ectopic activity or rotors e.g. spiral 
waves (Figure 1). Over the past years different studies have shown support for either main 
category and thus these mechanisms remain a controversial topic.29, 33-38
In 2010 it was demonstrated that breakthrough waves occur frequently during persistent 
AF.29 Breakthrough waves are waves of electrical activity that appear suddenly at a focal 
point and conduct radially from there, like a stone in water creating waves. A new proposal 
was made that dissociation of electrical conduction within the atrial wall was the cause 
for these breakthroughs and for persistence of AF. A wave of electrical activation traveling 
on only one side of the atrial wall due to electrical dissociation of the layers can create 
a new (breakthrough) wave at the other side when there is a pathway for electrical con-
Figure 1. Proposed mechanisms for persistence of atrial fibrillation.
Multiple wavelets theory: multiple (small) waves of electrical activity are simultaneously circling the atria 
and continue to encounter recovered excitable atrial tissue. Single and multiple driver theories: one site 
or multiple sites in the atria excite at a high rate, waves continuing to the remainder of the atria from such 
site(s) conduct in chaotic patterns due to the high frequency and different conduction properties through-
out the atria (fibrillatory conduction). Removing the driver(s) would stop atrial fibrillation. Drivers have 
been proposed as different mechanisms: 1) spontaneous depolarizing atrial cells from an ectopic site, 2) 
highly curved wave with very slow conduction at its core which thereby maintains itself as a continuing spi-
ral of electrical activity to the remainder of the atria (rotor), 3) a large pathway of electrical activity covering 
a large part of the atria that keeps circling due to recovery of cells at its tail (re-entry), 4) a small pathway of 




duction between the layers (Figure 2). The random pattern in which these breakthrough 
waves appeared during persistent AF did not resemble a driver. Therefore it was proposed 
that multiple wavelets, combined with epi-endocardial dissociation increasing the total 
surface for waves to conduct, explain persistence of AF.29 To record and visualize these 
atrial activation patterns a technique called electroanatomical mapping is used. Mapping 
of atrial activation is a tool that can help distinguish between these various mechanisms 
sustaining AF.
Mapping of atrial fibrillation
Electroanatomical mapping constructs a graphic (anatomical) representation of electrical 
activity measured by electrograms recorded -mostly- from the surface of the heart (Figure 
3). The two ways to record these electrograms are from the endocardial (in-) or epicardial 
(out-) side of the heart. The endocardial surface of the atria can be accessed via catheters 
introduced in the femoral vein and advanced upwards in the inferior caval vein to reach 
the right atrium, the left atrium is reached by transseptal puncture.
Standard electrophysiological catheters contain between 4-20 consecutive electrodes 
that record electrograms (Figure 4, left). Maps are created by software able to detect the 
location of the catheter in space and linking the successively recorded electrograms from 
different locations in the atria. Newer catheter techniques include an inflatable balloon 
Figure 2. Theory of endo-epicardial dissociation maintaining multiple wavelets.
It was proposed that electrical dissociation between the epicardial and endocardial layers of the atrial wall 
are the cause for epicardial breakthrough waves. A wave traveling only on the endocardial side that is able 
to break through where the endocardial and epicardial layers are connected results in a new wave of elec-
trical activity in the epicardial layer (white star).
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with 64 electrodes arranged in several spines (Figure 4, middle). The advantage of endo-
cardial mapping is the minimal invasiveness of the procedure and the ability to include 
the interatrial septum. Epicardial mapping, on the contrary, requires thoracotomy (e.g. 
cardiac surgery) and is usually only performed if thoracotomy is indicated for repair of 
structural cardiac diseases. However, during cardiac surgery there is enough space for 
multi-electrode arrays that record electrograms from 192-256 sites simultaneously (Fig-
ure 4, right). In mapping of AF this could be of utmost importance as spatial patterns of 
activation are very irregular during AF and differ between consecutive recordings. Until 
now, epicardial atrial mapping was limited to a few areas of interest and high-resolution 
mapping of the entire epicardial surface had not been performed.
The electrodes on catheters or arrays record extracellular potential changes of 10,000 
cardiac cells together residing underneath and surrounding the electrode. A continuous 
Figure 3. Demonstration of electroanatomical mapping.
An electrode array is placed directly on the surface of the atrium and records an electrogram of local electri-
cal activity at each electrode site. Electrograms are marked at the local atrial activation time e.g. the steep-
est negative slope for unipolar electrograms (V = ventricular activation). The first local activation time is set 
as T0 and all others are relatively measured to this time. Each activation time is placed in a map according 
to the site of the electrogram in the array (mapping). The activation pattern(s) can then be presented on 
an anatomical model of the atrium and this provides an overview of the atrial electrical activation pattern 




wave of depolarization passing by an electrode results in a positive peak followed by a 
negative peak on a unipolar recorded electrogram. A depolarization wave changing direc-
tion or discontinuous activation of the tissue in the electrode recording area can cause 
appearance of potentials with multiple positive and negative peaks (fractionation).39, 40 In 
clinical practice and mapping studies the most used recording mode has long been the 
bipolar recording mode. Only recently new mapping systems have also reverted back 
to unipolar electrograms. A bipolar electrogram is the diff erence between two unipolar 
electrograms and eliminates most farfield electrical activity (unintended recorded elec-
trical activity from sources at a distance). As farfield signals are very similar shaped and 
timed between two electrodes, they are nearly completely subtracted and the local signal 
remains (Figure 5). In atrial unipolar electrograms the farfield ventricular electrical activity 
is oft en prominently present and can interfere with marking atrial signals. Particularly dur-
ing atrial arrhythmias, ventricular electrical activity can occur simultaneously with atrial 
electrical activity and atrial and ventricular signals are less well coordinated complicat-
ing atrial marking of unipolar electrograms. However, unlike the morphology of bipolar 
electrograms, morphology of unipolar electrograms is not influenced by the direction 
of the wave front and distance between electrodes.41, 42 A bipolar electrogram requires a 
time shift  of the potential between the poles. If a wave fronts travels perpendicular to the 
two poles passing by each electrode at the same time, subtracting the similar unipolar 
potentials will lead to a zero bipolar potential or a bipolar potential of very low amplitude.
Figure 4. Examples of current mapping tools.
Left : standard electrophysiological catheter used for endocardial mapping containing 8 electrodes or 4 sets 
of bipolar electrodes. Middle: basket catheter containing 64 electrodes distributed over 8 spines, which are 
deployed within the atrium and adjusted to the atrial size for optimal endocardial contact. Right: electrode 
array of 192 electrodes closely spaced together used for epicardial mapping.
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Ablation procedures for atrial fibrillation
The past years, several ablation procedures have been introduced in order to treat persis-
tent AF based on the proposed mechanisms. First invasive procedure developed for AF was 
a surgical procedure that split the atria into an electrical maze by creating multiple lines 
of scar aiming to prevent circling of multiple wavelets or macro-re-entry circuits.43 Since 
then the Cox Maze procedure has been further developed over the years. The original final 
procedure was the Cox Maze III with a cut-and-sew technique with success in 97% after 5 
years.44 However, the Cox Maze III procedure is very invasive and time-consuming due to 
its complexity. The introduction of ablation tools for creating scars instead of cutting and 
sewing made the procedure more efficient and lead to the Cox Maze IV procedure.45 The 
Cox Maze IV remained very successful (90% after 2 years) with fewer complications than 
the Cox Maze III and is currently the standard surgical procedure for AF.46 Less invasive pro-
cedures trying to simulate the Maze procedure were developed in the electrophysiology 
laboratory where catheters were used to create ablation lines on the inside of the atria. 
Unfortunately, the success of the surgical procedure was not achieved.47 In 2004, ablation 
of complex fractionated atrial electrograms was performed in an attempt to target specific 
areas with conduction disorders or drivers sustaining AF, however no benefit was seen in 
later studies.47, 48 Eight years later, ablation of rotors and focal sources was introduced and 
became a popular new procedure for AF.33 The promising initial successful results have 
not been repeated in following studies.49, 50 All AF catheter ablation procedures in addition 
to isolation of the pulmonary veins are therefore not established as beneficial procedures 
in current consensus and surgical ablation has more established success in treatment of 
persistent AF.10 Because catheter ablation is less invasive, one or more additional catheter 
ablation procedures combined with inspection for re-connected pulmonary veins are 
Figure 5. Unipolar and bipolar electrograms. 
A catheter placed on the atrial wall records unipolar electrograms at each electrode, the electrogram at 
the negative pole (-) is subtracted from the electrogram at the positive pole (+) resulting in a bipolar elec-
trogram. Unipolar electrograms have prominent ventricular farfield electrical activity (V) which (nearly) 




often still attempted before surgical ablation. The greatest difference between AF and 
other atrial arrhythmias that usually have very high success rates of ablative treatment, is 
that the electrophysiological pathophysiological mechanism is known for these arrhyth-
mia contrary to AF. Diagnosing the electrophysiological mechanism in action during AF 
requires advancement of current mapping tools and procedures.
THESIS OUTLINE
The first chapters of this thesis will demonstrate new ways to map conduction disorders 
with high detail in patients with AF and to discriminate conduction disorders between 
patients with different heart diseases underlying AF. Chapters 2 and 3 explain the current 
troubles with ablation of AF due to limited knowledge of its electrophysiological patho-
physiology and propose a new study design to find the arrhythmogenic substrate under-
ling AF in different patients. Chapters 4 and 5 introduce a new high-resolution epicardial 
mapping approach for mapping of AF during standard and minimally invasive cardiac 
surgery. Chapters 6 and 7 focus on occurrence of high-resolution conduction disorders 
during sinus rhythm in the entire atria and specifically Bachmann’s bundle in patients with 
valvular heart disease and the differences between those with and without AF. Chapter 
8 presents the differences in occurrence of high-resolution conduction disorders during 
sinus rhythm at the pulmonary vein area, where ectopic discharges from the pulmonary 
veins first enter the atria, between patients with and without AF.
The second part of this thesis focusses on asynchronous activation of the epicardial 
and endocardial layers, its contribution to the pathophysiology of AF and the value of 
fractionation on unipolar electrograms to identify asynchrony between the atrial layers. 
Chapter 9 presents proof for the previously described theory of endo-epicardial dissocia-
tion in conduction during AF by simultaneous mapping of the endo- and epicardium in 
14 patients. Chapter 10 demonstrates the endo-epicardial distribution of breakthrough 
waves during 10 seconds in a case of longstanding AF. Chapter 11 reviews the patho-
physiology and heterogeneity in definitions of electrogram fractionation. The differences 
in morphology between epicardial and endocardial unipolar electrograms and reflection 
of endo-epicardial asynchrony on unipolar electrograms are described in Chapter 12. In 
Chapter 13, the occurrence, consequences and challenges in current clinical practice of 
endo-epicardial asynchrony are briefly explained. Chapter 14 clarifies if unipolar or bipo-
lar electrograms are better suited to detect endo-epicardial asynchrony in clinical practice. 
The presence of endo-epicardial asynchrony during atrial extrasystoles is demonstrated 
in Chapter 15. The implications of the findings in this thesis and future perspectives are 
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Treatment of atrial fibrillation (AF), the most prevalent tachyarrhythmia worldwide, 
remains a great challenge. About 15 years ago, when Haïssaguerre et al.1 first described 
episodes of AF triggered by focal activity originating from the pulmonary veins, the way 
was paved for ablative therapy of AF by pulmonary vein isolation (PVI). Despite a success-
ful PVI, electric pulmonary vein reconnections still occur frequently requiring additional 
procedures. To this end new mapping, navigation, imaging and ablation techniques con-
tinue to be developed thereby facilitating and increasing success rates of PVI.
The results of the endoscopic laser balloon ablation system (EAS) for PVI have been pre-
sented by Gal et al.2 in 50 patients with mostly paroxysmal AF (82%). The EAS provides an 
elegant manner for optimal circumferential contact and ablation lesions with one device ap-
plicable in pulmonary veins of various sizes. Furthermore, an endoscope within the device 
provides real-time visualisation of the ablation area. This resulted in isolation of 99.5% of the 
pulmonary veins during the ablation procedure. However, the long-term results were similar 
to other techniques and were somewhat lower compared with other studies using the EAS. 
The authors believe this may be due to inexperience with this novel technology, although 
other influential factors could be that this study, in contrast to others, also included some 
patients with persistent AF and had a longer follow-up period. Unfortunately, the study did 
not report how many pulmonary veins were in fact electrically reconnected with re-ablation 
procedures. This could provide more information on the long-term success of isolation with 
the EAS. In addition, it would give insight into the incidence of AF recurrence despite success-
ful isolation of the pulmonary veins. For example, one study3 using this technique reported 
AF recurrence in 28% of patients with persistent pulmonary vein isolation after a median 
of 12-month follow-up. Moreover, three months after PVI, 14% of ablated pulmonary veins 
were reconnected in 38% of the patients, which entails that a large proportion of patients 
had at least one pulmonary vein electrically reconnected. We commend the authors for their 
contribution to optimising PVI outcomes and encourage them in their ongoing efforts to im-
prove the PVI procedure with this refined technique. However, AF recurrences may also have 
aetiologies outside of our current understanding and perhaps these unknown pathological 
or physiological processes prevent further improvements in successful long-term outcomes. 
For this, it is of utmost importance to learn more about the pathophysiology of AF.
The revolutionary findings of Haïssaguerre et al. made it possible for a majority of patients 
with AF to be successfully treated with PVI. Unfortunately, another large proportion of pa-
tients continue to have AF, and PVI seems to be insufficient. For this reason different abla-
tion strategies were implemented, such as boxlines, roof, floor and isthmus lines, complex 
fractionated atrial electrogram ablation and ablation of ganglionated plexi. Nonetheless, 




To take new steps toward successful treatments for AF, we must further understand the 
underlying mechanism of AF, just as Haïssaguerre et al. did almost two decades ago. In 
previous mapping studies, we demonstrated that longitudinal dissociation in conduction 
and focal fibrillation waves are the key elements in persistence of AF.4,5 Figure 1 shows an 
example of an epicardial high-resolution wavemap (244 electrode, interelectrode distance 
2.5 mm) of the right atrial free wall obtained from a patient with longstanding persistent 
AF demonstrating a complex pattern of activation. The wavemap shows individual fibrilla-
tion waves represented by colors according to their sequence of appearance. A previously 
described mapping algorithm was used to classify them into peripheral waves (entering 
the mapping area from outside the electrode array), breakthrough waves (appearing at the 
epicardial surface inside the mapping area) or discontinuous conduction waves (fibrilla-
tion waves starting with a delay of 13 to 40 ms from boundaries of other waves). During this 
AF episode of only 140 ms, the mapping area (diameter: 4 cm) is activated by as many as 
15 fibrillation waves including 5 peripheral, 4 epicardial breakthrough and 6 discontinuous 
waves. Hence, when patterns of activation during AF become too complex, the end stage of 
AF might have been reached and it is likely that PVI in these patients will be unsuccessful. 
We believe that by understanding the pathophysiology of AF we can come to new success-
ful treatment strategies, which can be used when PVI just is not enough. Presumably, this 
will entail a tailor-made treatment determined by different mechanisms underlying AF.
Figure 1. Wavemap constructed during longstanding persistent atrial fibrillation.
Sites of epicardial breakthroughs are indicated by white stars; white arrows indicate direction(s) of expan-
sion of epicardial breakthrough or discontinuous fibrillation waves; black arrows indicate waves coming 
from outside the mapping area.
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The heterogeneous presentation and progression of atrial fibrillation (AF) implicate the 
existence of different pathophysiological processes. Individualized diagnosis and therapy 
of the arrhythmogenic substrate underlying AF may be required to improve treatment 
outcomes. Therefore, this single-center study aims to identify the arrhythmogenic areas 
underlying AF by intraoperative, high-resolution, multi-site epicardial mapping in 600 
patients with different heart diseases. Participants are divided into 12 groups according 
to the underlying heart diseases and presence of prior AF episodes. Mapping is performed 
with a 192-electrode array for 5-10 seconds during sinus rhythm and (induced) AF of the 
entire atrial surface. Local activation times are converted into activation and wave maps 
from which various electrophysiological parameters are derived. Postoperative cardiac 
rhythm registrations and a five year follow-up will show the incidence of postoperative 
and persistent AF. This project provides the first step in the development of a tool for 
individual AF diagnosis and treatment.
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INTRODUCTION
Atrial fibrillation (AF) is characterized by beat-to-beat changes in the pattern of activation 
within the atria, unlike organized arrhythmias such as atrial flutter and atrial tachycardia. 
This chaotic nature poses a challenge with regard to understanding the pathophysiology 
and effective treatment of AF as shown by the frequent recurrences after AF therapy.1-4 
Due to the limited knowledge about the mechanisms involved, each AF patient is cur-
rently approached in the same manner. Based on the symptomatology and a clinical 
assessment the arrhythmia is either accepted or attempts are made to retain sinus rhythm 
with non-selective treatment modalities. However, this approach does not take account 
of the diversity among AF patients. AF occurs, for example, in association with mitral 
valve disease, hypertension, congenital heart disease or cardiac surgery, or in young or 
older patients without any comorbidity (“lone AF”).5,6 Furthermore, AF can have different 
clinical manifestations including paroxysmal, persistent or longstanding persistent. On 
the structural level, the degree of fibrotic tissue in AF patients demonstrated heterogene-
ity as well and does not always predict the severity of the AF burden.7 Therefore, it is likely 
that the pathophysiological mechanisms may differ between patients with AF. If these can 
be unraveled the possibility for targeted treatments may arise.
So far, several ablation procedures have been developed aiming to ablate a trigger site for 
initiation of AF or an arrhythmogenic substrate perpetuating AF. The isolation of triggers re-
siding in the pulmonary veins demonstrated to be most successful in patients with paroxys-
mal AF. Nonetheless, recurrences occur frequently especially in patients with persistent AF, 
suggesting an incomplete eradication, reformation or progression of the arrhythmogenic 
substrate. Other strategies include the ablation of rotors, ganglionated plexi and complex 
fractionated electrograms.8-10 However, these therapies have similar, limited success rates 
and there are no guidelines as to which strategy to choose for an individual patient.
The present study has been designed to identify the arrhythmogenic substrate in indi-
vidual AF patients with the use of a high-resolution epicardial mapping approach. In pre-
vious studies, high-resolution epicardial mapping of patients with Wolf-Parkinson-White 
syndrome or longstanding persistent AF demonstrated to be a valuable tool in discrimi-
nating between patients.11,12 However, mapping was performed at only 3 locations and in 
a limited number of patients with a variety of heart disorders. In this study, subjects are 
categorized according to the underlying heart disorder(s) and predisposition for develop-
ing spontaneous episodes of AF before or after cardiac surgery and epicardial mapping 
will be performed of the entire epicardial surface.13,14 The electrophysiological properties 
of the atria will be analyzed aiming to find the arrhythmogenic substrate and to contribute 





All patients of 18 years and older with structural or coronary heart disease scheduled 
for elective cardiac surgery will be asked to participate. Patients who have a high risk of 
complications during surgery or hemodynamic instability by inducing AF such as Wolff-
Parkinson-White syndrome, poor left ventricular function (<40%), presence of assist 
devices, hemodynamic instability, usage of inotropic agents and kidney or liver failure 
are excluded from this study. Furthermore, patients with medical histories predisposing 
them for adhesions making epicardial mapping unfeasible or presence of an iatrogenically 
altered atrial electrophysiology such as prior radiation of the chest for malignancies, redo-
cardiac surgery, paced atrial rhythms and prior ablative therapy in the atria are excluded 
as well. Each patient, prior to enrolling in the study, will be provided with a written expla-
nation of the study procedure together with an assessment of risks in participating in the 
study. Patients will be enrolled after the written informed consent form is signed. After 
enrollment patients are assigned to a group according to the underlying heart disease and 
whether their medical history includes AF. These groups consist of the following surgi-
cal procedures: coronary artery bypass grafting (CABG), mitral valve surgery, aortic valve 
surgery, mitral valve surgery with CABG, aortic valve surgery with CABG, and congenital 
heart surgery. Each of these groups are divided into separate groups for patients with and 
without prior AF episodes. Figure 1 demonstrates the inclusion and following procedures 
for patients participating in the study.
Study procedure
Epicardial mapping is performed during open heart surgery.13 Patients will be under gen-
eral anesthesia and vital signs will be monitored continuously throughout the procedure. 
Mapping will be performed before going on extracorporeal circulation, during sinus rhythm 
and (induced) AF. AF is induced by fixed rate pacing at the right atrial appendage with a 
pulse width of 2 ms delivered by temporary pacemaker wires. Pacing bursts will start at a 
rate of 250 bpm and will be increased with steps of 50 bpm each time AF is not induced 
after 3 attempts. If AF is not induced at a pacing rate of 400 bpm or loss of capture occurs, 
attempts will be terminated. As AF is induced it may terminate spontaneously, otherwise, 
if an induced arrhythmia sustains after the mapping procedure, electrical cardioversion 
will be performed immediately afterwards. If a patient is in AF at the onset of the mapping 
procedure, mapping will be performed during AF and during sinus rhythm after electrical 
cardioversion if there is no atrial thrombus present on transesophageal echocardiogram.
Epicardial mapping of the right and left atria will be performed using a custom-made 
electrode array (192 electrodes, diameter 0.45 mm, 2 mm interelectrode distance; GS 
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Swiss, Küssnacht, Swiss). All electrograms recorded by the electrode are stored on hard 
disk after amplification (gain 1000), filtering (bandwidth 0.5-400 Hz), sampling (1 KHz) 
and analogue to digital conversion (16 bits). An indifferent electrode is attached to a steel 
wire fixed in subcutaneous tissue and a reference signal is attached to the right atrium. 
In addition, a ventricular surface electrocardiogram (ECG) is recorded simultaneously. 
Signals will be recorded at 9 right and left atrial sites during sinus rhythm for 5 seconds 
per site and during (induced) AF for 10 seconds per site. Mapping is initiated at the lower 
right atrium and is proceeded upwards over the right atrial appendage. Thereafter, the left 
atrium will be mapped starting between the pulmonary veins and will continue along the 
atrioventricular groove from the lower pulmonary veins to the left atrial appendage and 
finally at the roof of the left atrium for Bachmann’s bundle. The entire mapping procedure 
will not prolong the surgical procedure by more than 10-15 minutes.13
Figure 1. Flow-chart of patient inclusion and following study procedures.
After enrollment patients are assigned to 1 of 12 groups for data analysis according to the presence of previ-
ous atrial fibrillation (AF) occurrence and the type of surgery that will be performed (i.e. underlying heart 
disease). Subsequently, all patients are mapped during surgery and continuously monitored after surgery 
to detect postoperative AF. During the 5-year of follow-up (FU) the additional tests consist of an electro-
cardiogram (ECG) and Holter monitoring when patients indicate symptoms suspected of AF. ICF, informed 




Follow-up and study endpoint
The postoperative heart rhythm is continuously monitored until hospital discharge and 
rhythm registrations will be stored in order to determine the incidence of early postopera-
tive AF. After discharge, all patients will be scheduled to visit an out-patient clinic, 2 times 
during the first year and thereafter once a year during the following 4 years. Clinical history 
focused on tachyarrhythmias will be taken and a surface ECG will be made. If indicated, 
a 24-hour Holter recording will be performed. If patients, for any reason, are unable to 
visit the out-patient clinic, follow-up is done by telephone. In the event that documented 
rhythm disorders have occurred, records will be requested from the visited hospital. The 
main endpoint of the study is reached when persistent AF develops.
Data and statistical analysis
Local activation times of the recorded atrial signals will be marked, from which color-
coded activation and wave maps will be reconstructed by custom-made software which 
has previously been described in more detail.11 Data exclusion criteria include progressive 
in- or decrease in AF cycle length (AFCL) between sequential recordings (recorded via the 
reference signal) indicated by an approximately two times in- or decrease in AFCL, record-
ings of other rhythms than sinus rhythm or AF, or ≥50% of missing recording data. Data 
analysis and the criteria for data inclusion are demonstrated in Figure 2.
Electrophysiological parameters that will be derived include conduction velocity, inci-
dence of conduction block, number of fibrillation waves, incidence of epicardial break-
throughs, AFCL, dominant frequency, electrogram voltage (the amplitude of the highest 
deflection in case of fractionation) and fractionation.11,12 For analysis, the electrodes of the 
mapping array are assigned to quadrants of 1 cm2. The variables will consist of averaged 
values or the percentage of occurrence/ incidence for each quadrant. Figure 3 illustrates 
the construction of an activation map during sinus rhythm, quadrant partition and its 
conversion into various parameters of all atrial sites. Figure 4 shows a wave map during 
AF and the variables that will be analyzed. Furthermore, rotor occurrence and the relation 
between patterns of activation, fractionation, fibrillation intervals, conduction abnor-
malities and voltage will be studied and compared between the different atrial sites, atrial 
rhythms and patient groups. Rotors will be defined as a wave of excitation rotating around 
a phase singularity for one or more cycles15 and analyzed by determining the dominant 
frequencies at each recording site in order to identify high-to-low frequency gradients 
and determination of the degree of linking of fibrillation waves, indicative of repetitive 
patterns of activation. Linear regression analysis and paired Student’s t-test will be used 
to compare various electrophysiological parameters between different sites and different 
atrial rhythms. Unpaired Student’s t-test will be used to compare various electrophysi-
ological parameters between patient groups.
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The present study is the first that will explore the value of various parameters in discrimi-
nating the arrhythmogenic substrate of different patients with AF. We aim for a sample of 
(at least) 50 subjects in each group for the following reasons. First, our initiative should be 
considered as an exploratory study. We want to obtain early results in a relative limited 
number of patients, which will provide a basis for future (in depth) investigations. There-
fore, we accept that our study will be underpowered to draw definite conclusions with good 
precision. Additionally, it is relevant to obtain estimates with sufficient precision, also in 
early, hypothesis generating studies such as ours. In the binomial distribution, a probabil-
ity of an observation of 50% is achieved with the greatest measurement error. Taking that 
probability as the ‘worst case’, in a dataset of 50 patients, the 95% confidence intervals 
(CIs) around an observation would be ±14%. In the 6*50 = 300 AF patients together, the 
95% CIs would be ±6%. We consider these precisions acceptable for this exploratory study 
that will, hopefully, discover parameters that may be used in future studies to discriminate 
between AF patients with different underlying heart diseases.
Figure 2. Flow-chart of data evaluation.
Atrial fibrillation (AF) data from patients who were reinduced >2 times is excluded. Custom-made software 
detects atrial markings with the presented properties for sinus rhythm (SR) and AF. If ≥50% of a 1 cm2 quad-
rant is not marked, this quadrant will be excluded from further analysis. Rhythm evaluation is performed 
with use of the activation and wave maps and the position in SR is evaluated for overlap with a total SR map 





The study protocol was approved in February 2010 by the Medical Ethics Committee 
(2010-054) in the Erasmus Medical Center, Rotterdam, The Netherlands.
DISCUSSION
Study population and mapping sites
Previous epicardial mapping studies for AF were performed in small numbers of patients 
and at only a few atrial sites or with a low resolution.11,12,16-19 The present study is the first to 
perform intraoperative high-resolution epicardial mapping in a large number of patients 
and enables analyses between patients with different heart diseases. In addition, all 
Figure 3. Activation mapping and quadrant data analysis.
Left: Activation map constructed during sinus rhythm. The atrial complexes (A) of all 192 recordings are 
automatically detected and marked at the steepest deflection. The electrode with the earliest atrial mark-
ing is set at time (T) 0. Activation times of the other electrodes are in reference to T0. Isochrones are set at 5 
ms intervals after T0. The black/white arrow illustrates the direction of conduction. Conduction block (<17 
cm/s) is represented by thick black lines. V, ventricular complex. Right: The mapping surface is divided into 
quadrants and parameters such as block % and mean voltage are determined for each quadrant of each 
mapping location (total: 36 quadrants). LA, left atrium; PV, pulmonary veins; BB, Bachmann’s bundle; RA, 
right atrium.
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sites of both the right and the left atrium accessible from the epicardial side are mapped 
including Bachmann’s bundle. Bachmann’s bundle might have an important role in the 
pathophysiology of AF.20 By mapping the entire surface of both atria there is an increased 
chance of finding the arrhythmogenic substrate, which might be located in different atrial 
regions among AF patients.
The arrhythmogenic substrate in atrial fibrillation
The heterogeneous nature in which AF presents and the frequently failing AF treatments 
so far, demonstrate the importance for an individualized strategy in the treatment of AF. 
The first step is a better understanding of the pathophysiology underlying initiation and 
perpetuation of AF. The focus for initiation of AF often originates in the pulmonary veins 
and Moe et al. described the concept of self-sustaining fibrillatory waves responsible for 
Figure 4. Wave mapping and electrophysiological parameters
Left: Wave map during atrial fibrillation at the right atrial free wall. A total of 5 waves activate the record-
ing area in 41 ms; 3 peripheral waves (black arrows) and 2 initiate at epicardial breakthroughs (white star 
and white arrows). Black lines between electrodes indicate conduction block (<17 cm/s). Isochrones of 
waves are set at steps of 5 ms after T0. Parameters derived from the wavemap include number of epicardial 
breakthroughs, waves and conduction velocity. Right: Examples of corresponding electrograms are shown. 




perpetuation of AF.21,22 However, recurrences of persistent AF after successful isolation 
of the pulmonary veins cannot be explained by these concepts alone. The occurrence of 
longitudinal dissociation during AF was demonstrated later on and showed to be most 
prominent in persistent AF.11 Furthermore, focal fibrillation waves emerging within the re-
cording area, referred to as epicardial breakthroughs, occur much more frequently during 
persistent AF than during acute AF,12 as well as drivers such as rotors and focal sources.23 
These findings suggest that progressive electro-pathological changes within the atria are 
associated with persistent AF. Nonetheless, the exact pathophysiological changes and lo-
cations at which they occur are not yet known. The underlying diseases most likely initiate 
different pathophysiological mechanisms that lead to AF. For example, valvular disorders 
give rise to atrial pressure or volume overload, coronary artery disease can cause atrial 
ischemia and infarction, and congenital heart diseases may also include congenital atrial 
abnormalities. For this reason, the patients in this study are divided in separate groups 
according to the underlying heart disorders and AF occurrence prior to surgery.
Previous studies have investigated the underlying cause responsible for perpetuation of 
AF. Atrial fibrosis has been suggested to be an important element in the pathophysiology 
of AF. There is a significant larger amount of atrial fibrosis seen in patients with AF.7,24 An ex-
cessive extracellular matrix leads to uncoupling of cells and may facilitate inhomogeneous 
conduction, re-entry and multiple wavelets. MRI or electro-anatomical voltage mapping 
can be helpful diagnostic tools for the determination of degree of fibrosis in AF patients 
and identification of areas of fibrosis. However, no association has been found between the 
amount of fibrosis and clinical AF characteristics.7,24 Electrical signal conduction involves 
processes on a structural, cellular and molecular level and these together determine if 
conduction is altered and AF occurs. Therefore, the arrhythmogenic substrate can prob-
ably be more accurately localized by measuring electrical potentials and conduction. In 
the present study, both the recorded extracellular potentials and the spatial domain of the 
electrograms enables conversion into specific electrophysiological parameters that could 
identify areas with conduction abnormalities. If proven successful, this strategy can be de-
veloped into a diagnostic tool for each individual AF patient. In addition, current ablation 
strategies aimed at identifying and targeting arrhythmogenic areas are not effective in a 
large proportion of patients and might even lead to new arrhythmias.25 If patients that can 
benefit could be selected beforehand, effectiveness of these treatments might improve.
Study limitations
Currently, epicardial mapping can only be performed during open-chest cardiac surgery. 
Therefore, it is not possible to perform epicardial mapping in patients with non-diseased 
hearts. However, with constantly advancing techniques it may become possible in the 
future to perform epicardial mappings during video-assisted thoracoscopic surgery in 
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patients without any heart disease. Secondly, although epicardial mapping can reach 
sites endocardial mapping cannot, some sites are not accessible, for example, the atrial 
septum. Therefore, epicardial mapping is not able to analyze conduction in the entire 
area of the atria. In addition, recordings are performed sequentially, as simultaneous 
high-resolution mapping of the entire surface is not possible yet with currently avail-
able technical equipment. As time during surgery is limited, mapping is performed 
immediately after AF induction or electrical conversion. Consequently, if a progressive 
in- or decrease in AFCL occurs during the recordings, this data will have to be excluded.26-28 
General anesthesia may also increase AFCL.29 However, the same anesthetic protocol is 
applied in all patients and previous studies have shown that there remain differences in 
AF between patients despite anesthesia.11,12 Furthermore, recent studies have shown that 
endo-epicardial dissociation can occur during AF and might be associated with persistent 
AF.30 This suggests that it is important to investigate endocardial and epicardial conduc-
tion simultaneously as conduction can be disturbed in all 3 dimensions. Finally, there is a 
small chance asymptomatic persistent AF episodes may be undetected during follow-up. 
The measured incidence of persistent late postoperative AF may therefore underestimate 
the true incidence of persistent late postoperative AF.
Clinical relevance
This project can provide the tools to discriminate the arrhythmogenic substrate of AF in 
patients with different heart diseases and is potentially the first step towards a patient-
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Background: A new technique is demonstrated for extensive high-resolution intra-opera-
tive atrial mapping that will facilitate the localization of atrial fibrillation (AF) sources and 
identification of the substrate perpetuating AF.
Methods: Prior to the start of extra-corporal circulation, a 8x24-electrode array (2 mm 
interelectrode distance) is placed subsequently on all right and left epicardial atrial sites, 
including Bachmann’s Bundle, for recording of unipolar electrograms during sinus rhythm 
and (induced) AF. AF is induced by high frequency pacing at the right atrial free wall. A 
pacemaker wire stitched to the right atrium serves as a reference signal. The indifferent 
pole is connected to a steel wire fixed to subcutaneous tissue. Electrograms are recorded 
by a computerized mapping system and after amplification (gain 1000), filtering (band-
width 0.5-400 Hz), sampling (1 Khz) and analogue to digital conversion (16 bits) automati-
cally stored on hard disk. During the mapping procedure, real-time visualization secures 
electrogram quality. Analysis will be performed offline.
Conclusions: We introduce the first epicardial atrial mapping approach with a high 
resolution of ≥1728 recording sites which can be performed in a procedure time of only ±9 
minutes. This mapping technique can potentially identify areas responsible for initiation 
and persistence of AF and hopefully can individualize both diagnosis and therapy of AF.
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INTRODUCTION
Atrial fibrillation (AF) can be eliminated by ablation of either the trigger or the substrate 
perpetuating AF. A multi-site, high-resolution mapping approach of the entire atria which 
can, beside localizing sources generating AF in patients with trigger-driven AF, identify the 
substrate responsible for perpetuation of AF would be desirable. Such a mapping approach 
would allow individualization of the diagnosis of AF and subsequently also of AF therapy 
which is at present not available. In this report, we introduce a novel high-resolution, multi-
site epicardial mapping technique of the entire atria as a routine procedure during open 
chest surgery aiming for identification of the arrhythmogenic substrate underlying AF.
MATERIAL AND METHODS
Surgical technique
Prior to commencement to extra-corporal circulation, after heparinization and arterial 
cannulation, a temporary bipolar epicardial pacemaker wire is stitched to the right atrial 
free wall serving as a temporal reference electrode. The indifferent electrode consists of 
a steel wire fixed to subcutaneous tissue of the thoracic cavity (Figure 1). Epicardial map-
ping during sinus rhythm and (induced) AF is performed with a custom-made flexible 192 
unipolar electrode mapping array, mounted on a custom-made spatula if preferred by the 
surgeon. The spatula can be bended to match the atrial curvature (Figure 2). If AF is not 
the presenting rhythm, AF is induced by fixed rate pacing at the right atrial free wall using 
a different temporary bipolar pacing wire. Recordings of real-time epicardial electrograms 
from Bachmann’s bundle are used to confirm atrial capture. Fixed rate pacing is started 
at a rate of 200 beats per minute (bpm). If an AF induction attempt is not successful after 
3 burst attempts, the rate is increased by 50 bpm, up to maximal 400 bpm until AF occurs 
or atrial refractoriness is reached. After completion of the mapping procedure, AF is termi-
nated by electrical cardioversion or sustained until cardioplegia is conducted, depending 
on the operator’s preference. In case of AF as the initial heart rhythm, electrical cardiover-
sion is performed in order to map sinus rhythm after completing mapping of AF.
Mapping is sequentially conducted along several imaginary lines between anatomical 
borders in order to cover the entire right and left atrium (Figure 3). The mapping array is 
shifted along these imaginary lines with a fixed orientation at each position visually trying 
to avoid omission of areas at the expense of possible overlap between successive mapping 
sites. Mapping of the right atrium starts at the cavotricuspid isthmus continuing up to the 
right atrial appendage, perpendicular to the caval veins. Bachmann’s bundle is mapped 
from the roof of the left atrium towards the superior cavo-atrial junction. For the left 
Chapter 4
48
Figure 1. Epicardial mapping preparations.
Top: A pacemaker wire stitched to the right atrial free wall serving as a temporal reference electrode. Bot-
tom: A steel wire fixed to (sub)cutaneous tissue serving as the indifferent electrode. RA, right atrium; RV, 
right ventricle.
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atrium, mapping is performed along the left atrioventricular groove from the lower border 
of the left inferior pulmonary vein towards the left atrial appendage and from the sinus 
oblique fold along the border of respectively the right and left pulmonary veins down to 
the atrioventricular groove. Figure 4 shows the positions of the 192-electrode array along 
these mapping lines. The mapping array is held in place through either light manual 
pressure or by means of the spatula. In case of the posterior area between the pulmonary 
veins, pressure from the weight of the heart and underlying structures provides stability 
for the mapping array. This technique was performed in 168 patients of 18 years and older, 
with coronary and/or structural heart disease, with or without AF, electively scheduled for 
cardiac surgery and a ventricular ejection fraction above 40%. The mean duration of the 
entire mapping procedure including preparation time was 9±2 minutes. Complications 
related to the mapping procedure during or after cardiac surgery were not observed.
Figure 2. Electrode array for epicardial mapping.
Top left: Mapping array containing 192 unipolar electrodes. Top right: Examples of recorded electrograms 




Figure 3. Demonstration of intraoperative epicardial mapping.
The electrode array placed between the pulmonary veins in the oblique sinus (top) and on the right atrial 
wall (bottom) during recording of epicardial electrograms.
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Mapping technique
The mapping array consists of an electroless nickel immersion gold (ENIG) plated elec-
trode array, mounted on a thin, flexible DuPont™ Pyralux® copper-clad (25 μm thickness) 
polyimide laminate, and coverlay composite (25 μm) film (0.18 mm), manufactured by GS 
Swiss PCB AG, Küssnacht, Switzerland. Sterilization is performed by the local sterilization 
unit before use in the operation room. The sterilized array is connected to 3 meters long, 
shielded flat cables delivered to the surgeon in a sterile sack. The flat cables are connected 
to a battery-driven, custom computerized mapping system which is connected to a laptop 
computer. Custom-made software visualizes real-time atrial electrograms recorded at all 
192 electrodes to secure atrial recordings with good electrogram quality. Three channels 
are designated to display the surface ECG, reference signal and a calibration signal of 1 
mV amplitude and 1000 ms pulse width. Five seconds of sinus rhythm and 10 seconds of 
AF are recorded at every mapping site. All recordings are amplified (gain 1000), filtered 
(bandwidth 0.5-400 Hz), sampled (1 KHz) and analogue to digital converted (16 bits) and 
automatically stored on hard disk as E01-files labelled with the atrial rhythm, mapping site 
and patient identification code. Analysis will be performed offline as previously described.1
Figure 4. Mapping scheme demonstrating positions of the 192-electrode array on a 3D model.
The left and right atrium are covered by 4 positions each, to reach Bachmann’s bundle the array is placed 
within the transverse sinus between the aorta and pulmonary artery.
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Figure 5. Mapping of induced (A) vs longstanding persistent atrial fibrillation (B).
Intra-atrial variation in various electrophysiological parameters measured during 10 s of AF, including dom-
inant frequency (blue: <6 Hz, white: 6-7 Hz, red: >7 Hz), number of fibrillation waves (blue: <2 cm2/s, white: 
3-4 cm2/s, red: >3 cm2/s), number of focal waves (blue: <1 cm2/s, white: 1-4 cm2/s, red: >4 cm2/s), irregularity 
(blue: <20 ms, white: 20-50 ms, red: >50 ms), conduction velocity (blue: ≥70 cm/s, white: 51-69 cm/s, red: 
≤50 cm/s), incidence of slow conduction and block (red: >25%, white: 6-25%, blue: ≤6%). See text for further 
description.
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DISCUSSION
Previous AF mapping studies during surgery did not cover the entire surface of both atria, 
used low-resolution arrays or recordings of short durations.2,3 Our mapping approach is the 
first high-resolution, multi-site mapping approach. It consists of a fixed mapping scheme 
with a 192-electrode mapping array, which results in a minimum of 1728 recording sites. 
The mapping array covers large areas of atrial tissue at each position resulting in a short 
all-over procedure time of 9 minutes without increasing cardiopulmonary bypass time. 
Unfortunately, high-resolution multi-site mapping is not performed simultaneously as 
this is technically not yet possible. However, with the reference signal from the right atrial 
free wall we are able to construct a timeline between the different recordings and create 
an overall conduction map during sinus rhythm. This map can also demonstrate the pos-
sible overlap between recording sites. During AF, the reference signal obtains information 
about the changes in AF cycle length in order to assess the consistency of the arrhythmia. 
Previously, the indifferent electrode was fixed to the sternum, however, electrogram qual-
ity improved when the indifferent electrode was fixed to subcutaneous tissue. Mapping 
studies were only performed in patients undergoing elective cardiac surgery for the first 
time as mapping is technically unfeasible with prior cardiac surgery or pericardiocentesis 
due to pericardial scarring limiting access to atrial sites.
An advantage of epicardial mapping is that some potential arrhythmogenic structures 
such as Bachmann’s bundle can only be reached from the epicardial site and not from the 
endocardium. However, the interatrial septum cannot be mapped using a closed beating 
heart approach and the electrode array does not cover the myocardial sleeves within the 
pulmonary veins. In recent mapping studies of AF we introduced a so-called ‘wavemap-
ping’ technique to classify and quantify electrophysiological properties of fibrillation 
waves.1,4 This unique mapping approach makes it possible to study features of AF both 
in the spatial domain, like focal fibrillation waves or areas of conduction block, and the 
temporal domain, like irregularity of fibrillation intervals.
As an example, intra-atrial variation of various electrophysiological parameters, assessed 
during 10 s of induced AF in a patient with coronary artery disease is summarized in Figure 
5A. Using specific cut-off values, every quadrant was depicted as blue (low), white (inter-
mediate) or red (high). The dominant frequency was 6.1 Hz and ranged from 4.5 to 9.2 
Hz. The number of fibrillation and epicardial focal waves was on average respectively 2.3/
cm2/s and 2.1/cm2/s, varying between 1.5 to 4.4/cm2/s and 0.1 to 5.9/cm2/s. The averaged 
beat-to-beat irregularity was 35.0 ms and the averaged conduction velocity 72.2 cm/s; 




In comparison, electrophysiological parameters quantified during long-standing persis-
tent AF in a patient with mitral valve disease are demonstrated in Figure 5B. The dominant 
frequency was 6.7 (range: 4.7 to 7.8) Hz. Compared to all quadrants in the patient with 
coronary artery disease, the number of fibrillation and epicardial focal waves was consid-
erably higher (number of fibrillation waves: 3.5±1.3 (1.1-5.7)/cm2/s, P<0.001, number of 
focal waves: 4.3±3.2 (0.1-13.0)/cm2/s, P<0.001). The averaged beat-to-beat irregularity was 
comparable (32.9 ms). Conduction velocity was on average 63 cm/s (P<0.01) and the de-
gree of conduction delay and block varied from 0.4 to 45.4% (on average 24.8%, P<0.001). 
Hence, during longstanding persistent AF, the number of fibrillation waves and incidence 
of focal waves was higher and conduction abnormalities occurred more frequently; the 
areas involved are shown in the quadrant maps.
Therefore, this mapping technique can potentially identify vulnerable areas responsible 
for initiation and persistence of AF by localizing and quantifying the degree of electropa-
thology in the individual patient. Furthermore, by understanding the electropathological 
substrate in AF patients and providing individualized diagnoses, high-resolution mapping 
might be able to direct current AF therapies more efficiently or may lead to new insights 
for treatment strategies which could in turn improve current treatment outcomes.
55
A novel high-resolution atrial mapping approach
4
REFERENCES
 1. Allessie MA, de Groot NM, Houben RP, Schotten U, Boersma E, Smeets JL, Crijns HJ. Electropatho-
logical substrate of long-standing persistent atrial fibrillation in patients with structural heart 
disease: longitudinal dissociation. Circ Arrhythm Electrophysiol. 2010;3:606-15.
 2. Sueda T, Nagata H, Shikata H, Orihashi K, Morita S, Sueshiro M, Okada K, Matsuura Y. Simple left 
atrial procedure for chronic atrial fibrillation associated with mitral valve disease. Ann Thorac Surg. 
1996;62:1796-800.
 3. Nitta T, Ishii Y, Miyagi Y, Ohmori H, Sakamoto S, Tanaka S. Concurrent multiple left atrial focal activa-
tions with fibrillatory conduction and right atrial focal or reentrant activation as the mechanism in 
atrial fibrillation. J Thorac Cardiovasc Surg. 2004;127:770-8.
 4. de Groot NMS, Houben RPM, Smeets JL, Boersma E, Schotten U, Schalij MJ, Crijns H, Allessie MA. 
Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural 
heart disease: epicardial breakthrough. Circulation. 2010;122:1674-82.

5
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Mapping of the unorganized activation patterns of atrial fibrillation requires a high-
resolution mapping approach in order to diagnose substrate-mediated pathophysi-
ological mechanisms. Epicardial mapping is for now the only approach able to acquire 
electrograms of >200 high-density sites simultaneously. This study introduces a technique 
to perform high-resolution mapping in minimally invasive surgery. In three patients with 
mitral valve disease epicardial mapping of the right atrium, Bachmann’s bundle and parts 
of the left atrium was safely performed via minimal right thoracotomy.
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INTRODUCTION
Atrial fibrillation is often triggered by impulses from the pulmonary veins, and isolation of 
the pulmonary veins is the standard ablative approach. However, recurrences occur fre-
quently and can be due to recovery of pulmonary-atrial conduction or due to remodeling 
of atrial tissue serving as a substrate for persistence of atrial fibrillation.1 To improve the 
success of ablative therapy, patients would benefit from an individualized approach. Ana-
lyzing the electrical activation patterns of atrial fibrillation, or so-called mapping, could 
not only guide treatment strategies but also determine the effect of the applied scars and 
evaluate the need for additional treatment. Minimally invasive surgical approaches are 
gaining ground and are currently widely employed in patients with mitral valve disease, 
in whom a high incidence of atrial fibrillation is observed.2 Therefore, we developed a 
technique to map atrial activation patterns at high resolution during minimally invasive 
surgical procedures. Here, we present our first evaluation in three patients without a his-
tory of arrhythmia to assess the usability of the mapping approach.
Three patients, aged 67, 59 and 62 years, scheduled for mitral valve repair using a mini-
mally invasive approach were informed and gave consent to participate in the study pro-
tocol approved by the local ethics committee (Halt & Reverse, MEC2014-393). All patients 
had severe mitral valve insufficiency and normal left ventricular function and underwent 
mitral valve surgery alone.
SURGICAL TECHNIQUE
Preparation
General anesthesia was applied, and patients were intubated with a double-lumen respira-
tion tube and received a transoesophageal echo probe and a central and arterial line, with 
electrocardiogram (ECG) monitoring. The patients were positioned supine and turned 30˚ 
to their left side on the operation table with an inflatable cushion supporting the right 
scapula. Minimal right thoracotomy of 4-5 cm was performed at the 4th intercostal space, 
and the videoscope was introduced via a port in the 3rd intercostal space. The pericardium 
was opened with a reversed L-incision exposing the heart. Cannulas for cardiopulmonary 
bypass were placed in the femoral vein and femoral artery and advanced towards the su-
perior vena cava and aortic arch, respectively. The critical position of the tip of the venous 




A reference signal during mapping was obtained by a bipolar pacemaker wire stitched on 
the terminal crest of the right atrium. A steel wire was fixed to subcutaneous tissue at the 
femoral access site of the cannulas and served as an indifferent electrode. A rectangular 
flexible 192-electrode array (1.4x4.6 cm), fixed on a similar shaped spatula made from 
bendable steel for stability (Figure 1), was connected via 3 meter shielded cables wrapped 
in a sterile sack to a custom computerized mapping system.
For mapping, the electrode array is moved along imaginary lines to directly record electric 
potentials on the atrial surface. At the right atrium, the array is positioned perpendicular 
to the caval veins and recording starts at the top of the right atrial appendage, near the su-
perior caval vein (Figure 2). After each 5 to 10-second recording, the array is moved further 
downwards over the right atrial appendage until the cavotricuspid isthmus is reached. 
The intercaval area including the terminal crest is mapped from Waterston’s groove, with 
the array positioned in the longitudinal direction of the caval veins. The posterior left 
atrium is mapped below the inferior pulmonary veins along the atrioventricular groove 
from the left inferior pulmonary vein towards the right inferior pulmonary vein. Mapping 
of Bachmann’s bundle was performed from the roof of the left atrium towards the superior 
cava-atrial junction. Then, by advancing the array past Bachmann’s bundle, the left atrial 
appendage was reached and mapped from the tip to its base.
Figure 1. Epicardial mapping during minimally invasive surgery.
Left: The flexible 192-electrode mapping array fixed on a bendable steel spatula. Right: Epicardial mapping 
during a minimally invasive surgical procedure.
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Fixed high-rate pacing was performed at the right atrial appendage with the aim to induce 
atrial fibrillation and map atrial fibrillation patterns using the same protocol. If there was 
no spontaneous return of sinus rhythm after mapping of induced atrial fibrillation, sinus 
rhythm was restored with electrical cardioversion or atrial fibrillation stopped when car-
dioplegia was applied. The pacemaker wire and steel wire were removed and the opera-
tion proceeded as scheduled.
Postoperative course
Two patients did not have any arrhythmias or complications in the postoperative period, 
and the other patient had multiple episodes of postoperative atrial fibrillation, which 
converted spontaneously with amiodarone. Two weeks after surgery, this patient also 
developed Dressler syndrome which was successfully treated with medications. His atrial 
fibrillation episodes progressed to persistent atrial fibrillation 4 months after surgery and 
sinus rhythm was restored with electrical cardioversion .
DISCUSSION
Clinical results
The reported cases are the first experience with this technique performed using a mini-
mally invasive surgical approach. However, our experience in a large study cohort of, now, 
Figure 2. An overview of the high-resolution atrial activation pattern.




>500 patients with an open-heart surgical approach has demonstrated this mapping pro-
cedure to be safe, and it can be performed within 10 minutes with experienced personnel.3
Epicardial mapping
Epicardial mapping and ablation are being utilized nowadays for ventricular tachyarrhyth-
mias to treat origin sites that cannot be reached endocardially. Recently, we demonstrated 
that asynchrony of the epicardial and endocardial atrial wall occurs during atrial fibril-
lation, and epicardial activation can remain undetected recording from the endocardial 
side alone.4,5 Therefore, epicardial atrial mapping may be getting a more important role 
in the treatment of atrial fibrillation as well. Previous studies mapping atrial fibrillation 
epicardially were all performed during open-heart surgery and those arrays seem unsuit-
able for minimal invasive procedures.6,7 The large and specifically shaped arrays of Lee et 
al. for simultaneous biatrial mapping seem difficult and time consuming to position with 
retractors.6 The triangular shaped electrode with sides of approximately 4 cm in the study 
of Walters et al. will not be able to reach areas behind tight spaces such as the pulmonary 
vein area and Bachmann’s bundle.7 However, for clinical purposes, a minimally invasive 
approach would be preferred.
Advantages
One of the most important advantages of epicardial atrial mapping is that it has a higher 
resolution than endocardial atrial mapping. This feature is of great significance in the 
mapping of the complex patterns of electric activity during atrial fibrillation. The unor-
ganized activation patterns of atrial fibrillation differ beat-to-beat, and waves decrease 
in size with persistence of atrial fibrillation.8 Therefore, a high number of simultaneously 
acquired electrograms with small interelectrode spacing are required to map atrial fibril-
lation waves. Another advantage is that mapping can precisely evaluate the continuity of 
ablative lesions to pinpoint the exact location in case of a gap. If this technique is com-
bined with an electroanatomical mapping system that can store the location of the site 
and guide the ablation tool9, a gap can be located and treated accordingly. The minimally 
invasive approach makes high-resolution mapping potentially suitable for a much wider 
public of patients experiencing atrial fibrillation and not only patients needing cardiac 
surgery. A individually tailored approach could improve the success of atrial fibrillation 
therapy, which mapping of atrial fibrillation could provide by identifying for each patient, 
the remodeled atrial sites critical in supporting the persistence of atrial fibrillation and 
deliver targeted ablation therapy to those sites.10 In this study, we demonstrated that 
qualitative high-resolution epicardial mapping during sinus rhythm and (induced) atrial 
fibrillation is feasible during minimally invasive cardiothoracic surgery.
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Limitations
The standard incisions for minimally invasive mitral valve surgery do not provide access 
for epicardial mapping of the entire left atrium. The posterior left atrium below the pulmo-
nary veins could only be reached in one of the three patients. The left atrium could pos-
sibly be reached (better) with an additional incision site at the left side. The atrial septum 
cannot be mapped with an epicardial approach.
Future directions
To implement high-resolution mapping guided ablation during surgery, electroanatomical 
mapping systems that can guide ablation tools as set-up in electrophysiology laboratories 
should be made available for high-resolution mapping arrays.9 In addition, more research 
on atrial fibrillation mapping is required to find mechanisms sustaining atrial fibrillation 
and possible target sites to stop it. This may also result in the decision to not ablate a 
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Background: Chronic atrial stretch due to valvular heart disease initiates structural 
remodeling which in turn can disturb electrical conduction and lead to atrial fibrillation 
(AF). Different mechanisms of remodeling may underlie aortic valve (AV) and mitral valve 
(MV) disease. This study aimed to identify the differences in conduction disorders during 
sinus rhythm between patients with AV and MV disease and to find predilection sites of 
conduction disorders in AF patients.
Methods: High-density epicardial mapping was performed after sternotomy in patients 
undergoing AV or MV surgery. Unipolar electrograms were recorded from the entire left 
and right atrial surface during sinus rhythm with a 128 or 192-electrode-array (circa 1880 
electrograms per patient) and activation maps were analyzed for presence of conduction 
delay/block between electrodes (CD ∆7-11 ms; CB ∆≥12 ms).
Results: A history of AF was present in 17 of 85 AV patients and 21 of 54 MV patients. CD 
and CB was most pronounced at the superior intercaval area (2.5% of surface, maximal 
degree 6.6%/cm2). MV patients had a higher maximal degree of CD at the lateral left atrium 
than AV patients (4.2 vs 2.3%/cm2, P=0.001). A history of AF was most strongly correlated to 
CD/CB at Bachmann’s bundle (P<0.001, r=0.40) and age (P=0.006, r=0.31).
Conclusions: Although MV patients have more conduction disorders at the lateral left 
atrium, disturbed conduction at Bachmann’s bundle during sinus rhythm indicates the 
presence of atrial remodeling which is related to AF episodes.
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INTRODUCTION
Valvular heart disease predisposes to the occurrence of atrial tachyarrhythmias. Signifi-
cant stenosis or regurgitation of heart valves has important hemodynamic effects on the 
atria that lead to structural atrial remodeling. In situations of pressure or volume overload 
the increased pressure on the atrial wall causes atrial dilation.1 Chronic mechanical stretch 
initiates pathways that produce fibrosis and alter myocyte coupling and function.2,3 Conse-
quently, electrical conduction in the atria becomes disrupted and can result in areas with 
slow and discontinuous conduction which may act as a substrate for tachyarrhythmias. 
The incidence of atrial fibrillation (AF) is higher in patients with mitral valve (MV) disease 
(26-54%) then in patients with aortic valve (AV) disease (10-13%), most likely due to higher 
left atrial loads in MV disease.4,5 Therefore, different types of atrial remodeling may take 
place in AV and MV disease.
It has been previously demonstrated that structural remodeling and not electrical remod-
eling is the major contributor to development of AF in models of chronic atrial stretch.3 
The electrophysiological disturbances due to structural alterations in patients with valvu-
lar heart disease may also be identifiable during sinus rhythm. The purpose of this study 
is first to identify differences in the amount and distribution of high-resolution conduction 
disorders during sinus rhythm between patients with AV and MV disease. Secondly, we 
aim to determine if predilection sites of conduction disorders during sinus rhythm exist 
in patients with valvular heart disease who have developed clinical AF. A high-resolution 
epicardial mapping approach was performed to locate atrial areas with conduction abnor-
malities and identify the differences in conduction disorders between patients with AV and 
MV disease requiring surgical treatment.
METHODS
Study population
Patients of 18 years and older undergoing AV (mainly for aortic stenosis) or MV (for mitral 
regurgitation) surgery with or without coronary artery bypass grafting participated in this 
study. The study is part of the QUASAR study that was approved by the local ethics com-
mittee and all patients gave informed consent prior to surgery.6
Study procedure
During surgery and prior to cardiopulmonary bypass, epicardial mapping was performed 
of the entire atrial surface with an electrode array containing 128 or 192 unipolar elec-
trodes with an electrode diameter of 0.65 or 0.45 mm and interelectrode spacing of 2 mm 
Chapter 6
70
(GS Swiss PCB AG, Küssnacht, Switzerland). Five-second recordings of sinus rhythm were 
sequentially acquired from all epicardial accessible sites at the right atrium, left atrium 
and Bachmann’s bundle. Patients that were in AF at the start of the procedure were elec-
trically converted to sinus rhythm. A temporary pacemaker wire stitched to the terminal 
crest served as a reference signal during the recordings. The mapping procedure and map-
ping sites were previously described in detail.7 Mapping locations are also illustrated in the 
upper right panel of Figure 1. In case of the 128-electrode mapping array, each 192-array 
location consisted of two 128-array recordings. Unipolar electrograms were stored on hard 
disk after amplification, filtering (bandwidth 0.5-400 Hz), sampling (1 KHz) and analogue 
to digital conversion (16 bits).
Figure 1. Intraoperative epicardial mapping scheme and data analysis.
Left: Example of an isochronal and activation map demonstrating the analysis of conduction delay (CD) and 
conduction block (CB) on a high-resolution scale. An isochronal map with electrograms at the site of CB and 
the activation map demonstrate differences ≥12 ms in activation times between adjacent electrodes (interelec-
trode distance 2 mm). Thick (dashed) black lines indicate sites with CD (dashed line, ∆7-11 ms) and CB (solid 
line, ∆≥12 ms). In an area of 1 cm2 the number of lines with CD and CB are 2.8% and 9.9% of the total number of 
lines within the 1 cm2 quadrant. Right: High-resolution activation maps are recorded at all epicardial accessible 
sites: the right atrium, Bachmann’s bundle, posterior left atrial wall between the pulmonary veins and lateral 
left atrium including the appendage. The entire atrial surface in this patient is activated in 115 ms. The total 
recording area divided into 1 cm2 quadrants represents the amount of CD and CB at specific sites; the amount 
of CB is depicted in this example. The quadrants are assigned to 7 atrial areas: superior and inferior intercaval 
right atrium, the superior and inferior lateral right atrium (shades of green), Bachmann’s bundle (blue), pos-
terior left atrium (orange) and lateral left atrium (yellow). For Bachmann’s bundle, the average degree of CB in 
this example is 1.0%, and the maximal degree of CB is 2.8%. VCS, vena cava superior; VCI, vena cava inferior.
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Mapping data analysis
Atrial deflections were detected automatically by marking of the steepest negative de-
flection with a minimal slope of 80 mV/s and signal to noise ratio >4 for each recorded 
electrogram in order to construct activation maps.6 The marked electrograms and activa-
tion maps were thereafter checked and manually corrected if necessary. Aberrant and 
premature atrial beats were excluded from analysis. Sinus rhythm activation maps were 
used to determine the incidence of conduction delay (CD) and conduction block (CB) on 
a high-resolution scale (left panel, Figure 1). CD and CB were defined as a difference in 
activation time between adjacent electrodes of, respectively, 7-11 ms and ≥12 ms (trans-
lating to an effective conduction velocity of 17–28 cm/sec and <17 cm/sec).8 The amount 
of CD and CB was calculated as a percentage per 1 cm2 quadrants. Figure 1 illustrates the 
subdivision of the entire mapping surface of each patient in 1 cm2 quadrants in which the 
percentages of CD and CB were determined.
Atrial distribution
The prevalence and degree of CD and CB in the patient groups were assessed separately 
for 7 atrial areas: 4 areas at the right atrium (the superior (1) and inferior (2) intercaval/ 
terminal crest area and the superior (3) and inferior (4) lateral right atrium), Bachmann’s 
bundle (5), posterior left atrium between the pulmonary veins (6) and the lateral left 
atrium/ left atrial appendage (LAA) (7) (Figure 1, right lower panel). The prevalence of CD/
CB per area is defined as the percentage of patients with presence of CD or CB in that area. 
For each area in every patient, the average degree of CD and CB was determined (average 
percentage CD/CB of the 1 cm2 quadrants in that area) and also the maximal degree of CD 
and CB in 1 cm2 (CD/CB of the 1 cm2 quadrant with the highest amount of CD/CB).
Statistical analysis
Categorical clinical characteristics between the AV and MV group were compared with Chi-
square or Fisher’s exact tests. Continuous clinical data and electrophysiological data were 
not normally distributed and differences between the AV and MV group were evaluated 
with Mann-Whitney U tests. Electrophysiological mapping data are presented as median 
(minimum-maximum) values. To evaluate differences between areas, the area with the 
highest average and maximal degree of CD/CB was identified for each patient and the total 
incidences of highest amount of CD/CB were determined for each area. Differences in the 
incidence distributions between areas were first evaluated with the overall Cochran’s Q 
test. Subsequently, McNemar tests were applied for a pair-wise comparison of each of the 
areas. We applied Bonferroni correction to adjust for inflation of type I error with repeated 
tests. A P-value ≤0.05/7 was considered statistically significant for the comparison of 
patient groups (AV vs MV) within the 7 areas, whereas for the inter-areal comparisons a 
P-value threshold of ≤0.05/21 was used. The rank-biserial correlation coefficient (skewed 
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continuous/ordinal data) and Phi coefficient (binary data) were determined to quantify 
the correlation between electrophysiological/clinical variables and a history of AF. Binary 
logistic regression analysis was performed to relate electrophysiological and clinical 
variables with incidence of postoperative AF. All analyses were performed with IBM SPSS 
Statistics version 21 (IBM corp.,Armonk, NY).
RESULTS
Clinical characteristics
Epicardial high-resolution mapping during sinus rhythm was performed in 139 patients 
who underwent cardiac surgery for valvular heart disease. There were 89 (64%) male and 
50 (36%) female patients with a median age of 70 (IQR=62-75) years. MV surgery was per-
formed in 54 (39%) patients and 85 (61%) patients had valvular cardiac surgery for only AV 
disease. A total of 66 (47%) patients had significant coronary artery disease and 38 (27%) 
had a history of AF. All clinical characteristics are demonstrated in Table 1. Patients with 
MV disease presented more often with left atrial enlargement, left ventricular dysfunction 
and AF prior to surgery, hypertension was more often observed in AV disease.
Mapping data
The median number of electrogram recordings of the entire atrial surface acquired by 
high-resolution mapping was 1880 (945-2356) per patient. Quadrants containing <50% 
electrogram recordings were excluded from analysis, which resulted in exclusion of 2.6% 
of the 4644 quadrants in total, and 32 (18-42) quadrants per patient were analyzed for 
presence of CD and CB. Median cycle length during mapping of sinus rhythm was not dif-
ferent between AV and MV patients (786 ms (473-1735) and 784 ms (533-1178), P=0.28). 
Cardioversion was performed before mapping of sinus rhythm in 16 patients (42%) with a 
history of AF. However, there were no differences in the amount of conduction disorders 
between patients with AF who received a cardioversion and those who were spontane-
ously in sinus rhythm.
Overall conduction delay and block in valvular heart disease
A certain amount of both CD and CB was present in (nearly) all of the patients during sinus 
rhythm and the prevalence ranged respectively between 0.17-3.4% (median 1.26%) and 
0-3.58% (median 1.15%) of the atrial surface. Figure 2 demonstrates the degree of CD and 
CB of the entire atria in patients with AV and MV disease. There was no difference in the 
atrial amount of CD/CB between patients with AV or MV disease. Both maximal peak gradi-
ent of patients with only aortic valve stenosis (n=64, 78±23 mmHg) and cycle length were 
not correlated to the total amount of CD and CB (P=0.30 and P=0.93).
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No. of patients 139 85 54
Age, years [IQR] 70 [12] 69 [13] 70 [14] 0.641
Male gender 89 (64) 59 (69) 30 (56) 0.097
Hypertension 67 (48) 48 (57) 19 (35) 0.014
Hypercholesterolemia 29 (21) 18 (21) 11 (20) 0.909
Diabetes mellitus 22 (16) 15 (18) 7 (13) 0.461
Coronary artery disease 66 (48) 43 (51) 23 (43) 0.358
Peripheral vascular disease 7 (5) 4 (5) 3 (6) 1.000
Atrial fibrillation 38 (27) 17 (20) 21 (39) 0.015
Valvular disease*
Aortic stenosis 81 (58) 74 (87) 7 (13)
Aortic regurgitation 26 (19) 18 (21) 8 (15)
Mitral stenosis 5 (4) 0 5 (9)
Mitral regurgitation 54 (39) 0 54 (100)
Tricuspid regurgitation 13 (9) 0 13 (24)
Left ventricular function 0.019
normal 103 (74) 70 (82) 33 (61)
mild dysfunction 25 (18) 11 (13) 14 (26)
moderate dysfunction 11 (8) 4 (5) 7 (13)
severe dysfunction 0 0 0
Left atrial enlargement (>45 mm) 40 (29) 11 (13) 29 (54) <0.001
* Valvular heart disease for which corrective surgery was performed. AV = aortic valve; MV = mitral valve; 
IQR = interquartile range.
Atrial distribution of conduction delay and block
Figure 3 demonstrates the average degree of CD and CB in each area for both groups. In 
Table 2 the maximal degrees of CD and CB for each area are shown. The largest difference 
in CD/CB between patients with AV and MV disease was seen at the lateral left atrial/LAA 
area. The maximal degree of CD at the lateral left atrium was higher in patients with MV 
disease and there was an overall trend towards more CD/CB at this site in the MV disease 
group. The average and maximal degree of CB was highest at the superior intercaval/
terminal crest area of the right atrium (respectively 2.5% and 6.6%/cm2, all P≤0.001). Long 
lines of CB are often seen towards the posterior area of the right atrium, also in two out of 
three of the youngest patients in our study group (21-24 years).
Chapter 6
74
Figure 2. Overall conduction delay and block in valvular heart disease.
Histograms of the amount of conduction delay and block (CD/CB) of the entire atrial surface in patients with 
aortic valve (AV) and mitral valve (MV) disease.















CD 78 4.1 (0-20.8) 79 4.2 (0-17.4) 77 4.0 (0-20.8) 0.391
CB 73 6.6 (0-34.7) 74 6.3 (0-30.6) 72 6.9 (0-34.7) 0.635
RA-ICI
CD 70 2.8 (0-13.9) 72 2.8 (0-13.9) 66 2.9 (0-11.1) 0.578
CB 55 2.1 (0-22.5) 53 2.1 (0-22.5) 59 2.8 (0-22.5) 0.696
RA-RAS
CD 63 1.4 (0-13.0) 65 1.4 (0-13.0) 59 1.4 (0-9.7) 0.489
CB 32 0 (0-22.2) 38 0 (0-22.2) 24 0 (0-14.7) 0.138
RA-RAI
CD 53 1.4 (0-15.3) 47 0 (0-13.9) 62 1.5 (0-15.3) 0.118
CB 20 0 (0-12.5) 15 0 (0-10.3) 26 0 (0-12.5) 0.086
BB
CD 84 4.2 (0-18.1) 82 4.2 (0-18.1) 87 4.2 (0-13.9) 0.847
CB 70 3.5 (0-22.2) 71 2.8 (0-20.8) 67 4.2 (0-22.2) 0.630
PLA
CD 81 4.2 (0-18.8) 79 4.2 (0-18.8) 85 4.7 (0-18.1) 0.380
CB 58 2.0 (0-23.6) 58 2.1 (0-23.6) 59 1.8 (0-19.6) 0.975
LLA
CD 75 2.8 (0-23.6) 69 2.8 (0-12.5) 85 4.2 (0-23.6) 0.001†
CB 50 0 (0-20.8) 45 0 (0-20.8) 58 1.8 (0-17.4) 0.037
*P-value of maximal degree of CB/CD between AV and MV patients. †Significant after Bonferroni correction; 
CD = conduction delay; CB = conduction block; RA = right atrium; ICS/I = intercaval superior/ inferior; RAS/I 
= right appendage superior/ inferior; BB = Bachmann’s bundle; PLA = posterior left atrium; LLA = lateral left 
atrium.
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Relation of conduction disorders with pre- and postoperative AF
Table 3 illustrates the relation and differences in clinical and electrophysiological param-
eters between patients with and without preoperative AF. AF patients were older, had more 
left atrial enlargement (>45 mm), total CD/CB and more CD/CB at Bachmann’s bundle and 
the lateral left atrium. The strongest parameter correlated with preoperative AF was CD/CB 
at Bachmann’s bundle (rrb=0.40, P<0.001) followed by age (rrb=0.31, P=0.006).
Postoperative continuous rhythm registrations of 121 (87%) patients were available and 
analyzed for occurrence of early postoperative AF. Postoperative AF occurred in 52%. 
Presence of total amount of atrial CD and CB in the upper quartile, preoperative AF, left 
atrial enlargement, left ventricular dysfunction, hypertension, diabetes did not predict 
postoperative AF, only age was a limited risk factor for developing postoperative AF (OR 
1.071, CI 1.023-1.122, P=0.004). Neither univariate or multivariate logistic regression in-
cluding CD and CB in the upper quartile per area separately showed associations between 
electrophysiological parameters and postoperative AF.







Age, yr [IQR] 68 [12] 73 [11] 0.006 0.31
Hypertension (%) 58 45 0.161
Diabetes mellitus (%) 14 21 0.301
LA >45 mm (%) 22 47 0.003 0.25†
LV function (N-R-M %) 72 - 19 - 9 79 - 16 - 5 0.401
CD/CB (average % [IQR])
Total 2.3 [2.0] 2.7 [2.3] 0.044 0.22
RA-ICS 4.7 [6.6] 4.5 [5.0] 0.277
RA-ICI 2.5 [5.1] 1.1 [5.7] 0.183
RA-RAS 0.5 [1.8] 0.8 [1.8] 0.718
RA-RAI 0.4 [1.4] 0.4 [1.3] 0.456
BB 2.3 [4.4] 5.9 [6.4] 0.000* 0.40
PLA 1.6 [2.3] 1.8 [3.2] 0.125
LLA 1.0 [1.9] 1.8 [2.5] 0.009 0.29
* significant after Bonferroni correction; † Phi coefficient; AF = atrial fibrillation; IQR = interquartile range; LA 
= left atrium; LV = left ventricular; N-R-M = normal-reduced-moderate; CD = conduction delay; CB = conduc-
tion block; RA = right atrium; ICS/I = intercaval superior/ inferior; RAS/I = right appendage superior/ inferior; 
BB = Bachmann’s bundle; PLA = posterior left atrium; LLA = lateral left atrium.
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Figure 3. Conduction delay and block per atrial area.
Boxplots of the average percentage of conduction delay and block (CD/CB) in each area in patients with AV 
and MV disease (error bars indicate minimum and maximum, box indicates Q1-median-Q3). The right atrial 
intercaval superior area (RA-ICS) has the highest amount of CB (P<0.001, significant after Bonferroni cor-
rection). Patients with MV disease tend to have more CD/CB at the lateral left atrium (LLA). RA, right atrium; 
ICS/I, intercaval superior/ inferior; RAS/I, right appendage superior/ inferior; BB, Bachmann’s bundle; PLA, 
posterior left atrium; LLA, lateral left atrium.
DISCUSSION
High-resolution mapping of the atria in patients with valvular heart disease demonstrated 
a high and heterogeneous occurrence of disturbances in electrical conduction during sinus 
rhythm. The highest prevalence was seen at the high right atrium. The overall degree of CD 
and CB did not differ between patients with AV and MV disease. However, the lateral left 
atrium demonstrated a higher maximal degree of CD per 1 cm2 in patients with MV disease. 
Preoperative AF was most strongly correlated with conduction disorders at Bachmann’s 
bundle and age.
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Conduction block at the high right atrium
Both groups demonstrated a high prevalence and degree of CB at the high right atrium 
which is not specific for patients with left-sided valvular heart disease and is also observed 
in patients with coronary artery disease.8 The high right atrium is characterized by the si-
noatrial node area and fractionated atrial electrograms are common at this site in patients 
with sinus node dysfunction.9 However, likely CB seen at this site is not caused by sinus 
node disease with advancing age, but anatomically determined. Even young patients in 
this study had long lines of CB lateral to the site of first activation. Previous studies have 
demonstrated that the sinus node is surrounded by arteries and connective tissue pro-
tecting the node from external electrical influences and that action potentials of the sinus 
node are conducted to atrial myocardium via specific exit pathways located superiorly 
and inferiorly. Lateral conduction towards the atrial septum, however, is blocked by the 
insulating tissue.10,11 Furthermore, the neighboring terminal crest is known for anisotropic 
conduction properties and slow conduction parallel to the crest which may also contribute 
to the observed CB at the high right atrium.12
Conduction disorders in aortic versus mitral valve disease
Both AV and MV disease have been associated with changes in the myocardial structure of 
the atria due to the altered hemodynamic effects.13,14 Structural remodeling can alter atrial 
electrophysiology and predispose to development of atrial tachyarrhythmias. The higher 
incidence of AF in MV disease suggests the presence of a higher degree of atrial remodeling 
in these patients. Roberts-Thomson et al. indeed demonstrated a larger amount of func-
tional delay in conduction during pacing at the posterior left atrial wall in patients with 
MV disease compared to AV disease.15 However, these differences were not present during 
sinus rhythm. We have investigated the entire atrial surface and identified the lateral left 
atrium as a location with increased conduction delay in patients with MV disease.
Atrial fibrillation and conduction disorders during sinus rhythm
In sinus rhythm, more CD was observed at the left posterior wall in MV patients with per-
sistent AF than without AF.16 In our study, patients with MV disease had more conduction 
disorders at the lateral left atrium and a higher prevalence of AF. However, preoperative 
AF was most strongly correlated with conduction disturbances at Bachmann’s bundle. 
Teuwen et al. has recently found that a high amount and long lines of CB at Bachmann’s 
bundle during sinus rhythm predisposes for early postoperative AF in patients with 
coronary artery disease.17 The highly organized structure and anisotropic features could 
leave Bachmann’s bundle more vulnerable to structural remodeling and disturbances 
in conduction that can even be identified during sinus rhythm. The myocardial strands 
crossing the right and left atrial roof are not enclosed by fibrous tissue and may perhaps 
be easily disrupted by stretch due to overload of either atrium.18 The histological study 
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of Becker et al. demonstrated in fact that structural continuity of Bachmann’s bundle is 
often compromised, especially in patients with AF.19 Conduction disorders at Bachmann’s 
bundle have been proposed to be a measure of more general atrial electrical pathology.20 
However, we found that conduction disturbances in other areas during sinus rhythm are 
not related to AF.
Study limitations
The routine preoperative echocardiograms did not allow for a retrospective sampling of 
exact dimensions. This parameter was therefore limited to the used cut-off dimension. 
The atrial septum cannot be reached by epicardial mapping and is therefore not included 
in this study. The atrial areas are recorded in a sequential manner due to technical restric-
tions which may cause some overlap between recordings.
Clinical relevance
This study is the first to describe conduction disorders in high-resolution of the entire 
atrial surface during sinus rhythm in patients with valvular heart disease. It demonstrated 
that left atrial overload in MV disease also translates to more conduction disorders at the 
lateral left atrium during sinus rhythm and that Bachmann’s bundle is most affected in MV 
and AV patients with AF. These findings help to further understand the structural damage 
caused by valvular heart disease that alters electrical conduction and most likely creates 
susceptibility for AF.
CONCLUSIONS
Excitation of the atria during sinus rhythm is heterogeneously disrupted in patients with 
AV and MV disease, however, in MV disease more conduction disorders present at the 
lateral left atrium. The occurrence of AF in presence of valvular heart disease is associated 
with increased conduction disturbances in sinus rhythm at Bachmann’s bundle. Further 
research is necessary to determine the role of Bachmann’s bundle and lateral left atrium 
in the occurrence of AF in patients with valvular heart disease.
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Background: Valvular heart disease (VHD) is a common risk factor for atrial fibrillation 
(AF). Conduction abnormalities (CA) during sinus rhythm (SR) across Bachmann’s bundle 
(BB) are associated with AF development. The study goal is to compare electrophysiologi-
cal characteristics across BB during SR between patients with ischemic (IHD) and/or VHD 
either with or without ischemic heart disease ((I)VHD), with/without AF history using high-
resolution intraoperative epicardial mapping.
Methods: High-resolution intraoperative epicardial mapping of BB with 128 or 192-unipo-
lar electrode arrays was performed. Entry sites of SR wavefronts into BB were classified as 
right, middle and/or left. Length and amount of CA lines were calculated.
Results: In total, 304 patients (IHD: N=193, (I)VHD: N=111) were mapped; 40 patients (13%) 
had a history of AF. In 116 patients (38%) there was a mid-entry site with a trend towards 
more mid-entry sites in patients with (I)VHD vs IHD (P=0.061), whereas patients with AF 
had significant more mid-entry sites than without AF (P=0.007). CA were present in 251 
(95%) patients without AF compared to 39 (98%) with AF. The amount of CA was compa-
rable in patients with IHD and (I)VHD (P>0.05); AF history was positively associated with 
the amount of CA (P<0.05). ROC-curve showed 85.0% sensitivity and 86.4% specificity for 
cut-off values of CA lines of respectively ≤6 mm and ≥26 mm. Patients without a mid-entry 
site or long CA lines (≥12 mm) were unlikely to have AF (sensitivity 90%, P=0.002).
Conclusions: There are no significant differences in entry-sites of wavefronts and long 
lines of CA between patients with IHD compared to (I)VHD. Yet, patients with AF have more 
wavefronts entering in the middle of BB and a higher incidence of long CA lines compared 
to patients without a history of AF. Moreover, in case of absence of a mid-entry site or long 
line of CA, patients most likely have no history of AF.
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INTRODUCTION
Propagation of electrical wavefronts during sinus rhythm (SR) occurs from the right atrium 
towards the left atrium through different connections such as the coronary sinus, fossa 
ovalis and Bachmann’s bundle (BB).1 Because of limited access to the epicardially located 
BB, electrical activation across BB has rarely been studied. In patients with ischemic heart 
disease (IHD), it was recently shown that although BB was thought to be of paramount 
importance for interatrial conduction from the right to left atrium during SR, it was also 
activated by SR wavefronts emerging in the middle and left site of the bundle.2 In addition, 
patients with atrial fibrillation (AF) had a higher degree of conduction disorders across BB. 
This observation suggests a possible role of BB in development of AF which has also been 
proposed by other investigators.3, 4
The suggested role of BB in AF development was mainly based on subtle ECG changes.5 
These ECG findings were associated with clinical outcomes such as stroke and AF (Bayés 
syndrome).5 Furthermore, pacing at BB instead of the usual right atrial appendage might 
be effective for prevention of AF paroxysms and progression to persistent AF, although 
studies showed conflicting results.6, 7
Valvular heart disease (VHD) is one of the major risk factors predisposing to development 
of AF.8 Conduction across BB might be affected by VHD, as VHD and conduction disorders 
across BB are both correlated to development of AF. Yet, the effect of underlying heart 
disease such as VHD on conduction across BB is so far unknown in humans, as detailed 
activation mapping of BB has only been described in patients with IHD. The aim of the 
present study was 1) to examine electrophysiological properties during SR including 
entry sites and conduction disorders across BB during SR, 2) to compare these properties 
between patients with ischemic and/or valvular heart disease and 3) to correlate these 
electrophysiological properties with the occurrence of previous AF episodes.
METHODS
Study population
A total of 304 patients of at least 18 years of age who underwent open chest cardiac sur-
gery for coronary artery bypass graft and/or VHD (aortic or mitral valve) were included. 
Patients were classified into 2 groups; IHD and VHD. The group of IHD mainly consists 
of patients analyzed in our previous report (N=185).2 The latter containing patients with 
solely VHD and VHD in combination with IHD. As VHD is considered a leading risk factor 
for development of AF and to maintain sufficient statistical power by comparing similar 
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group sizes, these patients are initially categorized as one: (I)VHD. Yet, complete sub-
analyses for entry-sites and conduction disorders for patients with IHD only, IVHD and 
VHD only are shown in Supplemental Table 1. Echocardiographic examination was part of 
standard protocol prior to the surgical procedure, whereas other imaging techniques (e.g. 
MRI) were not. Patients were excluded in case of paced atrial rhythm, Wolff-Parkinson-
White syndrome, severe renal failure, previous open chest cardiac surgery, prior ablative 
therapy, hemodynamic instability (presence of assist devices, usage of inotropic) and prior 
radiation for chest malignancies.
This study is part of the prospective observational projects QUASAR and HALT & REVERSE 
which were both approved by the Medical Ethical Committee in the Erasmus Medical 
Center (MEC 2010-054 and MEC 2014-393).9 Written informed consent was provided by all 
patients prior to the surgical procedure.
Mapping procedure
High-resolution epicardial mapping was performed as previously described.2, 9 A bipolar 
pacemaker-wire was stitched to the right atrial free wall (terminal crest), serving as tempo-
ral reference electrode. A steel wire was fixed in the thoracic subcutaneous tissue serving as 
indifferent electrode. The initial 161 patients were mapped with a 128-unipolar electrode 
(8x16) mapping array, whereas the remaining patients were mapped with a mapping array 
containing 192-unipolar electrodes (8x24) (interelectrode distance 2.0 mm).2 The mapping 
array was positioned on BB by placing it over the interatrial roof behind the aorta with 
the tip against the left atrial appendage (upper panel Figure 1). Mapping of BB with the 
128-electrode array was performed by shifting the array backwards towards the superior 
cavo-atrial junction resulting in 2 consecutive positions. Solely patients with electrical 
activation present at >75% of the mapping area were included. Although this may be the 
result of low voltage areas, limited contact of the mapping array on the myocardium can-
not be excluded and therefore this cut-off value was chosen. SR was recorded during 5 
seconds, including a surface ECG lead, a calibration signal of 2 mV and 1000 ms, unipolar 
epicardial electrograms and a bipolar reference electrogram.2, 9
Mapping data analysis
Mapping data were analyzed using our custom-made software.2, 9 The steepest negative 
deflection of the unipolar atrial potentials was annotated as local activation time. Based 
on the activation times, color-coded activation maps were automatically constructed as 
demonstrated in the middle panel of Figure 1. An averaged beat was subsequently created 
after excluding premature and aberrant beats. The averaged maps were used for analysis 
of patterns of activation and quantification of conduction disorders. Patterns of activation 
were classified according to entry-sites; right, middle and left (lower panel Figure 1). A 
87
Conduction across Bachmann’s bundle during sinus rhythm
7
Figure 1. Mapping procedure of Bachmann’s bundle.
Top: 192-unipolar electrode mapping array including measurements of length, interelectrode distance and 
electrode diameter. The mapping array is subsequently positioned at Bachmann’s bundle, by placing the 
array behind the aorta with the tip against the left atrial appendage. Middle: unipolar electrogram with 
steep atrial deflection(A) and far-field ventricular signal(V). After marking all atrial deflections, a color-cod-
ed activation map is constructed. The arrows depict direction of wavefront propagation. The striped star il-
lustrates an area of simultaneous excitation/focal wave. In the current example, the mid-entry corresponds 
to location of the interatrial septum and transition of BB to left atrial roof (posterior). Bottom: schematic 
overview of 192-unipolar electrode mapping array. Entry sites are denoted with R (right), M (middle) and L 
(left). LAA, left atrial appendage.
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wavefront entering the area under the mapping array from the right atrial side from where 
it propagates towards the left side was defined as right entry site, whereas in case this was 
observed vice versa it was defined as left entry site. An area of simultaneous excitation 
or a wavefront emerging in the center of the mapping array as focal wave was defined 
as mid-entry site.2 Also wavefronts entering from the anterior or posterior borders in the 
middle part of the mapping array, were also defined as mid-entry. In a previous study from 
our group, we described the origin of these mid-entry wavefronts based on anatomy of 
dissected hearts. Either these wavefronts propagate from the interatrial septum upwards 
to BB, which are connected in some patients, or these wavefronts enter BB through paral-
lel bundles that merge either on the anterior or posterior site of BB.10 For quantification of 
conduction disorders, difference in local activation times between 2 adjacent electrodes 
were determined. Conform previous studies, conduction delay (CD) was determined as 
time differences of 7–11 ms (conduction velocity: <29 cm/s) between 2 adjacent electrodes. 
In case time difference was ≥12 ms between 2 adjacent electrodes (conduction velocity: 
<17 cm/s), this area was marked as conduction block (CB).2, 9 The amount of conduction 
delay and/or block was measured as a percentage of all interelectrode conduction times. 
The number of lines of CD/CB and their length were measured separately. When lines of CD 
and CB were connected to each other, they were denoted as CDCB.
Statistical analysis
Normally distributed data are described by mean±SD, whereas skewed data are described 
by median (interquartile range) and categorical data as numbers and percentages. Nor-
mally distributed data are analyzed with Student’s T-test or one way ANOVA, skewed data 
with Kruskall-Wallis test or Mann-Whitney U-test and categorical data with χ2 or Fisher 
exact test when appropriate. The correlation between patient characteristics in the entire 
study population or IHD/(I)VHD separately and conduction disorders was performed us-
ing Spearman rank correlation. A correlation of 0.1 – 0.3 was considered weak, 0.3 – 0.5 
moderate and >0.5 strong. For further clinical interpretation of observed conduction 
disorders, ROC-curves from previous AF episodes were extracted to calculate CB/CDCB 
cut-off values for sensitivity and specificity. Subsequently, based on previous data show-
ing an association between lines of CB ≥12 mm with development of postoperative AF, 
we also studied the relation of previous AF episodes and lines of CB/CDCB ≥12 mm. With 
current findings, we added a mid-entry site to these analysis and determined sensitivity 
and specificity with χ2. In addition, we investigated the relation between late postopera-
tive AF (LPAF) using previous long-term follow-up data and presence of lines of CB/CDCB 
≥12 mm and/or mid-entry site. LPAF was detected on ECG or 24-hour Holter recordings, 
performed either on regular base or on indication during outpatient clinic control. Finally, 
the association of potential determinants (e.g. age, left ventricular function, left atrial dila-
tation) with CB/CDCB ≥12 mm or mid-entry site was tested using univariate binary logistic 
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regression models. Due to skewness, age was transformed to a binary value with top 25% 
(≥72.5 years) set as ‘high’. Aging, gender and underlying heart disease were subsequently 
selected for multivariate binary logistic regression, next to determinants with a P-value 
≤0.20. A P-value <0.05 was considered statistically significant. Statistical Package of Social 
Sciences version 21.0 for Windows(SPSS Inc. Chicago, IL, USA) was used.
RESULTS
Study population
Study population characteristics (N=304, 237 male (78%), age 66±10 years) are shown in 
Table 1. Mean age in the entire study population was 66±10 years. Patients had either IHD 
(N=193, 63.5%), VHD (N=62, 20.4%) or a combination of ischemic and valvular heart disease 
(N=49, 16.1%). Patients underwent cardiac surgery different valvular pathology including 
aortic valve stenosis (N=70, 23.0%), aortic valve insufficiency (N=20, 6.6%), mitral valve 
stenosis (N=3, 1.0%) and mitral valve insufficiency (N=41, 13.5%). Two-hundred thirty pa-
tients (75.7) used antiarrhythmic drugs prior to surgical procedure; class II (N=211, 69.4%), 
class III (N=9, 3.0%) and class IV (N=10, 3.3%). The majority of patients had a normal left 
ventricular function (N=234, 77%) and only 10 patients (3%) had a moderate/severe left 
ventricular dysfunction. Left atrial dilatation was present in 54 patients (18%); half of them 
had isolated IHD.
A total of 40 patients (13%) had a history of AF; 32 paroxysmal, 7 persistent and 1 long-
standing persistent. Of the latter two groups, all patients underwent electrical cardiover-
sion prior to epicardial mapping. Comparing the presence of AF for different underlying 
heart disease, relatively most patients had AF in combination with mitral valve disease 
(N=14, 34%), aortic valve disease (N=12, 17%) and finally IHD solely (N=14, 7%). Due to a 
limited number of patients with (longstanding) persistent AF, further comparison is not 
performed between different types of AF. Mapping was performed with mean rate of 72±14 
beats/min.
For further comparison of groups, patients were divided in having IHD or VHD. The right 
side in Table 1 demonstrates differences between these groups. Although age was com-
parable (65.5±9.2 vs 66.8±11.4), other characteristics which may potentially affect atrial 
conduction were different; either with a higher incidence in patients with IHD including 
hypertension, hypercholesterolemia, diabetes mellitus, antiarrhythmic drug usage and 
history of myocardial infarction (P<0.004), or a higher incidence in patients with VHD such 
as left atrial dilatation and a history of AF (P<0.001).
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Impact of heart disease and atrial fibrillation on entry sites
We investigated whether the underlying heart disease and/or a history of AF has a relation 
with the number of wavefront entry sites into BB during SR and the location of these entry 
sites (right, middle, left or combinations). In total, the number of entry sites was either 1 
site solely in 211 patients (69%) or multiple sites (2 sites: N=73, 24%, 3 sites: N=20, 7%). 
As BB is a major route of interatrial conduction, the vast majority of patients (N=23, 92%) 
had at least 1 wavefront entering BB from only the right (N=186, 61%) or a right entry 
site combined with other entry sites (N=95, 31%) (upper panel Figure 2). Furthermore, 116 
Table 1. Patient characteristics
Total IHD (I)VHD P-value
Number of patients, N 304 193 111
Age, years (mean ± SD) 66.0 ± 10.1 65.5 ± 9.2 66.8 ± 11.4 0.415
Male gender, N (%) 237 (78.0) 163 (84.5) 74 (66.7) <0.001
BSA, m2 (mean ± SD) 2.02 ± 0.21 2.05 ± 0.20 1.96 ± 0.21 0.564
Hypertension, N (%) 170 (55.9) 120 (62.2) 50 (45.0) 0.004
Hypercholesterolemia, N (%) 111 (36.5) 84 (43.5) 27 (24.3) 0.001
Diabetes mellitus, N (%) 85 (28.0) 68 (35.2) 17 (15.3) <0.001
AAD, N (%) 230 (75.7) 166 (86.0) 64 (57.7) <0.001
PCI, N (%) 70 (23.0) 58 (30.1) 12 (10.8) <0.001
Myocardial infarction, N (%) 94 (30.9) 85 (44.0) 9 (8.1) <0.001
Indication VHD, N (%)
VHD 62 (20.4) 62 (55.9)
IVHD 49 (16.1) 49 (44.1)
Aortic valve stenosis 70 (23.0) 70 (63.1)
Aortic valve insufficiency 20 (6.6) 20 (18.0)
Mitral valve disease 3 (1.0) 3 (2.7)
Mitral valve insufficiency 41 (13.5) 41 (36.9)
Left ventricular function, N (%) 0.618
Normal 234 (77.0) 146 (75.6) 88 (79.3)
Mild dysfunction 60 (19.7) 39 (20.2) 21 (18.9)
Moderate dysfunction 8 (2.6) 6 (3.1) 2 (1.8)
Severe dysfunction 2 (0.7) 2 (1.0) 0
Left atrial dilatation >45mm, N (%) 54 (17.8) 27 (14.0) 27 (24.3) 0.001
History of AF, N (%) 40 (13.2) 14 (7.3) 26 (23.4) <0.001
Paroxysmal 32 (10.5) 14 (7.3) 18 (16.2)
Persistent 7 (2.3) 0 7 (6.3)
Longstanding persistent 1 (0.3) 0 1 (0.9)
AAD = antiarrhythmic drugs; AF = atrial fibrillation; BSA = body surface area; IHD = ischemic heart disease; 
(I)VHD = (ischemic) valvular heart disease; PCI = percutaneous coronary intervention; SD = standard devia-
tion.
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patients (38%) had a wavefront entering BB in the middle including an entry site in the 
middle only (N=22, 7.2%), right and middle (N=72, 23.7%), middle and left (N=1, 0.3%) and 
right, middle and left (N=21, 6.9%).
Whereas the number of entry sites was comparable between patients with IHD (N=59, 
31%) and (I)VHD (N=37, 33%) (P=0.48), patients with AF had more often >1 entry-site than 
patients without a history of AF (N=19, 48% vs N=77, 29%; P=0.02). Additionally, the middle 
panel of Figure 2 demonstrates that patients with a history of AF had more frequently a 
wavefront entering in the middle of BB compared to patients without AF (N=23, 58% vs 
N=93, 35%; P=0.007). In comparison, there was only a trend towards a higher incidence of 
mid entry sites in patients with (I)VHD compared to IHD (P=0.061). For all 3 groups sepa-
rately, solely patients with IVHD combined with AF had more mid-entry sites, although this 
group only consisted of 6 patients (see Supplemental Table 1).
Correlation between heart disease or atrial fibrillation with conduction 
disorders
A total of 283 (93%) patients had at least 1 area of CD, 236 (78%) patients CB and 212 (70%) 
patients a continuous line of CDCB. In these patients, the longest lines of CD, CB and CDCB 
consisted of respectively 6 mm (4–8), 6 mm (2–16) and 12 mm (0–22) (upper panels Figure 
3). In the entire study population, a median of 1.8% (0.9–2.9) CD, 1.2% (0.3–3.2) CB and 
3.2% (1.6–6.0) continuous lines of CDCB was measured, as demonstrated in the lower pan-
els of Figure 3. Although there was a significant positive correlation between the amount 
of CDCB and aging in the entire study population, the correlation was solely moderate (rho 
0.326, P<0.001). Furthermore, in patients with (I)VHD, diabetes mellitus and left atrial dila-
tation was weakly correlated with the amount of CDCB, respectively rho 0.257 (P=0.007) 
and rho 0.282 (P=0.008), whereas the remaining patient characteristics demonstrated no 
correlation. Furthermore, the amount of conduction disorders is comparable between 
patients with IHD only, IVHD and VHD only (see Supplemental Table 1).
Figure 4 demonstrates conduction disorders in patients with IHD (upper panels), (I)VHD 
(lower panels), without a history of AF (left panels) and with a history of AF (right panels). 
As shown in Figure 4, the amount of conduction disorders is nearly comparable between 
patients with IHD and (I)VHD; CB 0.9% vs 1.4% (P=0.155) and CDCB 3.0 vs 3.2% (P=0.488) 
in patients without a history of AF. Also in patients with a history of AF there were no sig-
nificant differences between IHD and (I)VHD; CB 2.9% vs 3.0% (P=0.90) and CDCB 6.5% vs 
5.7% (P=0.79) (see also Supplemental Table 1 for separate analyses).
In total, 39 (98%) patients with AF and 251 (95%) without AF had at least some areas of 
CDCB. Yet, patients with AF, both with IHD and (I)VHD, have a higher amount of CB and 
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CDCB compared to patients without a history of AF, respectively IHD 0.9% vs 2.9% CB 
(P=0.019), 3.0% vs 6.5% CDCB (P=0.006) and (I)VHD 1.4% vs 3.0% CB (P=0.018) and 3.2 vs 
5.7% CDCB (P=0.015).
Figure 2. Entry sites and patterns of activation at Bachmann’s bundle.
Top: frequency pie illustrating all different entry sites in the entire study population including right entry 
site only (green) and other entry sites (red). Middle: frequency pies demonstrating the number of patients 
without a mid-entry site (blue) and with a mid-entry site (yellow) of wavefronts. The left panels illustrate 
the difference for underlying heart disease, the right panels for patients with/without a history of AF. Bot-
tom: examples of color-coded activation maps of BB during SR demonstrating different activation patterns; 
entry site only from the right (left upper map), right and middle (right upper map), right and left (left lower 
map) and right, middle and left (right lower map). Arrows indicate the main propagation direction of wave-
fronts, stars an area of simultaneous excitation/focal wave. AF, atrial fibrillation; IHD, ischemic heart dis-
ease; (I)VHD, (ischemic) valvular heart disease; L, left entry; M, mid entry; R, right entry.
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In line with these results, patients with early postoperative AF also had a higher amount 
of conduction disorder, respectively IHD 0.9% vs 1.7% CB (P=0.022), 2.7% vs 4.2% CDCB 
(P=0.026) and (I)VHD 1.5% vs 1.7% CB (P=0.119) and 3.4 vs 3.8% CDCB (P=0.030). Further-
more, long-term follow-up was present in 266 patients (88%) with a median follow-up pe-
riod of 24 months (range 3–36). In these patients, solely 10 patients (4%) developed LPAF 
of whom 8 patients had preoperative AF. Comparison between patients with/without LPAF 
and the amount of conduction disorders was not performed due to the limited number of 
patients with LPAF.
Diagnostic value for atrial fibrillation
Figure 5 illustrates the diagnostic value of longest CB/CDCB for AF. The diagnostic value 
of the longest lines of CB/CDCB is shown in the ROC-curve in Figure 5 with an area under 
the curve of 0.697. In addition, cut-off values for high sensitivity and specificity (≥85%) are 
respectively 6 mm and 26 mm (right upper panel Figure 5).
Figure 3. Incidence and extensiveness of conduction disorders.
Top: Frequency histograms depicting the longest measured line of conduction delay (green), block (purple) 
and connected conduction delay and block (red) per patient. Bottom: Frequency histogram illustrating the 
percentage of conduction delay (green), block (purple) and combined (red) per patient. CB, conduction 
block; CD, conduction delay; CDCB (mm), length of connected conduction delay and block; CDCB (%), sum 
of conduction delay and block.
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The diagnostic value of a mid-entry and previous AF episodes was studied. As mentioned, 
patients with AF had relatively more frequently a wavefront entering in the middle of BB 
(see Supplemental Table 1). A total of 116 patients (38%) had a mid-entry of whom 23 
patients (58%) had AF, leading to a sensitivity and specificity of respectively 58% and 65%. 
Also, patients with AF, as previously described, had more conduction disorders. Thirty 
patients (75%) with AF and 124 patients (47%) without AF had a line of CB or CDCB ≥12 
mm, resulting in a sensitivity of 75% and specificity of 53% for previous episodes of AF 
(both not shown in Figure 5).
When combining these results, a mid-entry or a line of CB/CDCB ≥12 mm, nearly all patients 
with AF (N=36, 90%) met these criteria compared to 159 patients (60%) of patients without 
AF (lower panel Figure 5). Therefore, although there is a significant group of patients with-
out AF with a mid-entry or CB/CDCB ≥12 mm, a patient was highly unlikely to have AF in 
the absence of these criteria (sensitivity 90%). Absence of one of these electrophysiologi-
Figure 4. Relation between underlying heart disease, atrial fibrillation and conduction disorders.
Differences in the amount of conduction delay (green), block (yellow) and combined (red) between patients 
with ischemic heart disease (top panels) and valvular heart disease (bottom panels). In addition, difference 
in conduction disorders are shown between patients without atrial fibrillation (left panels) and with a his-
tory of atrial fibrillation (right panels). AF, atrial fibrillation; CB, conduction block; CD, conduction delay; 
CDCB, sum of conduction delay and block.
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cal criteria is strongly associated with patients without AF (P=0.002). If both a mid-entry 
and a line of CB/CDCB ≥ 12 mm are present, sensitivity is reduced to 50% (not shown in 
Figure). Furthermore, selection of patient characteristics (P≤0.20 univariate analysis) for 
multivariate analysis including age, gender, history of AF, IHD/VHD and diabetes mellitus 
demonstrated a history of AF (P=0.007) and aging (P=0.009) were both significantly associ-
ated with a mid-entry or CB/CDCB ≥12 mm, whereas gender (P=0.72), VHD (P=0.32) and 
diabetes mellitus (P=0.16) were not.
Figure 5. Predictive value of entry-site and conduction disorders.
Top: Predictive value of the length of conduction disorders for previous AF episodes. The left panel de-
picts a ROC curve for length of lines of conduction disorders, The right panel cut-off values of the length 
of conduction disorders and previous AF episodes. Bottom: Flowchart demonstrating the predictive value 
of mid-entry site and a line of conduction block or CDCB of 12 mm or more. Table shows sensitivity and 





The current study demonstrates that both patients with IHD and VHD mainly have propa-
gation of SR wavefronts across BB from the right towards the left atrial appendage. Yet, in 
over one third of patients, a wavefront emerges in the middle of BB towards surrounding 
sites. Furthermore, nearly all patients have conduction disorders across BB. There are no 
significant differences in wavefronts emerging in the middle of BB or the amount of con-
duction disorders between patients with IHD and VHD. In contrast, patients with previous 
episodes of AF have more conduction disorders and more frequently a wavefront entering 
BB in the middle compared to patients without a history of AF. Taking both electrophysi-
ological properties into account, patients without a mid-entry site or long lines of conduc-
tion disorders seldom have AF.
Atrial remodeling in atrial fibrillation
Both cardiovascular and non-cardiovascular diseases contribute to development of AF. 
However, how these different diseases exactly contribute to AF development is still not 
completely unraveled. In general, several mechanisms have been proposed to underlie AF, 
including an ectopic rapid firing focus or re-entry from which waves originate with fibril-
latory conduction or conduction of multiple wavelets.11 Moreover, electrical asynchrony 
between the epi- and endocardial layer was recently found as potential cause for mainte-
nance of AF.12 Irrespective of the underlying mechanism, conduction abnormalities (e.g. 
due to atrial fibrosis) have always been found to increase AF vulnerability. Müller-Edenborn 
et al. performed endocardial high-density voltage mapping in patients with persistent AF 
undergoing pulmonary vein isolation.13 They investigated the location of areas or bipolar 
low voltages in the left atrium (peak-to-peak <0.5 and <1.0 mV) during SR. Subsequently, 
they related these areas of low voltages with alterations of P-wave morphology and risk 
of AF recurrence. The investigators concluded that low voltage areas are most often ob-
served at the anteroseptal left atrial area which consists of myocardial fibers originating 
from BB. Furthermore, depending on location of low voltages in the left atrium, P-wave 
morphology may be altered and increased. Moreover, P-wave alterations and areas of low 
voltage enable risk stratification of AF recurrence after pulmonary vein isolation. They 
suggested, also based on previous anatomical studies14, that conduction disorders might 
be correlated to local fibrosis. In our previous study focusing on conduction across BB in 
patients with IHD, we observed that patients with AF have a higher amount and longer 
lines of conduction disorders across BB compared to patients without AF.2 As expected, 
the current study illustrates again that patients with AF have more and longer lines of 
conduction disorders. In line with findings by Müller-Edenborn et al., conduction disorders 
observed in the current study may be the result of local fibrosis. Although conduction 
disorders at BB may reflect pathology through the entire atrial myocardium such as the 
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anteroseptal insertion, in our preliminary data with epicardial mapping of the entire atrial 
surface, conduction disorders seem mainly limited to BB in patients with AF which was 
not shown in the current study due to the extensiveness of data.15 Yet, it remains unknown 
whether conduction disorders at BB facilitated development of AF or whether AF episodes 
further increased the amount of conduction disorders.
It is commonly known that atrial remodeling during AF enhances AF maintenance (“AF 
begets AF”).16 AF initiates electrical remodeling and is considered a cause of progression to 
persistent AF. In brief, electrical remodeling consists of e.g. shortening of atrial refractori-
ness due to ion-channels adaptations.17-20 The remodeling is reversible; time until normal 
state depends on the duration of AF. Next to electrical remodeling during AF, structural 
remodeling has been characterized as well, such as myocyte hypertrophy, myolysis and 
accumulation of glycogen (dedifferentiation).17-20 It is still a matter of debate whether AF 
itself also causes degeneration of myocytes with fibrotic deposition. In the goat model of 
persistent AF, structural remodeling was observed without production of fibrosis after >20 
weeks of persistent AF induced by rapid atrial pacing.18 In contrast, others suggest that 
atrial fibrosis might be enhanced during AF which in turn makes AF more persistent and 
therapeutic resistant.19, 20
The current study showed that conduction disorders are more present in patients with 
previous AF episodes, but the cause of the higher amount of conduction disorders is 
unknown. This is a non-longitudinal observational study and therefore the previous ef-
fects of conditions such as hypertension (blood pressure alterations) and atrial pressure 
that change over time and which may contribute to conduction disorders remain poorly 
understood. In addition, we did not observe clear differences in conduction disorders 
between patients with IHD and VHD after correction for AF history, although the incidence 
of AF was higher in patients with VHD conform previous many clinical studies. The similar 
amount of conduction disorders between IHD and VHD may be caused by the complex 
pathophysiology in patients with IHD (e.g. atrial ischemia, elevated left ventricular pres-
sure, diastolic dysfunction) and VHD (e.g. myocyte loss, increased effective refractory 
period due to reversible interstitial fibrosis, diastolic atrial dilatation).21, 22 Moreover, there 
were differences in patient characteristics such as gender, hypertension and diabetes mel-
litus that may have a confounding effect on conduction disorders. Yet, further analyses 
demonstrated either no significant effect or a weak significant correlation (r <0.30) in each 
group.
Altogether, this leads to a chicken-and-egg situation; does VHD contribute to conduction 
disorders across BB predisposing to AF development? Or does AF enhance production of 
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fibrosis resulting in a higher amount of conduction disorders across BB? Future longitudi-
nal and experimental studies could provide more insights in these unanswered questions.
Relation between mid-entry and patients with atrial fibrillation
BB is described as an important inter-atrial connection for conduction of electrical wave-
fronts.5 As expected, BB was in the majority of our patients activated from the right to left. 
Yet, in line with a previous study,2 we also observed SR wavefronts entering in the middle 
of BB. This pattern of activation was more frequently observed in patients with AF.
There are 2 possible explanations why patients with AF have a higher incidence of wave-
fronts activating BB from the middle area. First, patients with AF have significantly more 
conduction disorders across BB which are also frequently longer than in patients without 
AF. Due to these long lines of conduction disorders, wavefronts are forced to propagate 
outside BB and around these lines, subsequently entering BB in the middle (‘quasi mid-
entry’) behind these lines of conduction disorders. Second, previously it was demon-
strated that the interatrial septum has connections with BB that provides the possibility 
for wavefronts to propagate to the middle of BB.23 Propagation of SR wavefronts across BB 
from either right to left or from the middle (septum) to surrounding areas could depend 
on 2 factors: distance (S) or conduction velocity (CV) from sinus node to BB. Dobrzynski 
et al. and Ho et al. previously described that the sinoatrial node is more a sleeve rather 
than a node like structure at the intercaval region.24, 25 In patients with AF, the sinus node 
origin may vary, resulting in a longer distance between the initial excitation site and the 
right side of BB (↑ S), although Li et al. did not always find a relation between origin of 
the sinus node (intranodal) ‘pacing’ area and earliest atrial activation sites.26 Furthermore, 
patients with AF have more conduction disorders across BB. These conduction disorders 
might also be more present between the sinus node and BB such as the preferential upper 
sinoatrial conduction pathway.26 As a result, wavefronts propagate slower towards the 
right side of BB (↓ CV) and, therefore, propagation occurs through a different faster route 
such as towards the septum and subsequently upwards to BB.
Study limitations
High-resolution epicardial mapping was performed of BB, but conduction properties of 
the remainder of the atria were not described. Therefore, it is unknown what the effect 
of conduction disorders in the remaining of the atria is on for example wavefront entry 
sites. Simultaneous endo- and epicardial of the entire atria could provide more insight in 
e.g. wavefront propagation, but this is so far technically impossible. Furthermore, patients 
were using antiarrhythmic drugs including mainly class II. Although some patients were 
using class III antiarrhythmic drugs which may affect conduction properties, these effects 
were not analyzed due to the limited number of patients. Patients with AF episodes were 
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included. Yet, asymptomatic AF episodes in patients might have been missed which could 
result in an underestimation of the number of patients with a history of AF. In line with 
that, both sensitivity and specificity of a mid-entry site and long lines of conduction disor-
ders for the presence of AF episodes could be positively/negatively affected in case none 
of the AF episodes were missed. Moreover, this also accounts for LPAF as episodes of LPAF 
may have been missed during follow-up which made further analyses impossible for e.g. 
conduction disorders and development of LPAF.
CONCLUSION
Conduction disorders are equally present between patients with IHD and VHD, but 
patients with AF have more and longer lines of conduction disorders. Propagation of 
wavefronts across BB during SR occurs mainly from the right atrial site towards left atrial 
site, but wavefronts also emerge in the middle of BB. Wavefronts entering BB in the middle 
were seen in patients with all different types of underlying heart diseases, but these were 
especially observed in patients with a history of AF. Altogether, a wavefront entering BB 
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SUPPLEMENTAL MATERIAL CHAPTER 7
Supplemental Table 1. Sub-analyses electrophysiological characteristics in patients with ischemic heart 
disease only, valvular heart disease only and ischemic and valvular heart disease combined.
IHD VHD IVHD
CD (%), med (Q) 1.8 (0.9–2.9) 1.6 (0.9–2.7) 1.8 (0.9–3.0) ns
CB (%), med (Q) 1.1 (0–2.9) 1.3 (0.2–2.9) 2.1 (0.7–4.5) ns
CDCB (%), med (Q) 3.0 (1.5–5.6) 3.2 ( 1.5–5.5) 3.8 (2.3–7.3) ns
Total, N 193 62 49
Mid-entry (%) 66 (34%) 28 (45%) 22 (45%) ns
CDCB ≥12mm (%) 90 (46%) 35 (56%) 29 (59%) ns
Mid-entry or
CDCB ≥12mm (%)
116 (60%) 44 (71%) 35 (71%) ns
No AF, N 179 42 43
Mid-entry (%) 60 (34%) 17 (40%) 16 (37%) ns
CDCB ≥12mm (%) 81 (45%) 19 (45%) 24 (56%) ns
Mid-entry or
CDCB ≥12mm (%)
104 (58%) 26 (61%) 29 (67%) ns
AF, N 14 20 6
Mid-entry (%) 6 (43%) 11 (55%) 6 (100%)
CDCB ≥12mm (%) 9 (64%) 16 (80%) 5 (83%) ns
Mid-entry or
CDCB ≥12mm (%)
12 (86%) 18 (90%) 6 (100%) ns
AF = atrial fibrillation; CD = conduction delay; CB = conduction block; CDCB = connected conduction delay 
and block; IHD = ischemic heart disease; IVHD = ischemic and valvular heart disease; med = median; N = 
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Background: Areas of conduction delay (CD) or block (CB) are associated with higher 
recurrence rates after ablative therapy for atrial fibrillation (AF). Thus far, there are no 
reports on quantification of the extensiveness of CD and CB at the pulmonary vein area 
(PVA) and their clinical relevance.
Methods: Intraoperative high-density epicardial mapping of the PVA (interelectrode dis-
tance: 2 mm) was performed during sinus rhythm (SR) in 268 patients (67±11 (21-84) years) 
with and without preoperative AF. For each patient, extensiveness of CD (17-29 cm/s) and 
CB (<17 cm/s) was assessed and related to the presence and type of AF.
Results: CD and CB occurred in respectively 242 (90%) and 183 (68%) patients. AF patients 
showed a higher incidence of continuous CDCB lines (AF: N=37 (76%); No AF: N=132 (60%); 
P=0.046), a two-fold number of lines per patient (CD: 7 (0-30) vs 4 (0-22), P<0.001; CB: 3 
(0-11) vs 1 (0-12), P=0.003; CDCB: 2 (0-6) vs 1 (0-8), P=0.004) and a higher incidence of CD or 
CB lines ≥6 mm and CDCB lines ≥16 mm (P=0.011, P=0.025, P=0.027). Extensiveness of CD, 
CB, CDCB could not distinguish between the different AF types.
Conclusions: AF patients more often present with continuous lines of adjacent areas of 
CD and CB, whereas in patients without AF, lines of CD and CB are shorter and more often 
separated by areas with normal intra-atrial conduction. Between patients with a history of 
paroxysmal and persistent AF, however, a considerable overlap in the amount of conduc-
tion abnormalities at the PVA was observed.
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INTRODUCTION
The pulmonary vein area (PVA) has been of particular interest in the pathophysiology of 
atrial fibrillation (AF) ever since Haïssaguere et al. demonstrated bursts of rapid ectopic 
beats as triggers for spontaneous AF.1 Since then, treatment strategies for AF mainly focus 
on isolation of the pulmonary vein area by endocardial and/or epicardial ablation. Yet, 
recurrence rates are considerable for both patients with paroxysmal and persistent AF and 
are likely the result of either reconduction or transition of AF from a trigger driven to a 
more substrate driven disease.2 To date, AF recurrences after ablation procedures remain 
difficult to predict. Yet, fibrosis at the left atrial posterior wall, resulting in conduction 
delay or block, appears to be associated with higher recurrence rates.3, 4 It has been sug-
gested that assessment of electropathology - including low voltages, fractionation and 
conduction abnormalities - during SR at the PVA may facilitate identification of target sites 
for ablation or can be used to predict AF recurrences after ablative therapy.5–9
In several mapping studies, a line of conduction block (CB) running vertically between the 
right and left pulmonary veins during SR was identified.10–12 This CB line varied between 
patients in its continuity and could in some patients be altered by pacing, indicating that 
it was partly functional in nature.10–12 Furthermore, this line was more frequently observed 
in patients with AF or mitral valve regurgitation.11, 12 Based on histological findings in 
post-mortem hearts, the authors suggested that abnormal conduction was the result of 
a change in myocardial fiber direction.10 Aside from this line of CB, other areas of conduc-
tion disorders were observed in only a minority of patients.10–12 However, the degree and 
extent of conduction abnormalities during SR at the PVA have never been quantified and 
correlated with the different types of AF as defined by the ESC guidelines.13 The goal of the 
present intraoperative high-resolution epicardial mapping study was therefore to detect 
and quantify conduction abnormalities at the PVA in a large cohort of patients during 
sinus rhythm (SR) and to investigate the association with AF persistence.
METHODS
Study population
The study population consisted of 268 successive adult patients undergoing elective 
coronary artery bypass grafting, aortic or mitral valve surgery, or a combination of valvular 
and bypass grafting surgery. This study was approved by the institutional medical ethical 
committee (MEC2010-054/MEC2014-393). Written informed consent was obtained from all 




Epicardial high-resolution mapping of the PVA was performed during SR from the sinus 
transversus along the borders of the right and left pulmonary veins (PVR and PVL) down 
towards the atrioventricular groove (Figure 1), as previously described in detail.14 Local 
activation maps of PVR and PVL during SR were constructed by annotating the steepest 
negative slope of atrial potentials recorded at every electrode (see also Supplemental 
Figure 1). Heterogeneity in conduction was determined by quantifying the amount, num-
ber and length of lines of CD, CB and CDCB and its differences between patient groups 
on a 2 mm resolution scale. Lines of CD and CB were defined as time differences (∆t) of 
respectively 7-11 ms and ≥12 ms between adjacent electrodes.15, 16
Figure 1. Mapping of the pulmonary vein area.
Top: Mapping of the pulmonary vein area with a 192-electrode array and corresponding electrograms re-
corded during 5 seconds of SR. Bottom: Schematic view of the pulmonary vein area (PVA) (left) and activa-
tion maps and conduction delay/block map (right, CD: blue lines, CB: red lines). A, atrial; V, ventricular; 
LAA, left atrial appendage; SCV, superior caval vein; ICV, inferior caval vein; PVL, pulmonary veins left; PVR, 
pulmonary veins right; LS, left superior; LI, left inferior; RS, right superior; RI, right inferior; CD, conduction 
delay; CB, conduction block.
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Statistical analysis
Normally distributed data are described by mean±SD (minimum-maximum). Skewed 
data are described by median (minimum; interquartile range; maximum) and analyzed by 
Mann-Whitney U tests. Categorical data are expressed as numbers and percentages and 
analyzed with χ2 or Fisher exact test when appropriate. ROC-curves for the difference in 
CD and CB lengths were constructed and cut-off values were based on sensitivity >50% 
and 1-specificity <50%. Multivariate regression analysis was performed to identify inde-
pendent predictors for CD and CB. A P-value <0.05 was considered statistically significant.
RESULTS
Study population
Characteristics of the study population (N=268, 196 male (73%), 67±11 (21-84) years, BMI 
28±5 (18-55) kg/m2) are summarized in Table 1. Patients had either IHD (N=157, 59%) or (i)
VHD (N=111, 41%; only valvular disease: N=63 (24%)). LA dilation was present in 58 patients 
(22%) and 49 patients (18%) had a history of AF. Most patients had a normal left ventricular 
function (N=203, 76%) and used class II antiarrhythmic drugs (AAD) (N=183, 68%).
Incidence of conduction delay and conduction block
Most patients showed lines of CD (N=242, 90%) and CB (N=183, 68%) at the PVA during 
SR. The number of lines of CD (4 (0-30)) was significantly higher than of CB lines (1 (1-
12); P<0.001), though the maximum length of CB lines was longer (CD: 6 (2;4-10;20) mm; 
CB: 8 (2;4-12;44) mm; P<0.001, Figure 2). A clear turning point was observed at a length 
of ≥8 mm, from which point on, the incidence of CB lines exceeded the incidence of CD 
lines. Most patients also had continuous lines of CDCB (N=169 (63%), median no. 1 (0-6)); 
maximum length: 14 (4-72) mm.
A longitudinal line of CD or CB running vertically between the left and right pulmonary 
veins from superior to inferior was observed in 14 patients (5%), though varying in its 
continuity and length. Typical examples of activation maps and corresponding isochrones 
and CD/CB maps of these patients are shown in Figure 3. The incidence of this line was 
similar between patients without and with AF (P=0.295), as well as between IHD and (i)
VHD patients (P=0.503). However, this line was more often observed in patients with LA 
dilation (N=6 (10%) than patients without LA dilation N=8 (4%), P=0.048). As displayed 
in Table 2, multivariate regression analysis revealed only the presence of AF episodes as 
an independent predictor for long lines of CD and CB at the PVA; clinical characteristics, 
including IHD, (i)VHD, LA dilation, gender, BMI, older age and LV dysfunction were not.
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Association between atrial fibrillation and heterogeneity in conduction
The upper panel of Figure 4 displays typical examples of activation maps and corresponding 
CD/CB maps obtained from a patient without AF and a patient with AF. Patients with AF more 
often have continuous lines of CDCB compared to patients without AF, as demonstrated in 
the middle left panel (AF: N=37, 76%; No AF: N=132, 60%; P=0.046). The number of lines of 
CD, CB and CDCB in patients with AF was approximately two-fold the number observed in 
patients without AF (CD: 7 (0-30) vs 4 (0-22), P<0.001; CB: 3 (0-11) vs 1 (0-12), P=0.003; CDCB: 
2 (0-6) vs 1 (0-8), P=0.004 respectively). As demonstrated in Figure 4, the incidence of both 
CD and CB lines ≥6 mm was higher in patients with AF compared to patients without AF (CD: 
69% (N=34) vs. 49% (N=108), P=0.011; CB: 59% (N=29) vs. 42% (N=91), P=0.025 respectively). 
Maximum lengths of continuous CDCB lines in patients with AF ranged from 8 to 72 mm, 
whereas in patients without AF these lengths ranged from 4 to 42 mm; CDCB lines ≥16 mm 
occurred more often in patients with AF (N=20 (41%) versus N=50 (25%), P=0.027).
Table 1. Patient characteristics
Number of patients 268
Age (years) 67±11 (21–84)
Male 196 (73)
BMI (kg/m2) 28±5 (18-55)
Underlying heart disease N (%)
IHD 157 (59)
(i)VHD 111 (41)
Aortic valve stenosis 69 (26)
Aortic valve insufficiency 6 (2) 
Mitral valve insufficiency 36 (13) 
Left Atrial Dilation >45mm 58 (22)
History of AF 49 (18)
Paroxysmal 38 (14)
Persistent 11 (4) 
Left ventricular function
Normal 203 (76)
Mild dysfunction 52 (19)
Moderate dysfunction 11 (4)
Severe dysfunction 2 (1)
Antiarrhythmic drugs 197 (74)
Class I 2 (1)
Class II 183 (68)
Class III 12 (5)
Class IV 3 (1)
AF = atrial fibrillation; BMI = body mass index; IHD = ischemic heart disease; VHD = valvular heart disease; (i)
VHD = ischemic and valvular heart disease.
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Hence, the presence of AF episodes was strongly associated with increased heterogeneity 
in conduction, marked not only by a higher incidence of CB and CDCB, but also by a higher 
number of lines of CD, CB and CDCB and more importantly longer lines of CD, CB and 
CDCB. Thus, AF patients more often present with continuous lines of adjacent areas of CD 
and CB, whereas in patients without AF, lines of CD and CB are more often separated by 
areas with normal intra-atrial conduction. These findings were validated in an age (5 year 
range), BMI (2 kg/m2 range), gender and type of surgery matched case–control analysis 
(AF-No AF, 35-35). In addition, patients who developed de novo AF in the early postopera-
tive phase (N=70, 32% of patients without preoperative AF) showed a trend towards more 
CB lines (P=0.055), a higher number of continuous CDCB lines (P=0.030) at the PVA and a 
trend towards a higher incidence of long CB lines >6 mm (P=0.073).
Table 2. Analysis of risk factors for CD and CB maximum length in the upper 50th percentile
Univariate Analysis
CD CB
OR 95%CI P OR 95%CI P
Age (per year) 1.026 0.999-1.053 0.060 1.005 0.982-1.028 0.700
Male gender 0.602 0.339-1.067 0.082 0.961 0.547-1.688 0.891
(i)VHD 1.183 0.696-2.011 0.535 0.797 0.478-1.330 0.386
IHD 0.846 0.497-1.437 0.535 1.254 0.752-2.093 0.386
LA dilation 1.347 0.725-2.503 0.346 0.702 0.373-1.319 0.271
LVF (compared to normal function)
mild dysfunction 1.390 0.726-2.659 0.320 1.162 0.620-2.179 0.640
moderate dysfunction 1.500 0.423-5.322 0.530 0.697 0.179-2.711 0.603
severe dysfunction 2.625 0.161-42.69 0.498 1.859 0.115-30.17 0.663
AF history 2.082 1.097-3.950 0.025 1.630 0.869-3.057 0.128
Multivariate Analysis
Age (per year) 1.020 0.993-1.048 0.139
Male gender
(i)VHD
IHD 1.370 0.792-2.370 0.260
LA dilation 0.670 0.347-1.292 0.232




AF history 1.872 0.971-3.609 0.061 1.967 1.005-3.851 0.048
Hosmer and Lemeshow 0.808 0.778
AF = atrial fibrillation; CB = conduction block; CD = conduction delay; CI = confidence interval; IHD = isch-
emic heart disease; LA = left atrial; LVF = left ventricular function; OR = odds ratio; VHD = valvular heart 
disease; (i)VHD = ischemic and valvular heart disease.
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Severity of conduction abnormalities versus clinical atrial fibrillation 
classification
Figure 5 provides typical examples of PVA activation combined with corresponding CD and 
CB maps obtained from 2 patients with paroxysmal AF and 2 patients with persistent AF; 
the amount of conduction abnormalities in the one patient with paroxysmal AF is even 
higher than in the patient with persistent AF. Figure 5 shows that there is a large inter-
individual variation in the amount of conduction abnormalities in both the paroxysmal 
and persistent AF group. There is also no difference between patients with paroxysmal 
AF and persistent AF in the number of CD, CB, CDCB lines (P=0.442, P=0.535 and P=0.951). 
Also, incidences of CD, CB and CDCB were similar (P=0.204, P=0.835 and P=0.708); nor 
could ROC-curve analyses identify a cut-off value for the length of lines distinguishing 
patients with persistent AF from paroxysmal AF. Duration of AF history was similar for 
patients with paroxysmal and persistent AF (P=0.429). Hence, although this is only a small 
group of patients, the overlap in severity of conduction abnormalities suggests that sever-
ity of conduction abnormalities at the PVA does not seem to clearly discriminate patients 
with paroxysmal AF from patients with persistent AF.
Figure 2. Characteristics of conduction delay and block.
Activation maps showing the typical difference between lines of conduction delay (blue lines) and lines of 
conduction block (red lines): lines of conduction block occur less frequently, yet extent over longer lengths. 
A turning point was observed at a length of 8 mm, as displayed in the lower panel. CD, conduction delay; 
CB, conduction block. Color-classes per 10 ms.
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Figure 3. Longitudinal line of conduction delay/ block between the right and left pulmonary veins.
Typical examples of activation maps with a line of CD (blue lines), CB (red lines) or CDCB running down-
wards between the right and left pulmonary veins, varying in its continuity. Corresponding isochrone maps 
(per 5 ms) and CD/CB maps are shown next to the activation maps. Arrows indicate the main wave trajec-
tory; local activation times are provided next to the arrows. Lightning bolts indicate areas of simultaneous 
activation. Color-classes per 10 ms.
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Figure 4. Differences in electropathology between patients without and with atrial fibrillation.
Top: Typical examples of activation maps of a patient without AF and a patient with AF. Patients with AF 
show more electropathology at the PVA, as displayed in the middle and bottom panels. AF patients par-
ticularly show a higher incidence of CB and continuous CDCB, a higher number of CD, CB and CDCB lines 
per patients and also longer lengths of CD (blue lines), CB (red lines) and CDCB lines. AF, atrial fibrillation; 
CD, conduction delay; CB, conduction block; CDCB, continuous conduction delay and block. Color-classes 
per 10 ms.
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Figure 5. Overlap in electropathology between paroxysmal and persistent atrial fibrillation.
The top left panel shows activation maps of an IHD and VHD patient with paroxysmal AF both diagnosed 3 
months prior to surgery. Corresponding CD/CB maps (CD: blue lines, CB: red lines) show a relatively small 
amount of CD/CB in the first patient, whereas the second patient has a large amount of CD/CB. The top right 
panel shows activation maps of patients with persistent AF. Both patients underwent mitral valve surgery 
and were diagnosed with persistent AF respectively 3 and 6 months prior to surgery; both patients under-
went electrocardioversion to SR prior to mapping. In this case also the one patient has a relatively small 
amount of electropathology, whereas the other patient has a large amount of CD/CB. Hence, a considerable 
overlap in the amount of conduction disorders is observed between paroxysmal and persistent AF, which is 
also quantified in the bottom panel showing the number of lines per patient and the distribution of lengths 





Intraoperative high-resolution epicardial mapping of the PVA during SR for the first time 
quantified and characterized different types of conduction abnormalities and related it 
to the presence of AF episodes. Current data demonstrated that patients with AF have 
more and longer lines of CD, CB and continuous CDCB whereas in patients without AF, 
short lines (<6 mm) of CD and CB separately are more diffusely present. Furthermore, the 
severity of conduction abnormalities at the PVA during SR does not discriminate between 
patients with paroxysmal and persistent AF.
Conduction abnormalities at the pulmonary vein area
To our best knowledge, only 3 previous studies have investigated conduction abnor-
malities at the posterior wall of the LA in humans during SR. In an endocardial noncontact 
mapping study by Markides et al., conduction at the LA was analyzed during SR in 19 
patients with a history of paroxysmal AF.10 They observed a vertical line of conduction 
block (interelectrode time interval 30 ms) extending from the LA roof across the posterior 
LA wall turning septally below the ostium of the right inferior pulmonary vein proceeding 
anteriorly towards the septal mitral annulus.10 This CB line was present in all patients, 
though varied in its continuity, particularly during pacing from different sites.10 In a minor-
ity of patients, the CB line disappeared completely during pacing.10 Based on histological 
findings in postmortem hearts they suggested that the line of CB was caused by an abrupt 
change in myocardial fiber orientation at the subendocardium.10
Roberts-Thomson et al. performed epicardial mapping during SR in 34 patients without 
AF.11 They observed a similar line of functional CD, defined as a conduction velocity be-
tween 10-20 cm/s, running vertically across the PVA, though only occurring in a minority of 
5 patients.11 In contrast to the findings of Markides et al., during pacing from superior and 
inferior positions at the PVA the line of CD now appeared in all patients.11 In a subsequent 
study, epicardial SR mapping after electrocardioversion in 16 patients without AF and 
5 patients with persistent AF showed a similar vertical CD line in 2 patients without AF, 
whereas this was observed in 4 of the AF patients.12 However, when pacing from different 
sites, the CD line again appeared in all patients without AF and the number of CD lines 
increased in patients with AF to a maximum of 3 vertical lines running parallel to each 
other across the PVA.12 Though the findings of Markides et al. and Roberts-Thomson et 
al. appear to contradict each other, it may be concluded that this line of CD was more 
evident in AF patients and was, at least in part, functional, as it varied during different 
pacing conditions. Moreover, besides the vertical line of abnormal conduction, no other 
CD/CB lines were observed in these studies.
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In contrast to these previous studies, we observed conduction abnormalities scattered 
across the PVA with no clear predilection site. Lines of CD occurred in almost all patients and 
CB in approximately seventy percent of the population. The fact that the aforementioned 
studies did not observe any other lines of CD or CB at the PVA is remarkable, especially 
since study populations consisted of IHD patients, AF patients and patients with LA dila-
tion due to mitral regurgitation. In all these patients, areas of fibrosis would be expected, 
particularly at the LA posterior wall. Our CB criteria correspond with a conduction velocity 
<17 cm/s, which is in the range of the CD criteria of Roberts-Thomson et al. Therefore, 
although our cut-off criteria are slightly more sensitive, the higher incidence of CD/CB 
cannot be totally explained by differences in cut-off values. Yet, the higher resolution of 
the mapping system used in current study may be the explanation for this discrepancy, 
as it contains the unique ability to identify lines of CD and CB with a minimum length of 
2 mm. Furthermore, we did not set a minimum length or wavefront propagation criterion 
for lines of CD and CB, as opposed to previous studies. In our cohort, only a minority of 
patients showed a longitudinal line running downwards between the left and right pulmo-
nary veins, which might be similar to the line observed in previous studies. However, this 
line varied in length and continuity and practically never consisted of a line of CB running 
continuously from the superior to the inferior of the posterior wall. The precise nature of 
this line, so far, remains unclear. If, as suggested by previous studies, a histological change 
in fiber direction would be the underlying cause, we would expect it to occur in the major-
ity of patients during SR.
Conduction abnormalities and atrial fibrillation
In correspondence to previous studies, increased amounts of CD, CB and CDCB at the 
PVA were observed in AF patients. In AF patients, a higher incidence of CB, continuous 
CDCB and an almost two-fold number of separate CD, CB and CDCB lines per patient was 
observed. Also, CD, CB and CDCB lines extended over larger areas. These observations 
suggest a critical role for the spatial distribution of conduction abnormalities in AF devel-
opment. A certain length of an area of abnormal conduction is required for re-entry to oc-
cur; this phenomenon was first demonstrated by Ortiz et al. in 7 canine hearts with sterile 
pericarditis.17 In this study, the critical role of the length of an area of functional block in 
the right atrial free wall was observed. In case of stable atrial flutter, a functional CB line 
of 24 mm was observed, enabling re-entry to occur.17 When the cycle length decreased, 
areas of slow conduction disappeared, resulting in a shorter line of functional CB with a 
mean length of 16 mm.17 This resulted in unstable re-entrant circuits migrating across the 
atrial wall, giving rise to AF.17 When the atrial wall already contains continuous long lines of 
structural CD and CB, it is likely more vulnerable to re-entry circuits to occur or for areas of 
functional block to connect, thereby reaching the critical length for AF initiation.
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The future of atrial fibrillation therapy
Despite the fact that conduction abnormalities are more profound in patients with AF, the 
clinical categories of AF do not correspond with the amount of conduction disorders at the 
PVA during SR. In a previous study, we demonstrated a considerable intra-atrial variation 
in the distribution of conduction disorders across the right and left atrium, indicating that 
a low amount of CB at the PVA does not necessarily implicate a low amount of CB at other 
atrial regions.18 Hence, either the arrhythmogenic substrate underlying AF is not located 
at the PVA in these patients or, although CD and CB measured during SR are indicators 
of structural conduction abnormalities, functional conduction disorders may only be re-
vealed during triggers or AF. To date, ablative treatment strategies for AF focus primarily on 
isolation of the pulmonary veins. However, recurrence rates remain unsatisfactory. Recent 
studies have shown the complex and heterogeneous etiology of fractionated potentials, 
providing a possible explanation of the low success rate of ablative therapy targeting these 
complex fractionated potentials.19
Furthermore, recent studies have revealed that, aside from well-known effects of in-
creased renin-angiotensin-system activation, cardiac endothelin-1 levels may also play 
an in important role in AF pathogenesis.20 Endothelin-1 expression, promoting myocyte 
hypertrophy and interstitial fibrosis, was increased during AF compared to SR.20 Particu-
larly, endothelin-1 levels were higher at the LA and in patients with VHD, leading to the 
presumption this may play a substantial role in the vulnerability of these patients for AF 
development.20 Also, increased endothelin-1 levels are regarded as an important factor in 
AF persistence. As endothelin-1 production is stretch mediated, atrial regions subjected 
to greater wall stress may also produce higher levels of endothelin-1, thereby leading to a 
regional differences in conduction abnormalities.20
Limitations
Whether general anesthesia influences conduction is yet to be investigated; however, as a 
standard anesthetic protocol was used for all patients, equal dispersion of possible effects 
can be assumed. The number of AF patients was relatively small; thereby, when comparing 
patients with persistent and paroxysmal AF, conclusions should be drawn cautiously. In 
addition, although LGE-MRI is a feasible technique to detect cardiac fibrosis, it was logisti-
cally and financially not possible to perform LGE-MRI prior to surgery in these patients.
CONCLUSION
Intraoperative high-resolution epicardial mapping of the PVA during SR for the first time 
quantified and characterized different types of conduction abnormalities and dem-
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onstrated that presence of AF episodes is associated with continuous lines of adjacent 
areas of CD and CB, whereas in patients without AF, lines of CD and CB are shorter and 
more often separated by areas with normal intra-atrial conduction. AF patients showed a 
two-fold number of CD, CB and CDCB lines per patient, which also extended over longer 
lengths. This study demonstrated a considerable overlap in the amount of conduction 
abnormalities at the PVA between patients with a history of paroxysmal and persistent 
AF. Studies quantifying of the extensiveness of electropathology by various parameters, 
including conduction abnormalities, may contribute to the future development of a more 
accurate risk estimation of recurrent AF after ablative therapy and will thereby enable 
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SUPPLEMENTAL MATERIAL CHAPTER 8
Supplemental Figure 1. Identification of conduction abnormalities.
From left to right, first a sample of potentials recorded simultaneously from the first 2 rows of electrodes on 
the electrode array at the left PVA is shown. The surface electrogram and the atrial reference electrogram 
are recorded on electrode 1 and 8 respectively. The steepest negative slope is annotated by a red marking 
and indicates the local activation time. Note the clear difference in the position of the red marking between 
electrode 2 and 3 and between electrode 10 and 11. Following, the conduction delay and block map is 
shown, in which the line of conduction block between electrodes 2 and 3 and between electrodes 10 and 
11 is visualized by a red line, which is also identifiable by the shift in color-class (per 10 ms) in the activation 
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Background: The presence of focal fibrillation waves during atrial fibrillation (AF) can, 
beside ectopic activity, also be explained by asynchronous activation of the atrial endo- 
and epicardial layer and transmurally propagating fibrillation waves. In order to provide 
direct proof of endo-epicardial asynchrony, we performed simultaneous high-resolution 
mapping of the right atrial endo- and epicardial wall during AF in humans.
Methods: Intraoperative mapping of the endo- and epicardial right atrial wall was 
performed during (induced) AF in 10 patients with AF (paroxysmal: N=3, persistent: N=4, 
longstanding persistent: N=3) and 4 patients without a history of AF. A clamp made of two 
rectangular 8x16 electrode arrays (interelectrode distance 2 mm) was inserted into the 
incision in the right atrial appendage. Recordings of 10 seconds of AF were analyzed to 
determine the incidence of asynchronous endo-epicardial activation times (≥15 ms) of 
opposite electrodes.
Results: Asynchronous endo-epicardial activation ranged between 0.9-55.9% without 
preference for either side. Focal waves appeared equally frequent at endocardium and 
epicardium (11% vs 13%, P=0.18). Using strict criteria for breakthrough (presence of an 
opposite wave within 4 mm and ≤14 ms before the origin of the focal wave), the majority 
(65%) of all focal fibrillation waves could be attributed to endo-epicardial excitation.
Conclusions: We provided the first evidence for asynchronous activation of the endo-
epicardial wall during AF in humans. Endo-epicardial asynchrony may play a major role 
in the pathophysiology of AF and may offer an explanation why in some patients therapy 
fails.
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INTRODUCTION
Epicardial high density mapping in patients with AF and valvular heart disease has dem-
onstrated that a considerable portion of fibrillation waves showed a focal spread of activa-
tion.1 These focal waves were rarely repetitive and mainly appeared as solitary events. 
They could occur virtually everywhere in the atria and their coupling interval was often 
longer than the dominant AF cycle length. In addition, unipolar electrograms recorded 
at the origin of focal waves, exhibited small R-waves. Based on this indirect evidence, 
it was postulated that fibrillation waves with a focal pattern of activation could result 
from endo-epicardial breakthrough (EEB).1 Since EEBs can only occur in the presence of 
electrical asynchrony between the endo- and epicardial layer, we hypothesized that the 
substrate of AF consists of layers of dissociated fibrillation waves that constantly ‘feed’ 
each other.1 In order to demonstrate that endo-epicardial asynchrony (EEA) exists during 
AF, we performed simultaneous high-resolution, mapping of the endo- and epicardial wall 
of the right atrium in patients with or without a history of AF undergoing cardiac surgery 
for coronary artery disease and/or valvular heart disease.
METHODS
Study population
The study sample consisted of 14 patients (10 male, 67±8.3 years) without a history of AF 
(N=4) and with a history of AF (N=10). Surgical procedures that were performed included 
cardiac coronary bypass surgery (N=9), mitral valve surgery (N=7), aortic valve replacement 
(N=2) and tricuspid valve surgery (N=4). Three patients had paroxysmal AF, 4 persistent AF 
and 3 had persistent AF lasting longer than a year (LSPAF). Atrial enlargement was present 
in 5 patients. Clinical characteristics of the study population are provided in Table 1.
The mapping protocol was approved by the institutional ethical committee (MEC2010-
054) and written informed consent was obtained from all patients prior to the surgical 
procedure. This study adhered to the declaration of Helsinki principles.
Intraoperative mapping procedure
The mapping study was performed immediately after sternotomy. Following hepariniza-
tion and arterial cannulation, a temporary bipolar epicardial pacemaker wire was stitched 
to the right atrial free wall and served as a temporal reference electrode. The indifferent 
electrode consisted of a steel wire fixed to subcutaneous tissue of the thoracic cavity. If 
patients were in sinus rhythm at the onset of the mapping procedure, AF was induced by 
fixed rate pacing at the right atrial free wall using an additional temporary bipolar pacing 
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wire. The induction protocol started at a rate of 200 beats per minute (bpm). If induction 
was not successful after 3 burst attempts, the rate was increased by 50 bpm, up to maximal 
400 bpm until AF occurred or atrial refractoriness was reached.
Prior to commencement to extra-corporal circulation, a high-resolution endo-epicardial 
mapping clamp was introduced through the right atrial incision for the venous cannula and 
closed with a purse-string suture. The mapping device was positioned towards the crista 
terminalis and consisted of two identical rectangular electrode arrays of 8x16 electrodes 
(interelectrode distance 2 mm) positioned opposite to each other (Figure 1). The electrode 
arrays (GS Swiss PCB AG, Küssnacht, Switzerland) consist of an electroless nickel immersion 
gold (ENIG) plated electrode array, mounted on a thin, flexible DuPont™ Pyralux® copper-
clad (25 μm thickness) polyimide laminate, and coverlay composite (25 μm) film (0.18 mm). 
As the space constant of the atrial myocardium is ≈2 mm, the effective spatial resolution of 
2.0 mm makes it unlikely that narrow fibrillation wavefronts will not be detected.2
All recordings were amplified (gain 1000), filtered (bandwidth 0.5-400 Hz), sampled (1 KHz) 
and analogue to digital converted (16 bits). A calibration signal of 2 mV amplitude and 1000 
ms pulse width was stored simultaneously with atrial electrograms on hard disk using a 
computerized mapping system. After completion of the mapping procedure, AF was termi-
nated by electrical cardioversion or sustained until cardioplegia was conducted, depend-
ing on the operators’ preference. Ten seconds of AF were recorded from every patient.
Table 1. Clinical characteristics
ID no. Age (y) Gender History of AF Cardiac surgery LVF Atrial dimension
1 65 M No AF CABG good normal
2 56 M Persistent MVP+TVP good normal
3 82 M No AF CABG good normal
4 53 M Persistent CABG poor RA enlargement
5 66 M Persistent MVP+AVR moderate LA+RA enlargement
6 80 M Paroxysmal CABG+MVP good normal
7 63 F No AF CABG good normal
8 67 M No AF CABG good normal
9 75 F LSPAF MVP+TVP good LA+RA enlargement
10 59 M Persistent CABG moderate normal
11 64 F LSPAF MVP+TVP good LA enlargement
12 64 M Paroxysmal CABG+AVR good normal
13 70 F LSPAF MVP+TVP good LA+RA enlargement
14 71 M Paroxysmal CABG+MVP moderate normal
M = male; F = female; AF = atrial fibrillation; LSPAF = longstanding persistent atrial fibrillation; CABG = coro-
nary artery bypass grafting; MVP/R = mitral valve plasty/ replacement; TVP = tricuspid valve plasty; AVR = 
aortic valve replacement; LVF = left ventricular function; RA = right atrium; LA = left atrium.
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Mapping data
Series of endo- and epicardial wavemaps of 10 seconds AF were reconstructed from the 
two sets of 128 unipolar fibrillation electrograms, using custom-made software which has 
been previously described in detail.1,3 For every electrode, local activation times were 
determined by marking the steepest negative deflection of the unipolar fibrillation elec-
trograms. In case of a fractionated potential, the steepest negative deflection was chosen. 
At every electrode at either the endo- or epicardial layer, differences in endo-epicardial 
activation times were determined by measuring the smallest time delay within the op-
posite square base of 3x3 electrodes (Figure 2). The total amount of EEA during the entire 
recording period was expressed as the percentage of transmural differences of ≥15 ms for 
all endo- and epicardial recording sites. The combined asynchrony map (lower right panel 
of Figure 2) shows the longest time delay for every endo-epicardial electrode couple.
Wavemapping was used to identify the individual fibrillation waves. The starting point of 
the first fibrillation waves was the earliest activated site within the mapping area. Next, the 
entire mapping area was scanned in steps of 1 ms. For all electrodes activated during every 
step, the shortest time difference with the 8 neighboring electrodes was calculated. When 
the time difference was ≤12 ms (17 ms for oblique distances), the electrode site was added 
Figure 1. Endo-epicardial mapping device and technique.
The mapping device consists of two rectangular 8x16 electrode arrays with an interelectrode distance (IED) 
of 2 mm fixed to spatulas and positioned precisely opposite to each other. During endo-epicardial map-
ping, the endocardial leg is inserted in the right atrium (RA) through the incision of the venous cannula and 




to the territory of the surrounding wave. In case of a time difference >12 ms, the electrode 
was annotated as the starting point of a new wave. In the wavemap, fibrillation waves are 
color-coded according to their moment of entrance in the mapping area and the colors 
demarcate the area activated by that specific fibrillation wave.4 Wavemaps also identify 
focal waves at either the endo- or epicardial surface. Focal fibrillation waves had to meet 
previously defined criteria. The breakthrough site of the focal fibrillation wave had to be 
located at least 2 electrodes away from the border of the mapping array and at least 1 reli-
able activation time should be available between the breakthrough site and the border of 
the mapping area. The morphology of the electrograms in the breakthrough region should 
not be distorted by large QRS complexes or artifacts. If this is the case, the wave is excluded 
from analysis. The focal wave should at least cover 4 electrodes. The origin of a focal wave 
Figure 2. Construction of activation, wave and asynchrony maps.
Activation times determined at each individual electrode of endocardial and epicardial arrays are depicted 
in color-coded activation maps starting at the time of first activation. Wavemaps are automatically con-
structed which demonstrate the number and sequence of appearance of different waves activating the 
mapping area and also illustrate the origin of focal waves beginning within the mapping area (white star). 
Isochrones are set with intervals of 5 ms and indicate the main trajectory of each wave (black/white ar-
rows). Thick black lines indicate conduction block (∆≥12 ms). The asynchrony map of either the endocar-
dial or epicardial layer consists of the endo-epicardial activation times defined by the smallest interval of 
the opposite nine activation times; the total asynchrony map shows the longest time delay assessed at 
every coupled recording site.
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had to be activated earlier than all surrounding electrodes. If electrodes adjacent to the 
origin were activated simultaneously, all electrodes surrounding this area should also be 
activated later. Shift of the local activation time to a maximum of 3 ms earlier or later at 
the earliest activated electrode(s) should not result in disappearance of the focal wave. If 
a breakthrough site emerged along the border of another fibrillation wave, the time delay 
between that wave and the origin of the breakthrough had to be at least 40 ms.1 All these 
criteria were checked manually by 2 independent investigators. A more detailed descrip-
tion of the mapping criteria with examples is provided in the supplemental material.
Figure 3. Endo-epicardial asynchrony in a patient with longstanding persistent atrial fibrillation.
The maps represent a single AF-cycle of 190 ms. The left and right panels show simultaneous wavemaps of 
the sub-epicardium and sub-endocardium of a part of the free wall of the right atrium (3.0 x 1.4 cm). The 
colors indicate the sequence of appearance of the different fibrillation waves (rainbow scheme followed 
by a grayscale). The arrows indicate the main trajectories of the waves. The sub-epicardium of the right 
atrium was activated by 7 narrow fibrillation waves, entering the mapping area from various directions. The 
endocardium was activated by 9 waves, 3 of them arising as focal waves in the middle of the mapping area 
(white stars). The local endo-epicardial time-differences are plotted in the central map. As a result of the 
different activation patterns at the endocardial and epicardial surface, major differences in endo-epicardial 
activation times existed (up to >50 ms). There was considerable spatial dispersion in EEA, with differences 
in endo- and epicardial activation times ranging from 0 to >50 ms. The 3 electrogram-pairs at the bottom, 
clearly show the marked differences in endocardial and epicardial activation times. Sometimes the epicar-
dium was activated earlier (left panel), sometimes the endocardium (middle and right panels).
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To assess whether focal fibrillation waves could originate from endo-epicardial break-
through, in each case the opposite layer was examined for the presence of a fibrillation 
wave that could have served as a source for the focal wave. The presence of an opposite 
wavefront, within 4 mm distance and less than 15 ms before the origin of the focal wave, 
was considered to reflect transmural conduction based on normal atrial conduction prop-
erties. In this case, the focal wave could from a theoretically point of view be attributed to 
endo-epicardial breakthrough.
Statistical analysis
The Wilcoxon signed rank test was performed to assess the occurrence of EEA and focal 
waves between the epi- and endocardium.
Figure 4. Spatial and temporal variation in endo-epicardial asynchrony during longstanding persistent AF.
Endo-epicardial asynchrony plots of 10 seconds of AF, recorded at 3 different locations of the right atrial 
free wall in a patient with AF. The dashed horizontal lines demarcate the band of endo-epicardial synchro-
ny; data points > ±50 ms are clipped. At different sites, the degree of EEA (delay ≥15 ms) varied from 5% 
(top panel), 31% (middle) and 50% (bottom). In addition to spatial dispersion, EEA also showed a strong 
temporal variation. As can be seen from the middle and lower plots, differences in endo-epicardial activa-
tion time seemed to occur randomly, without a clear predominance of either the sub-endocardial or sub-
epicardial layer. Examples of pairs of unipolar endocardial and epicardial electrograms demonstrating the 
spatial temporal variation are given around the plots.
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In the entire study population, the average percentage of missing data due to poor contact 
of the mapping array was 7.8±4.9%. The amount of conduction block was similar in the epi-
cardial and endocardial plane with incidences of respectively 10.8±5.1% and 10.8±4.6%. 
Simultaneous epi- and endocardial wavemaps of a single AF-cycle recorded in a patient 
with longstanding persistent AF demonstrating EEA are shown in Figure 3. In this example, 
marked differences in activation patterns of the endo- and epicardial wall existed; almost 
all fibrillation waves at the endo- and epicardial surface appeared at different times and/
or propagated in different directions.
Figure 5. Endo-epicardial asynchrony levels and focal waves.
A: Graph demonstrating the total amount of EEA plotted for every patient separately; patients are ranked 
according to the degree of EEA. Type of AF (none, paroxysmal, persistent, longstanding persistent) is illus-
trated by the different grayscale tones. B and C: Dot plots and medians of (b) the incidence of asynchrony 
where endocardium versus epicardium is activated earlier in respect to the other and (c) the percentage of 
focal waves (of total number of waves) recorded at the endocardium and epicardium. For both parameters, 
there was no difference between the endocardial and epicardial layer (P=0.51 and P=0.18).
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In this same patient, the spatio-temporal variation in EEA during 10 seconds of AF is dem-
onstrated in Figure 4. The degree of EEA varied considerably at different locations and at 
different times. No clear predominance of either the endocardial or the epicardial layer 
was observed. Examples of unipolar electrogram-pairs around the plots illustrate the high 
spatio-temporal variation in EEA.
As demonstrated in Figure 5, the total degree of EEA in our study population varied widely 
between 0.9 and 55.9% and there was no clear difference between endo-epicardial and 
epi-endocardial asynchrony (respectively 7.8±7.7% and 7.2±7.2%).
Focal fibrillation waves
In total 1199 focal fibrillation waves were observed, 579 arising at the sub-endocardium 
and 620 at the sub-epicardium. The equal distribution of focal fibrillation waves between 
both sides is shown in panel C of Figure 5. Applying the previously stated strict criteria for 
endo-epicardial breakthrough, 784 of all 1199 focal waves (65%) could be attributed to 
result from endo-epicardial excitation presuming that normal conduction occurs between 
Figure 6. Three examples of endo-epicardial breakthroughs in a patient with longstanding persistent AF.
A: A focal wave appeared at the epicardial surface at t=24 (white star). As can be seen from the associ-
ated endocardial wavemap, just a couple of milliseconds before an endocardial fibrillation wave (red) had 
passed that site at t=16 ms. A transmural conduction time of only 8 ms was taken as supportive evidence 
that the focal wave could be due to endo-epicardial breakthrough. B: An example of a focal wave arising 
at the endocardium at t=46. Again a fibrillation wave in the opposed layer (green) had passed that site just 
5 ms before (at t=41). C: Two breakthroughs occurred at about the same time, one at the endocardium at 
t=66 and one at the epicardium at t=73 ms. In both cases, in the opposite layer a fibrillation wave passing 
the site of origin of the focal waves a few ms earlier at respectively t=64 and t=69, indicating that the focal 
waves could result from endo-epicardial breakthrough.
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endo-epicardium (66% of the endocardial and 65% of the epicardial focal waves) (Table 2). 
Examples of pairs of endo-epicardial wavemaps showing focal fibrillation waves originat-
ing from EEB of fibrillation waves from the opposite layer are given in Figure 6.
DISCUSSION
Despite the relatively small number of patients, our data clearly show that a significant de-
gree of EEA is present in the right atrium in patients with AF. Simultaneous endo-epicardial 
mapping of isolated canine atria, both during sinus rhythm and atrial pacing, only showed 
small differences in activation times (<1 ms). However, during atrial tachyarrhythmias, ac-
tivation of the endo- and epicardial layers has been shown to become more asynchronous 
(up to 25 ms), particularly in the thicker parts of the atria.5,6 In isolated fibrillating sheep 
atria, breakthrough sites appeared to be related to sub-endocardial muscle structures, 
the three-dimensional structure of the atria determining the appearance of focal waves 
during AF.7 The concept that endo-epicardial dissociation might play an important role in 
the maintenance of AF, stems from experimental studies in the goat model of persistent 
AF.8-10 These studies showed that the endo- and epicardial layers of the atrial wall became 
progressively dissociated during the first 6 months of AF. After that time, fibrillation waves 
in the endo- and epicardial layers often propagated at different speed and in different 
directions, and endo-epicardial breakthroughs became more abundant.8,9
In this study, the incidence of endo-epicardial asynchrony tended to be higher in patients 
with AF, though we did not observe a clear relation between duration of AF and degree of 
EEA. This can be explained by the fact that we did not map the left atrium and that if EEA 
of the left atrial wall also exists, it may play a more important role in the pathophysiology 
of AF. Also, our study population contained a small number of patients with a variety of 
cardiac diseases.
We provided additional data that most focal fibrillation waves could be explained by endo-
epicardial excitation. Lee et al. also frequently observed focal fibrillation waves without 
any sustained focal activity in 18 patients with persistent AF.11 In contrast, low-density 
mapping studies using a 64-pole basket catheter, have suggested that AF is maintained 
by a limited number of rapid stable sources (rotors and/or ectopic foci).12,13 Body surface 
mapping during AF elucidated the presence of non-sustained re-entries and focal break-
throughs in certain domains of the atria.14 Recently, we have discussed the discrepancies 
in the interpretation of high- and low-resolution mapping of AF in detail in a crosstalk 
paper.15,16 The present study supports the concept that during AF, the endo- and epicardial 
layers of the atrial wall can be asynchronously activated.1,16 The presence of dissociated 
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layers of fibrillation waves, will highly stabilize the fibrillatory process because, as soon as 
fibrillation waves die out, they can be replaced by breakthroughs from the opposite side.
In such a substrate, each layer will serve as a multi-site generator for the other layer. 
During 10 seconds of AF, more than 20-30 focal waves appeared at each side of the atrial 
wall, in an area of only 2.6 cm.1 Extrapolating this number to the entire atrial surface, the 
total number of focal breakthrough waves can be estimated to exceed 10.000 per minute. 
However, we like to emphasize that the presence of EEA, off course does not disprove that 
also re-entry and focal activity may contribute to the maintenance of AF. In different stages 
of the development of a substrate of AF, the contribution of different mechanisms for per-
petuation of AF may vary. We fully acknowledge the large body of evidence that re-entrant 
and focal mechanisms are operative during atrial fibrillation.17-20 In fact, not all focal fibril-
lation waves in our patients could be attributed to endo-epicardial breakthrough, and 
sometimes two focal waves appeared simultaneously at the endo- and epicardial surface. 
Equally, our data do not rule out the possibility that some of the endo-epicardial break-
throughs formed part of a transmural re-entrant circuit. However, we venture to suggest 
that progressive, AF induced, structural atrial remodeling gradually transforms the atrial 
wall into multiple layers of narrow dissociated wavelets. With time, more and more focal 
breakthroughs will be generated, which progressively stabilizes the fibrillatory process. At 
the end, the main source of fibrillation waves is formed by an abundant number of focal 
breakthroughs, occurring virtually everywhere in the atria. This is in agreement with the 
recent finding of Haïssaguerre et al., that the number of driver regions increased with the 
duration of AF, until after 6 months almost the entire atrial wall acted as a driver (6 of 
all 7 regions).14 It also explains why the termination rate of AF by driver ablation sharply 
declined after 6 months of AF.14
Study limitations
Our study population is presently limited to 14 patients and a larger number of patients is 
obviously required for a meaningful statistical analysis and to study the relation between 
persistence of AF and the degree of electrical asynchrony. Expanding the study population 
will also allow for statements about a possible correlation between EEA and breakthroughs. 
Moreover, the effective spatial resolution of the recordings is dependent on the number of 
electrodes with good tissue contact. Another limitation is, that so far, only a limited part 
of the atria has been accessible for endo-epicardial mapping (4.2 cm2 of the right atrium). 
In order to get a full understanding of the role of EEA in the development of the substrate 
of AF, endo-epicardial mapping of the left atrium is needed as well. However, the left 
atrium is not standardly opened during cardiac surgery, only during selected procedures. 
In addition, opening the left atrium before cardiopulmonary bypass is associated with a 
considerable increase in the risk for air embolism which may cause brain injury. Therefore, 
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we decided it was not ethically responsible to perform endo-epicardial mapping of the left 
atrium for this pilot study.
Clinical implications
Knowledge of the substrate and various mechanisms of perpetuation of human AF is of 
great importance to understand the natural history of AF. At different stages, the substrate 
of AF may require different treatment modalities. At an early stage pulmonary vein 
isolation alone might be sufficient, whereas in a later stage also compartmentalization 
of the atria will be necessary to restore sinus rhythm. Furthermore, when the endo- and 
epicardial layers of the atria have become electrically dissociated, even extensive ablative 
therapies may be ineffective and palliative therapy would be a better option. Knowledge 
of the vulnerable parameter(s) for perpetuation of AF, and the ability to diagnose the 
stage of development of the substrate of AF, are essential for an individualized and staged 
therapy of atrial fibrillation.
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SUPPLEMENTAL MATERIAL CHAPTER 9: MAPPING CRITERIA
Step I. Subtraction of ventricular complexes
Before determination of the local activation time, ventricular complexes were eliminated 
from the unipolar electrograms using a subtracting technique as previously described in 
detail by Hoekstra et al.1 In short, for each fibrillation electrogram an individual template 
of the ventricular far field was obtained by averaging all time windows of ±70 ms around 
the R-waves detected from surface ECG lead I. Subtraction of these individual QRS tem-
plates from the fibrillation electrograms reduces the ventricular far field potentials and 
results in a more or less ‘clean’ unipolar atrial fibrillation electrograms.
Step II. Determination of the local activation time
Examples of electrograms recorded from both the endo- and epicardium showing endo-
epicardial (a)synchrony are demonstrated in Supplemental Figure 1.
Local activation times were determined by detecting the maximum downslope of the 
unipolar fibrillation potential, as this coincides with the moment of maximum rate of rise 
of the transmembrane potential (time differences less than 50 μs).2 In turn, the maximum 
rate of rise of the transmembrane potential corresponds with the maximum increase in 
sodium current and its conductance.3 The height of the negative slope is measured dur-
ing a 2 ms period. From the moment of the maximum downslope, time windows both 
backward and forward in time are scanned to detect the moment of respectively the 
positive and negative peak of the fibrillation potential. The duration of a non-fractionated 
potential is then defined as the time difference between the moment of its negative and 
positive peak. In case of a fractionated potential, the deflection with the steepest down 
slope was chosen; its duration is defined as the time between the preceding positive and 
following negative deflection.4 The duration of a fibrillation potential had to be ≤35 ms. 
The negative slope and amplitude of the unipolar fibrillation potentials depend on numer-
ous variables.5,6 Hence, cut-off values applied also vary, depending on the signal-to-noise 
ratios of the recordings and lower limits were set at 0.05 V/sec and 0.2 mV.5,6,7,8 All fibrilla-
tion potentials with slopes <0.05 V/sec, amplitudes < 0.2 mV and durations >35 ms are thus 
regarded as either far field or poor contact potentials.
After detection of the local activation time, a blanking period of 40 ms was applied in 
both directions. Though we do not know exactly what the refractory period during AF is, 
it is estimated to be approximately 50±13 ms.9 Hence, comparable to previous studies, by 
choosing a blanking period of 40 ms we avoid overestimation of the number of fibrillation 
waves by marking fibrillation potentials, which are most likely double potentials with 




A wavemapping approach was used to identify individual fibrillation waves. This wave-
mapping technique has also been described in prior studies.2,3,12,13 The starting point of 
the first fibrillation waves was the earliest activated site within the mapping area. Next, 
the entire mapping area was scanned in steps of 1 ms. For all electrodes activated during 
every step, the shortest time difference with the 8 neighboring electrodes was calculated. 
When the time difference was ≤12 ms (17 ms for oblique distances), the electrode site was 
added to the territory of the surrounding wave. In case of a time difference >12 ms, the 
electrode was annotated as the starting point of a new wave. In the wavemap, fibrillation 
waves are color-coded according to their moment of entrance in the mapping area and the 
colors demarcate the area activated by that specific fibrillation wave. The cut-off value of 
>12ms used for separating individual fibrillation waves corresponds for 2 mm interelec-
trode distances with an effective conduction velocity of 17 cm/s, which is equivalent to 
the continuous conduction velocities reported for atrial myocardium of intact hearts.14 For 
separation of the fibrillation waves the requirement of a lower limit CV must be fulfilled 
along the whole boundary of the wave which off course does not exclude the possibil-
ity of slow conduction within parts of the fibrillation waves. Choosing a different cut-off 
value will lead to a lower or higher number of fibrillation waves. However, this change 
is very gradual and has no major effects on the measured differences in the number of 
focal waves. Only at extreme cut-off values our analysis will become useless because it 
either no longer separates the different fibrillation waves, or results in a very high degree 
of spatial fractionation, resembling a mosaic-like pattern of numerous small waves that 
only propagate over very short distances.
Based on the origin of the fibrillation wave, three different types of fibrillation waves were 
distinguished 1) peripheral waves, entering the mapping area from outside the electrode 
array, 2) epicardial breakthrough, appearing at the epicardial surface inside the mapping 
area, and 3) discontinuous conduction waves; defined as fibrillation waves starting with a 
delay of 13 to 40 ms from the boundary of another wave.12-13 If a fibrillation wave originates 
along the border of another fibrillation wave it could theoretically be the result of very 
slow conduction. In order to avoid overestimation of the number of focal waves, we clas-
sified these waves as discontinuous fibrillation waves. Applications of this wavemapping 
technology have been described previously.12-13
Focal fibrillation waves had to meet several criteria. The breakthrough site of the focal fi-
brillation wave had to be located at least 2 electrodes away from the border of the mapping 
array and at least 1 reliable activation time should be available between the breakthrough 
site and the border of the mapping area in order to exclude propagation from the border 
of the mapping array. An example is given in Supplemental Figure 2. The relation between 
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the percentage of endocardial or epicardial focal fibrillation waves and the distance from 
the origin of the focal wave to the border of the mapping array is shown in Supplemental 
Table 1. Next, it is manually checked whether the morphology of fibrillation potentials 
in the breakthrough region is distorted by large QRS complexes or artifacts due to e.g. 
movements of the electrodes in order to avoid false positive focal waves; examples are 
shown in Supplemental Figure 3.
In case of a fractionated electrogram, marking of one of the other deflections should not 
result in disappearance of the focal fibrillation wave (Supplemental Figure 4). In order to 
include only focal waves which have a more or less considerable impact on endo-epicardial 
asynchrony, we choose cut-off value of 4 electrodes. Supplemental Table 2 shows how 
many focal waves will disappear when a cut-off value of 5 or 6 electrodes would have been 
chosen. The origin of a focal wave had to be activated earlier than all surrounding elec-
trodes. If electrodes adjacent to the origin were activated simultaneously, all electrodes 
surrounding this area should also be activated later. Shift of the local activation time to 
a maximum of 3 ms earlier or later at the earliest activated electrode(s) should not result 
in disappearance of the focal wave. Typical examples of focal waves resulting from these 
criteria are provided in Supplemental Figure 5.
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Supplemental Figure 1. Examples of two opposite electrogram recordings showing synchronous and 
asynchronous activation.
Supplemental Figure 2. Focal wave originating near the border of the mapping array.
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Supplemental Figure 3. Distortion of the morphology of an atrial fibrillation potential by a far field ven-
tricular complex.
Supplemental Figure 4. Fractionated potential next to the origin of a ‘focal’ wave.
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Supplemental Figure 5. Wavemaps demonstrating typical examples of focal fibrillation waves.
Supplemental Table 1. Location of the origin of focal fibrillation waves




Supplemental Table 2. Size of the focal waves
Endocardial focal waves Epicardial focal waves
4 electrodes 5.0% 5.6%
5 electrodes 4.5% 5.2%
6 electrodes 3.8% 4.6%
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Focal waves appear frequently at the epicardium during persistent atrial fibrillation 
(AF), however, the origin of these waves is under debate. We performed simultaneous 
endo-epicardial mapping of the right atrial wall during longstanding persistent AF in a 
patient undergoing cardiac surgery. During 10 seconds 53 and 59 focal waves appeared 
at random at respectively the endocardium and epicardium. Repetitive focal activity did 
not last longer than 3 cycles. Transmural asynchrony and conduction might be the origin 
of focal waves. Asynchronous propagation of fibrillation waves in three dimensions would 
stabilize the arrhythmia and could explain the limited success of persistent AF ablation.
Persistent atrial fibrillation (AF) is associated with the frequent occurrence of epicardial 
fibrillation waves presenting focally which may represent important drivers for the per-
petuation of AF. These focal waves appear mainly as single events widely spread over 
the epicardial surface without any clear preferential site.1 However, not much is known 
about the occurrence of focal waves at the endocardial side and the interplay between 
both sides. This could provide more insights into the origin of focal fibrillation waves. In 
this report we demonstrate the dynamics of focal fibrillation waves at the epicardium and 
endocardium simultaneously in a patient with longstanding persistent AF.
A 63-year-old female patient underwent mitral and tricuspid valve surgery due to rheu-
matic mitral valve disease with severe insufficiency. A preoperative echocardiogram 
showed a mildly reduced left ventricular function and an enlarged left atrium. AF had been 
persistent for 1.5 years and was medically treated with digoxin and verapamil. Before sur-
gery, the patient gave informed consent for a mapping study approved by the local ethics 
committee. Before the start of cardiopulmonary bypass, the endo- and epicardial side of 
the right atrial free wall were simultaneously mapped during longstanding persistent AF. 
Mapping was performed with two 8x16 electrode arrays (2 mm interelectrode distance) 
positioned precisely opposite to each other in a clamp, and inserted in the right atrium 
through the incision for the venous cannula. Ten-second recordings of the endo- and 
epicardium were analyzed with custom-made software for focal fibrillation waves that 
appear within the mapping area as previously described in detail.1,2 Figure 1 shows the ap-
pearance of focal fibrillation waves at the endocardium and epicardium during 10 seconds 
of longstanding persistent AF. Each star represents an emerging focal wave and the star 
size increases each time another focal wave presents at the same location. Focal waves 
appear equally frequent at the endocardium and the epicardium (53 vs 59). Mostly, they 
appear at random either on one side, or at different locations on both sides. A few appear 
at the same time and location on the epicardial and endocardial side. Repetitive focal 
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activation at a single location is seen at most for only 3 cycles with a variable cycle length. 
Rotor activity was not responsible for these repetitive focal waves as shown in Figure 2.
Several mechanisms for focal waves have been proposed such as re-entry, rotors, ectopic 
foci and endo-epicardial breakthrough.1,3 The random appearance of focal waves pleads 
against stable ectopic foci or fixed rotors being the source for focal fibrillation waves in this 
example. Furthermore, most focal waves appear as single events on only one side instead 
of both sides, which translates either to an ectopic focus/ re-entry or rotor with transmural 
conduction block or transmural conduction of an opposite traveling wave. Both explana-
tions suggest the occurrence of dissociative endo-epicardial conduction. Previously, a 
correlation was demonstrated between the anatomy of the right atrial appendage with 
the pectinate muscles and endo-epicardial conduction delay and epicardial focal waves.4,5 
The distinctive architecture of the right atrial appendage may be an important contribu-
tor to the occurrence of endo-epicardial breakthroughs, though, perhaps not always in 
the way of stable intramural re-entry circuits acting as drivers.5 Theoretically, if random 
endo-epicardial breakthroughs indeed occur this frequently in longstanding persistent AF, 
it might offer an explanation why therapies for persistent AF are not always effective even 
after the elimination of AF drivers. After all, a 3-dimensional source for new fibrillation 
waves would highly stabilize the process of AF.
Figure 1. Focal fibrillation waves during 10 seconds of atrial fibrillation.
Summary of the 112 focal fibrillation waves (red stars) that occurred during 10 seconds of longstanding 
persistent atrial fibrillation at the endocardium and epicardium. The size of the star is proportional to the 
number of focal waves that appeared (size increases with each focal wave).
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A mitral valve and tricuspid valve repair was performed in combination with cryoablation 
of the right and left atrium following a Cox-Maze III pattern. The patient developed epi-
sodes of postoperative AF with spontaneous conversions to sinus rhythm. During the last 
days before discharge there were no more AF episodes.
Figure 2. Three repetitive focal waves.
Three repetitive focal waves (white star) on the endocardial side demonstrated in 3 consecutive wave maps. 
Different colors illustrate the different fibrillation waves. Activation times are depicted in each electrode 
and are in respect to the first activated electrode (T=0). White circles refer to the site from where transmural 
conduction could theoretically be responsible for the opposite focal wave. Rotor activity was not the cause 
of the only repetitive focal activity that was observed in this patient. This is mostly clearly demonstrated 
in the second and third set of maps where the focal wave appears much later than the surrounding tissue 
with only limited conduction.
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The Inhomogeneity and Complexity 
in defining Fractionated 
Electrograms





Background: Ablation strategies targeting areas of complex fractionated atrial electro-
grams (CFAE) are not successful in the treatment of atrial fibrillation. Fractionation of 
atrial electrograms may have multiple causes of both pathological and non-pathological 
origin. In order to get insight in the definitions used for determining areas of fractionation 
a literature search was performed using a systematic approach.
Methods and Results: A Pubmed search for studies describing fractionation during hu-
man atrial electrophysiological measurements resulted in 348 articles that were screened 
for new definitions of fractionation. The 24 studies remaining after screening described 11 
different visual definitions for fractionation, 3 automated CFAE detection programs and 
7 new parameters for measuring fractionation. Five different definitions for continuous 
electrical activity were presented. Electrode properties were often not described and 
endocardial bipolar recordings in recent studies used electrode diameters ranging from 
1-8 mm with a 2-5 mm interelectrode distance.
Conclusions: No uniform definition or recording method is used for measuring frac-
tionation of cardiac atrial electrograms. The different electrophysiological causes for 
fractionation and the influence of recording device properties on fractionation complicate 
identification of true pathological inhomogeneous conduction. The first step in discrimi-
nation between origins for fractionation may be accomplished by relating electrogram 
morphology to the spatial patterns of activation. Before revisiting ablation of areas with 
fractionated electrograms, we need to determine the correct method for identifying 
pathological fractionation.
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INTRODUCTION
To this day, atrial fibrillation (AF) is a major concern complicating worldwide healthcare 
and novel strategies are continuously being developed in an attempt to effectively treat 
this arrhythmia. One invasive modality developed in the previous decade is ablation of 
complex fractionated atrial electrograms (CFAE). It was first performed by Nademanee et 
al1 and many studies have investigated the value of CFAE ablation.2-6 In recent perspective, 
there seems no clinical beneficial effect of CFAE ablation in addition to pulmonary vein 
isolation for both paroxysmal and persistent AF.4-6 There might even be an increased risk 
of organized atrial tachycardias after CFAE ablation.3 Notably, the electrophysiological 
origin for CFAEs that are targeted during these ablation procedures is actually not exactly 
known, and different methods are used for identifying fractionated electrograms (EGMs). 
Therefore, we reviewed the electrophysiological basis of fractionation and investigated 
the measurement methods and definitions of atrial EGM fractionation using a systematic 
approach.
Pathophysiology
A unipolar recording of extracellular cardiac EGMs in homogenous tissue consists of a 
positive spike followed by a negative deflection, representing a depolarizing wave front 
approaching and moving away from the electrode, respectively. If the wave front origi-
nates or ends at the electrode site, the unipolar EGM morphology can also consist of only 
a negative or positive deflection.7 The steepest point of deflection coincides with the rapid 
depolarization phase (phase 0) of the membrane potential and therefore local depolar-
ization. Bipolar recordings subtract the potential at one recording site from an adjacent 
recording site, resulting in clearance of most farfield signals. Here, the initial peak is the 
local depolarization time.7 However, bipolar EGM morphology is also affected by other 
factors that do not affect unipolar EGMs. For instance, the amplitude of the signal depends 
on the direction of the wavefront. A small spacing between the electrodes is important to 
diminish the impact of wave orientation. Furthermore, a bipolar EGM is the sum of two 
unipolar EGMs with a time delay due to the interelectrode distance. A significant time 
delay between two simple unipolar EGMs will result in a fractionated EGM when converted 
to a bipolar EGM as illustrated by Figure 1.
Fractionated electrograms consist of multiple deflections and are often prolonged. 
Several sources have been demonstrated to result in EGM fractionation. The causes for 
fractionation can be divided into three categories8: 1) artifacts, 2) remote activation, 3) 
inhomogeneous conduction of the tissue beneath the electrode. First, artifacts due to 
movement, signals from other muscles or filter settings can mimic fragmentation of the 
EGM.9 Second, activation of remote regions may be recorded due to their proximity to 
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the recording area. For example, excitation of adjacent macroscopic structures such as 
the coronary sinus or pulmonary veins, which may occur later in time than the recording 
site itself, can be recorded simultaneously. Besides recording artifacts or the activation of 
neighboring structures, fractionation can also originate from inhomogeneous conduction 
within the recording area. A single 1-mm electrode translates excitation of approximately 
10,000 to 100,000 cardiac muscle cells into one signal. In case of a nonuniform pattern of 
myocyte excitation, EGM fractionation occurs (Figure 2).
Microscopic electrophysiological measurements have shown that even in normal cardiac 
tissue conduction velocity decreases and fractionation occurs with a transverse direction 
of propagation (anisotropy). Propagation in the transverse direction occurs more inhomo-
geneously with age, probably due to electric uncoupling caused by an increased presence 
Figure 1. Fractionation in bipolar electrograms.
A depolarizing wavefront travels from electrode 1 to electrode 2 that are separated by an interelectrode dis-
tance of 2 mm. In situation A, the wavefront passes the electrodes with a time delay of 2 ms which results in 
a simple bipolar EGM. In situation B, the time delay is increased to 17 ms either due to increased electrode 
spacing or decreased velocity of the wavefront. This will result in an extra negative and increased positive 
bipolar deflections. C is an example of two real unipolar electrograms recorded during AF by electrodes 
with a diameter of 0.45 mm and 2 mm interelectrode spacing and filtered from 0.5-400 Hz. The time delay 
is 12 ms and conversion to a bipolar electrogram gives rise to a fractionated EGM.
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of nonmuscular fibrous tissue.10, 11 These structural barriers may lead to the circuitous path 
of conduction as proposed by Gardner et al.11 Furthermore, high resistant gap junctions 
between myocytes or disrupted ion channel function due to antiarrhythmic drugs or ge-
netic mutations can result in intracellular and/or intercellular barriers for conduction.11 In 
normal functioning cardiomyocytes, premature or high-frequency stimulation within the 
refractory period creates an opportunity for dispersion of excitability and fractionation. 
In addition, it has recently been demonstrated that the right atrial endo- and epicardial 
myocardium is asynchronously activated during AF, which translates to a transmural inho-
mogeneity in conduction as well.12, 13 Therefore, inhomogeneous conduction can occur in 
the presence of normal functionality and anatomy or occur due to pathological processes 
that cause structural or cellular barriers for homogeneous conduction. Figure 3 shows an 
overview of causes for fractionation. The methods and definitions used for identifying 
EGM fractionation need careful consideration because significant methodological differ-
ences can lead to a disparity in study results.
Figure 2. Myocardial activation patterns of simple and fractionated electrograms.
A homogeneous activation front across myocardial cells results in a simple electrogram (top panels). An 
inhomogeneous activation front, where the direction of the activation front changes, either due to the 
direction of propagation and coupling structure of myocardial fibers (anisotropy) or due to functional or 





A PubMed database search was performed with the following MeSH terms: atrial fibrilla-
tion or heart atria, and humans, and cardiac electrophysiologic techniques or body surface 
potential mapping or electrocardiography or electrophysiology, and also containing in 
any of the fields: fractionated or fractionation or fragmented or AF nests. Editorials, com-
ments, reviews and case reports were excluded from the search. The search resulted in 
345 articles. To also include the most recent articles not yet indexed, an additional search 
without MeSH terms was performed within all fields containing the following words: 
atrial fibrillation or atria, and electrophysiology or epicardial mapping, and fractionated 
or fractionation or fragmented or AF nest. The results published in the past two years were 
screened for inclusion and three more articles were added. All 348 articles were screened 
for inclusion and exclusion criteria. A flowchart of inclusion and exclusion with criteria is 
shown in Figure 4. The definitions of these articles were compared and only the articles 
first describing a (different) definition were included. Dominant frequency was not consid-
ered a definition for fractionation, and these articles were excluded. A total of 24 articles 
remained after selection. Thereafter, definitions were checked for references to a previous 
article and, if so provided, the references were included instead.
Figure 3. Schematic overview of the causes of fractionation.
161




The descriptions of fractionation that were found are given in Table 1. Eleven definitions 
were described in the articles found.1, 14-24 Six studies that investigated characteristics 
of CFAE or aimed to find new manners to quantify CFAE introduced new parameters to 
describe CFAE.25-30 In addition, 3 different automated software algorithms to detect CFAE 
were described: interval confidence level (ICL)31, 32, CFE mean32, 33 and an automated 
program calculating a CFAE percentage34. Figure 5 illustrates the manner in which these 
programs detected CFAE. Ablation of CFAE or continuous electrical activity was performed 
in 5 studies.1, 18, 22, 33, 35 The definition of Nademanee et al.1 is most often used, combined 
with the derived automated detection analysis algorithm CFE mean (Figure 4). Rostock 
et al.36 made a minor change to the definition from ≥2 to ≥3 deflections. When continuous 
Figure 4. Flowchart of article in- and exclusion and definitions.
After the initial screening, 164 articles remained of which 24 described 27 methods/ definitions for fraction-
ation. Of the 164 studies, 56 used multiple or a combination of these methods/ definitions. Fractionated 
electrogram ablation was performed by 84 studies, 10 used multiple or a combination of methods/ defini-
tions. †/ ‡ all/ all but one article(s) of same research group, § ICL cut-offs described of >5 and >7 during 2.5 
sec and ≥26 during 5 sec, ¶ Mean interval upper limit between 50-80 ms. # 70 or 75% of the recording time 
absence of isoelectric intervals of 70 or 50 ms. CEA, continuous electrical activity.
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Table 1. Definitions of fractionation
Study Year Electrogram Definition of Fractionation
Wells14 1978 Beat-to-beat complexes of variable morphology with an isoelectric baseline having 
perturbations of varying degrees.
Leier15 1980 Duration ≥80 ms
Konings16 1997 >2 deflections within 50 ms
Saksena17 1999 Prolongation of the duration of the local EGMs >50 ms with or without appearance of 
double or multiple potentials.
Nademanee1 2004 1) ≥2† deflections and/or perturbation of the baseline with continuous deflection of 
a prolonged activity complex over 10 sec recording,
2) very short cycle length ≤120 ms averaged over 10 sec.
Oral18 2007 Cycle length ≤120 ms or shorter than in the coronary sinus or that were fractionated 
or displayed continuous electric activity
Narayan19 2007 High-frequency with duration ≥60 ms
Hunter20 2009 Discrete, <70 ms and complex ≥5 direction changes
Nam21 2010 Highly fractionated, nearly continuous
Lü22/ Rostock23 2013/ 
2008
Fractionated or continuous electrical activity, or locally short AF cycle length (<120 
ms) or intermittent local burst activity
Lee24 2014 ≥3 deflections over >50 ms duration separated by a discrete iso-electric baseline
Fractionation in parameters
Yoshida25 2008 1. Complexity index: how often depolarizations changed polarity (+/-) per sec
2. Fractionation index: how often the direction (polarity) of the depolarization 
slope (dV/dt) changed per second
Takahashi26 2008 Number of deflections with an absolute value of >0.05 mV from the baseline
Berntsen27 2009 Number of deflections >50 μV/s
Haley28 2013 Percentage of time, deflections above baseline occurred, <120 ms apart
Brakel29 2013 Number of subsequent negative deflections within one EGM with a defined cycle 
length between two deflections of <120 ms expressed as median over a 10-s AF file







During 2.5 sec recording, deflection peaks within 0.05-0.15 mV tagged, all interval 
measured between 2 peaks, number of intervals between 70-120 ms determined = 





During 8 sec recording, CFE mean interval is determined of consecutive deflections 
exceeding a sensitivity threshold and down stroke morphology with maximum and 
minimum within a set time duration, and exceed a refractory period. CFAE site: CFE 
mean <120 ms
Chaldoupi34 2012 CFAEs: periods of successive atrial deflections with (a) dV/dt < –0.04 V/s, (b) 
amplitude >2% of the highest unipolar electrogram recorded in every tracing, (c) 
continuous atrial activation or deflections separated by an interval ≤104 ms
Electrogram definitions of continuous electrical activity
Saksena17 1999 Variable morphology and cycle length, but indistinct/ absent isoelectric interval
Lin37 2008 Mean interval <50 ms
Tada38 2008 No isoelectric segments for ≥1 sec
Hunter20 2009 Continuous deflections without pause at the isoelectric line for ≥70 ms, occupying 
≥70% of sample, with an uninterrupted segment of 1 sec
Lo35 2009 Fractionation or repetitive rapid activity lasting for >8 seconds
† Rostock et al. (2006)36: ≥3 deflections. AF = atrial fibrillation; CF(A)E = complex fractionated (atrial) electro-
grams; EGM = electrogram; ICL = interval confidence level.
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activity is defined apart from fractionation almost all studies define the absence of an 
isoelectric interval. However, different durations of continuous electrogram (EGM) deflec-
tions are described for the definition of continuous activity. The automated detection for 
continuous activity is set as a mean interval between deflections <50 ms.17, 20, 35, 37, 38
EGM parameters used to define fractionation are 1) number of deflections, 2) EGM dura-
tion, 3) interval duration between deflections, 4) number of short duration intervals 
between deflections, 5) amplitude of deflections, 6) slope of deflection, 7) number of 
polarity changes of deflections or slope of deflections (Figure 6), and 8) baseline. Three 
definitions use descriptive terms to define fractionation.19, 21, 22 Nademanee et al.1 use the 
most properties to define fractionation: number of deflections, EGM complex duration, 
baseline and interval duration between deflections. The automated CFE mean derived 
from this definition sets boundaries for the sensitivity of deflection detection with also a 
selectable amplitude level, refractory period and EGM width.
Figure 5. Algorithms for automated fractionation detection.
Schematic electrogram example illustrates the methods for determining CFE mean (blue), CFAE% (green), 
ICL (red). * >2% of highest amplitude. CF(A)E complex fractionated (atrial) electrograms; ICL interval con-
fidence level.
Example calculations: CFE mean = (150+130+90+80+110+120+85+140+70+60+150+110)/12; CFAE% = % 
time periods intervals ≤104 ms = (280+85+130)/1295; ICL = number of intervals 70-120 ms = 4.
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Figure 6. Fractionation parameters complexity index and fractionation index.
The complexity index (red) counts the number of polarity changes. The fractionation index (blue) counts 
the number of polarity changes of the derivative.
Table 2. Measuring method and device properties
Study Endo-/ 
epicardial






Wells, 1978 epi bi - 5-10 12-500
Leier, 1980 endo bi - 10 30-500
Konings, 1997 epi uni 0.3 2.25 1-500
Saksena, 1999 endo bi - 2-5/8-2 + 5-10-5 -
Nademannee, 2004 endo bi - - 30-500
Rostock, 2006 endo bi 1 4-4-4 30-500
Oral, 2007 endo bi 8 - 30-500
Narayan, 2007 endo bi - - 30-500
Hunter, 2009 endo bi 3.5 2-5-2 30-250
Nam, 2010 endo bi - - 30-500
Lü, 2013 endo bi 3.5 2-5-2 30-500
Lee, 2014 epi bi - 2.5 0.05-400
Yoshida, 2008 endo bi - 2.5 -
Takahashi, 2008 endo bi - - 30-250
Berntsen, 2009 endo bi 8 + 1 -    + 2-5-2 30-400
Haley, 2013 endo bi 3.5 2 0.5-250
Brakel, 2013 epi bi - 5 -
Gal, 2015 endo bi 1 4-4-4 30-500
Scherr, 2007 endo bi 3.5 - 30-400
Verma, 2008 endo bi 3.5 2 30-500
Chaldoupi, 2012 endo uni - 5 0.05-500
Lin, 2008 endo bi 4 - -
Tada, 2008 endo bi 3.5 2-5-2 30-500
Lo, 2009 endo bi 4 - -
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Measuring methods
Table 2 lists the device properties and measuring methods that were used in these studies. 
Twenty studies used endocardial and 4 used epicardial mapping approaches. Two studies 
used unipolar recordings. In 11 studies electrode size was not described and in 8 the elec-
trode spacing was not reported or could not be derived from the catheters that were used. 
Minimal electrode size for endocardial recordings was 1 mm, used in 3 studies, while the 
other 9 studies used electrode sizes of 3.5, 4 or 8 mm, substantially larger than the 0.3-mm 
electrode of the epicardial mapping study of Konings et al.16 Interelectrode spacing mostly 
ranged between 2-5 mm and was only larger in the studies before the year 2000.
DISCUSSION
Clinical practice
Pathophysiological studies have shown that inhomogeneous conduction can give rise to 
both initiation and maintenance of AF.39, 40 Therefore, Nademanee et al. proposed the abla-
tion of areas with fractionated EGMs in order to terminate AF. At first, fractionated areas 
were identified visually; today automated detection software has been implemented in 
the CARTO (Biosense Webster, Diamond Bar, CA) and NavX (St. Jude Medical, Minneapolis, 
MN) 3-dimensional mapping systems and is most often used for the identification of CFAE 
areas. However, functional areas of fractionation could also be targeted during ablation. 
Limiting the number of unnecessary scars is important to decrease the risk of postabla-
tive iatrogenic atrial tachycardias. The first step towards delineating pathological from 
normal areas of fractionation or artefacts is to optimize the method in which fractionation 
is measured and to use a uniform definition for fractionation. This review has shown that 
definitions to date have widely varied, including definitions applied for ablation purposes.
Relation between definitions and the electrophysiological basis
Over 35 years, at least 11 definitions and 7 fractionation parameters have been used to 
define fractionation using 8 different EGM parameters. The studies that defined frac-
tionation only by prolonged EGM duration, could have included areas where slow but 
homogeneous conduction occurs. Descriptive terms, mainly used in early studies, such 
as high-frequency, highly fractionated, or burst activity, provide insufficient information 
to distinguish the intended EGM morphology. Therefore, automated techniques for CFAE 
detection were developed including CFE mean, ICL and CFAE%, which utilize the AF 
cycle length to determine areas with highly frequent or short coupled activations. These 
methods are most often used in recent studies. However, the morphology of the EGM is 
not included with these methods. In addition, the refractory period that is set can over-
look ‘true’ fractionated deflections caused by inhomogeneous conduction of myocytes 
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within the recording area. The close intervals that are detected are actually a measure 
of high-frequency activations, not inhomogeneous conduction per se. These CFAE could, 
for example, also represent a rotor or an ectopic focus (driver). In fact, these automated 
methods have shown to correlate poorly with each other and also corresponded poorly to 
inhomogeneous conduction patterns.41
Fractionated EGMs have been found both at the center and periphery of AF drivers.42, 43 
Narayan et al. found that electrograms with ≥7 short intervals in 4 sec mainly presented 
peripheral to driver sources.42 Lin et al. reported fractionated electrograms defined as 
Nademanee et al.1 at the center in 70% of rotors.43 At high frequencies of activation, in-
termittent conduction block and interrupted patterns of activation occur, characterizing 
inhomogeneous or fibrillatory conduction. Anatomical transition sites demonstrated to 
be preferential sites for frequency-dependent conduction block44 and could also exhibit 
significant conduction disturbances at an earlier stage in response to remodeling. The 
nature of conduction disorders during fibrillatory conduction can be physiological be-
cause of activation frequencies close to the refractory periods of surrounding myocytes 
or frequency-depended source to sink mismatch, or pathological because of structural/ 
electrical remodeling of surrounding myocytes causing frequency-dependent conduction 
disorders. Fractionation at the center of rotors may be due to the sharp angle of the activa-
tion front representing as close-interval or continuous activity on the EGM, or the electrical 
remodeling is not homogeneously in the entire center causing conduction disturbances as 
well. In a recent report, rotors were accompanied by functional conduction disorders at 
the center that demonstrated “core” fractionation.45
EGMs in which atrial deflections comprise the entire recording time without an apparent 
baseline are referred to as continuous activity. Although definitions of continuous activity 
are more uniform, the length of the electrical activity before defining the EGM as continu-
ous activity differed among studies. Continuous activity during AF is associated with mul-
tiple wavelets entering and exiting the recording area causing frequent wave collision and 
wave break.46 Consequently, conduction is more inhomogeneous in areas with continuous 
activity and this explains the appearance of non-stop activity on the EGM. It features a high 
degree of inhomogeneous conduction of the multiple fibers representing the recording 
area. Therefore, continuous activity is likely the result from a low spatial resolution of the 
recording area and accordingly is related to the electrode diameter and recording modus.
Electrode size and spacing
The atrial EGM is the sum of the activation pattern of all muscle fibers underneath and 
closely surrounding the electrode. Therefore, a larger electrode size should increase the 
chance of the occurrence of fractionation. High-resolution epicardial mapping studies 
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recording with 0.3-mm electrodes have shown that delays in activation of >12 ms occur 
between sites at 2.25 mm distance.47 Endocardial mapping studies often use electrode 
diameters of 3.5-4 mm covering an area of more than two high-density electrodes. Conse-
quently, activation of an area with conduction block below the endocardial electrodes will 
exist of multiple activations leading to fractionation of the recorded signal. A computational 
model has shown that increasing the inhomogeneity of wavefronts increases the degree 
of fractionation more with a larger electrode size.48 However, if a wavefront propagates 
homogeneous, the electrode size does not influence EGM morphology because there is 
no cause for fractionation to occur. The advantage of a smaller electrode size would thus 
be the ability to locate the inhomogeneous site more accurately. In addition, the required 
ratio of the area of inhomogeneity to the electrode size before the EGM becomes fraction-
ated remains unclear and a smaller electrode also might be able to identify small areas 
of inhomogeneous conduction. On the other hand, a larger recording area may have the 
advantage of a zoomed-out perspective of the myocardial area creating a distant view for 
inhomogeneous conduction. However, a larger electrode will also increase the chance 
of recording remote activation. Nevertheless, this has not been validated in vivo yet, so 
the clinical relevance of electrode diameter can only be speculative. Increased electrode 
spacing in bipolar recordings has been shown to increase the degree of fractionation in 
vivo.9, 41, 48 It is probably the consequence of the bipolar EGM being formed by the area 
of two, often, large electrodes of 3.5 or 4 mm. Increasing the interelectrode distance is 
followed by an increase of the recording area and of the differences between the EGMs 
recorded from the two poles. Because of the high level of inhomogeneity in AF, recordings 
of two poles can differ significantly during AF, making bipolar recordings less suitable, 
or should be recorded with an interelectrode distance <1 mm.46 The multidirectional 
waves during AF can also cause a variation in bipolar EGM amplitudes. The study of Lau 
et al. demonstrated that unipolar fractionation is a better measure for inhomogeneity in 
conduction.41 In the present study, electrode properties were often not described and the 
bipolar interelectrode distance was 2 mm or more.
Future directions
In future investigations, both the technical aspects and physiological causes of fraction-
ation need to be determined in order to identify pathological areas of fractionation. We 
propose the following steps. First, device properties such as electrode diameter, inter-
electrode distance and filter settings will need to be investigated by using different device 
properties in areas with inhomogeneous conduction of different complexities. The next 
step is to relate spatial patterns of activation to EGM morphology. The complex patterns 
of high frequency, inhomogeneous activations during AF make it difficult to distinguish 
inhomogeneous conduction from “new” or remote activations. High-resolution electro-
physiological mapping and optical mapping can provide more detailed answers in this 
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matter and could help discriminate between fractionation due to the presence of multiple 
wavefronts within the recording area and “true” fractionation due to discontinuity in 
propagation between cardiac myocytes. Finally, the functional and anatomical causes for 
fractionation should be identified. The significant role of the underlying atrial structure 
in physiological causes for fractionation means an approach will be required in which the 
anatomical structure of the recording site can be visualized. To this end, both in-vivo and 
ex-vivo human studies are necessary because the current, clinically applicable techniques 
have certain limitations that can be overcome by ex-vivo studies. In vivo local anisotropy in 
conduction determined by previously described methods49 can be correlated to the degree 
of EGM fractionation and imaging techniques, such as magnetic resonance imaging, can 
be combined with EGM recordings to help identify fibrotic-related fractionation.50 How-
ever, ex-vivo human studies that combine high-resolution endo-epicardial mapping with 
imaging or histology are essential to determine the specific anatomical structural causes 
of fractionation.10, 51
When these technical and pathophysiological issues in identifying pathological fraction-
ation have been resolved, the clinical benefits of ablation of (pathological) fractionated 
EGMs can be reevaluated. Although research would benefit from a universal definition of 
fractionation, it does not seem possible at this time because of multiple factors compli-
cating the interpretation of fractionation. In our opinion, fractionation during AF should 
be defined based on an EGM morphology with multiple deflections (>1 in unipolar and 
>2 in bipolar recordings) within the refractory period indicating “true” inhomogeneous 
conduction.
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Background: Endo-epicardial asynchrony (EEA) and the interplay between the endocar-
dial and epicardial layers could be important in the pathophysiology of atrial arrhythmias. 
The morphological differences between epicardial and endocardial atrial electrograms 
have not yet been described, and electrogram morphology may hold information about 
the presence of EEA. The purpose of this study was to directly compare epicardial to 
endocardial unipolar electrogram morphology during sinus rhythm (SR) and to evalu-
ate whether EEA contributes to electrogram fractionation by correlating fractionation to 
spatial activation patterns.
Methods: In 26 patients undergoing cardiac surgery, unipolar electrograms were simul-
taneously recorded from the epicardium and endocardium at the inferior, middle and 
superior right atrial (RA) free wall during SR. Potentials were analyzed for epi-endocardial 
differences in local activation time, voltage, RS ratio and fractionation. The surrounding 
and opposite electrograms of fractionated deflections were evaluated for corresponding 
local activation times in order to determine whether fractionation originated from EEA.
Results: The superior RA was predisposed for delayed activation, EEA and fractionation. 
Both epicardial and endocardial electrograms demonstrated an S-predominance. Frac-
tionation was mostly similar between the two sides; however, incidentally deflections up 
to 4 mV on one side could be absent on the other side. Remote activation was responsible 
for most fractionated deflections (95%) in SR, of which 4% could be attributed to EEA.
Conclusion: Local epi-endocardial differences in electrogram fractionation occur occa-
sionally during SR but will likely increase during arrhythmias due to increasing EEA and 
(functional) conduction disorders. Electrogram fractionation can originate from EEA and 
this study demonstrated that unipolar electrogram fractionation can potentially identify 
EEA.
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INTRODUCTION
Differences in electrophysiological properties of the ventricular epicardial and endocar-
dial wall have been long recognized and linked to arrhythmogenesis.1 Although wavefronts 
traveling out of sync at the epicardium and endocardium of the thin atrial wall were already 
demonstrated more than two decades ago,2 unravelling of the link between endo-epicardial 
asynchrony (EEA) and atrial arrhythmias only started recently.3 Asynchrony in epicardial ver-
sus endocardial propagating waves and the complex fiber arrangement of the atria may also 
give rise to epi-endocardial differences in the morphology of electrograms. Houben et al. have 
proposed that the ratio between the R-peak and S-peak of unipolar atrial electrograms may 
differ between the epicardium and endocardium and could identify the leading layer.4 Other 
features of electrogram morphology such as amplitude and fractionation have been used to 
identify areas with scar tissue and arrhythmogenic areas.5 Electrogram fractionation occurs 
when inhomogeneity in conduction occurs within or remotely from the recording site and can 
have structural or functional causes.6 The intricate structure of the atria might be a substrate 
for epi-endocardial differences in fractionation and occurrence of EEA. Asynchronous activa-
tion within the wall could in turn be responsible for additional deflections in electrograms.
In a clinical setting, epicardial and endocardial mapping is never performed simultane-
ously; therefore, the differences and relationships between epi- and endocardial atrial 
electrogram morphology are so far unknown. This study is the first to directly compare 
unipolar epicardial electrograms to endocardial electrograms that were recorded simul-
taneously at the right atrial wall during sinus rhythm (SR) in order to evaluate whether 
1) (local) morphological features differ between epicardial and endocardial electrograms 
and 2) a fractionated electrogram morphology can arise from local EEA in activation. To 
this end, we developed a method to classify fractionation to its electrophysiological origin 
by correlating fractionated potentials to spatial patterns of activation.
METHODS
Study population
Twenty-six adult patients undergoing first-time cardiac surgery with use of cardiopul-
monary bypass were included (21 male; age 67±10 years). Nineteen patients (73%) were 
operated for coronary artery disease, 12 (46%) for (concomitant) valvular heart disease, 
11 (42%) patients had a history of atrial fibrillation (AF), and 6 (23%) had impaired left 
ventricular function. Clinical characteristics are described in detail in Supplemental Table 
1. The study protocol was approved by the local ethics committee (MEC2015-373) and all 




Two multi-electrode arrays, each containing 128 electrodes with 2 mm interelectrode 
spacing, were fixed on spatulas and positioned directly opposite to each other (Figure 1, 
left panel). After arterial cannulation for cardiopulmonary bypass, an incision was made in 
the RA appendage for venous cannulation. Before venous cannulation, one spatula was in-
troduced in the right atrium through the incision and the opening around the spatula was 
closed with a purse-string suture.7 Atrial epicardial and endocardial unipolar electrograms 
were simultaneously recorded for 5-10 seconds during SR at three different locations of the 
RA free wall: 1) inferior RA, 2) mid-RA, 3) superior RA. Unipolar electrograms were sampled 
at 1 kHz and stored on hard disk after amplification, filtering (0.5-500 Hz) and analogue-to-
digital conversion. Detailed methods are provided in the Supplemental Material.
Figure 1. Endo-epicardial mapping and signal analyses.
Left: Two spatulas with 128-electrode arrays are fixed together and one spatula is introduced in the right 
atrium through the incision for venous cannulation. Unipolar electrogram recordings are made on 3 loca-
tions: towards the inferior vena cava (inferior RA), the superior vena cava (superior RA) and in between, 
towards the terminal crest (mid-RA). Middle: the steepest deflection is marked as local activation time (AT, 
red cross) and additional deflections (blue crosses) are marked as fractionated deflections if the criteria for 
fractionation are met (see text). Signal morphology is analyzed for number of deflections, the RS-ratio (only 
single potentials) and peak-to-peak amplitude (potentials with multiple deflections: amplitude between 
the maximal and minimal peak). Fractionation interval (FI) is the time between the fractionated deflec-
tion and local AT within the potential. Right: An example of epi-endocardial activation time maps with iso-
chrones are shown on the top. For classification, two rings of electrograms around a fractionated deflection 
(blue dot) in the same and opposite plane are searched for coinciding (peak-to-peak time distance ±3 ms 
error margin) deflections of local ATs.
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Data analysis
Electrogram morphology was analyzed semi-automatically in MATLAB R2016a (The Math-
Works Inc., Natick, MA). Electrograms with injury potentials were excluded from analysis 
and recording sites with ≥25% excluded or missing electrograms were excluded in total 
(Supplemental Figure 1). SR potentials were analyzed for fractionation (number of deflec-
tions), peak-to-peak amplitude (voltage) and RS ratios; atrial extrasystoles were excluded. 
The potentials in each electrogram were averaged for voltage and RS ratio comparison. 
The steepest negative deflection of a potential was marked as local activation time (AT) 
if the slope was ≥0.05 mV/ms and the deflection had a signal-to-noise ratio >2. Additional 
deflections with a slope ≥10% of the local AT (and ≥0.05 mV/ms), peak-to-noise ratio >2, 
and either an amplitude >1/6 of the amplitude of the local activation deflection or a signal-
to-noise ratio >5 were marked as fractionation (Supplemental Figure 2). Only nonfraction-
ated potentials (single deflections) were analyzed for the ratio between the R-peak and 
S-peak (RS ratio).4 All signal markings were manually checked and corrected in case of 
markings on electrical artifacts evaluated by a consensus of two investigators. Figure 1 
shows the analysis of signal amplitudes and RS ratios. Delayed activation is defined as 
interelectrode differences in AT >11 ms (<17 cm/s) of electrodes in the same plane. The 
amount of delayed activation is expressed in millimeters: number of interelectrode differ-
ences >11 ms × interelectrode distance (2 mm).
Analysis of local epi-endocardial differences
Local differences in AT, RS ratio and fractionation between the epicardium and endo-
cardium were determined by comparing each electrogram with the electrograms in the 
opposite square: the exact opposite electrogram and its 8 surrounding electrograms. The 
local difference was the minimal difference of the potentials in the opposite square, as 
previously described.3 Border electrodes were excluded from analysis of local differences. 
For local differences in RS ratio, only recordings with <25% fractionated potentials were 
included. Fractionated potentials with ≥15 ms between the first and last deflections were 
analyzed for detection of all (separate) deflections on both sides at the same time (epi-
endocardial comparison of coinciding deflections). Each deflection was tested whether 
its steepest point fell within peak-to-peak time limits (±3 ms error margin) of deflections 
at the opposite square. The deflections that were not detected on the other side, as no 
coinciding deflection meeting the annotation criteria was present, were also manually 
examined for visual absence.
Classification of fractionation
Each fractionated deflection was evaluated if it could be attributed to remote activation, 
that is, to delayed (discontinuous) activation in the surrounding tissue in the same layer 
or to EEA. The adjacent and opposite, first and second electrode rings around the fraction-
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ated potential were searched for deflections of local ATs coinciding with the fractionated 
deflection. If the fractionated deflection fell within peak-to-peak time limits (±3 ms) of the 
deflections of local ATs, it was classified based on the plane(s) where the corresponding 
local AT(s) was located (Figure 1, right panel). Corresponding ATs were present in either 1) 
the same plane, 2) the opposite plane, 3) both planes or 4) none of the planes (absence 
of corresponding local AT). Border electrodes were excluded from analysis. Fractionation 
interval for fractionated deflections was defined as the time interval between the fraction-
ated deflection and the deflection of the local AT (Figure 1, middle panel).
Statistical analysis
Normally distributed data are given as mean±SD and skewed data are given as median 
(p10-p90). Electrophysiological parameters were in square root or log-transformed in case 
of a non-normal distribution. Linear mixed models were used to investigate the associa-
tions between location (independent variable) and electrophysiological parameters (de-
pendent variable). Random intercepts were used for location. When normal distributions 
could not be obtained using transformations, the Friedman test was used to investigate 
the associations. Comparison of epicardial and endocardial amounts of delayed activa-
tion was done with the Wilcoxon signed rank test. Spearman rho coefficient was used to 
determine the correlation between cycle length and amount of delayed activation.
The associations of location and side with morphological parameters of electrograms 
were evaluated using Generalized Estimated Equations. The skewed distribution of RS ra-
tios could not be transformed to a normal distribution; therefore, RS ratios were converted 
to a binomial distribution by setting the lowest-quartile (<-0.51) of RS values as “highly” 
S-dominant. Correlation structure was chosen based on the goodness of fit in the guasi-
likelihood function and the inferior RA served as the reference in the models evaluating 
locations. Statistical analyses were performed using IBM SPSS Statistics version 21 (IBM 
corp.,Armonk, NY).
RESULTS
Electrophysiological data and parameters
Recordings at the inferior, mid and superior RA of 26, 25 and 21 patients, respectively, were 
included. SR cycle lengths did not change between the RA locations; inferior 902±202, 
mid 908±193 (P=0.72) and superior 827±162 (P=0.17). The amount of delayed activation 
increased from the inferior to the superior RA: 12 (0-80) mm, 32 (0-99) mm (P=0.095), 74 
(18-178) mm (P<0.001). At the superior RA, the endocardium demonstrated more delayed 
activation than the epicardium; 26 (0-61) mm vs. 44 (7-124) mm (P=0.010). No correlation 
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was present between SR cycle length and amount of delayed activation (r=0.05, P=0.81). 
A total of 102,129 potentials were analyzed in 16,954 electrograms, including 50,714 po-
tentials of 8423 electrograms recorded at the epicardium and 51,415 potentials of 8531 
electrograms recorded at the endocardium. An overview of the individual patient results 
is provided in Supplemental Table 2.
Unipolar voltages
From the inferior to the middle and superior RA, electrogram voltage decreased gradually 
from 8.0 (3.1-16.3) mV, to 6.4 (2.4-13.3) mV (P=0.001) and to 4.9 (1.7-11.7) mV (P<0.001). 
Opposite epicardial and endocardial electrogram amplitudes demonstrated a positive 
linear relationship (Figure 2, bottom left panel). Because it was expected that voltage is 
dependent on fractionation, potentials were categorized into singles, doubles and com-
plex fractionated (>2 deflections) potentials. Figure 2 shows that unipolar voltage indeed 
decreased with more fractionated potentials at both the epicardium and endocardium. 
The largest epi-endocardial difference in amplitude was observed for unipolar potentials 
with single deflections that had an epicardial vs endocardial amplitude of respectively 
8.3 (3.8-14.7) mV vs 6.7 (2.8-16.1) mV (P=0.08). Double potentials had epi-endocardial 
amplitudes of 4.1 (1.6-8.3) mV vs 3.8 (1.3-8.5) mV (P=0.45). Complex fractionated potentials 
had amplitudes of 2.5 (1.1-4.7) mV vs 2.7 (1.2-5.1) mV (P=0.08). The percentile ranges of 
endocardial potentials were wider than of epicardial potentials.
Figure 2. Epi-endocardial unipolar voltage.
Top left: Example of epicardial and endocardial voltage maps. Bottom left: Scatter plot of epi-endocardial 
unipolar voltages. Right: Relative frequency histograms of unipolar epicardial and endocardial electrogram 
voltage for singles, doubles and complex fractionated potentials. Vertical lines indicate the median.
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RS ratio of epi-endocardial single deflections
The RS ratios of potentials with single deflections recorded at the epicardium and en-
docardium are shown in Figure 3 for each RA location. Both sides demonstrated a clear 
S-predominance, which increased at the mid-RA (P=0.001) and superior RA (P<0.001). 
Epicardial vs endocardial median RS ratios at the inferior RA were -0.23 (-0.53 to +0.26) vs. 
-0.25 (-0.53 to +0.26); at the mid-RA were -0.32 (-0.78 to +0.06) vs. -0.34 (-0.72 to +0.07); and 
at the superior RA were -0.43 (-0.96 to +0.09) vs. -0.46 (-0.97 to +0.11). Many potentials at 
the superior RA, the area of the sinus node, had an S-morphology (RS ratio of -1) at both 
sides (11% vs 13%). Local differences in RS ratios were between 0 and 0.22 for 95% of the 
data, without either side having more S-predominance than the other side (Figure 3).
Epi-endocardial differences in fractionation
Relative incidence of singles, doubles, triples and potentials with >3 deflections was 76%, 
20%, 3% and <1%, respectively. The incidence of fractionated potentials (>1 deflection) 
showed an increasing trend from the inferior RA (16%) towards the mid-RA (22%, P=0.136) 
and was highest at the superior RA (36%, P<0.001). Epicardial vs endocardial incidence of 
Figure 3. Relative frequency histograms of epicardial and endocardial RS-ratios and local epi-endocardial 
RS differences.
Top 3 panels: RS-ratios per location, negative values represent increasing S-predominance, positive values 
represent increasing R-predominance. Medians are indicated by vertical colored lines. Bottom panel: local 
differences in RS-ratio between epicardium and endocardium. Negative values represent smaller RS-ratio 
values at the epicardium, positive values represent smaller RS-ratio values at the endocardium. Between 
the dashed grey lines 95% of the data is represented.
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fractionation at the inferior RA was 15% vs 17% (P=0.29), at the mid-RA was 21% vs. 22% 
(P=0.45), and the superior-RA demonstrated a trend towards more fractionated potentials 
at the endocardium: 33% vs. 38% (P=0.09). Local epi-endocardial differences in the num-
ber of detected deflections occurred in 6.6% (Table 1).
Table 1. Epicardial vs. endocardial fractionation
Total fractionation (%) Local differences in fractionation
∆ Epi-endo no. of deflections (%)Singles Doubles Triples Complex(>3)
Epi Endo Epi Endo Epi Endo Epi Endo 0 1 2 3>
Inferior 84.7 82.9 12.8 14.5 2.3 2.4 0.2 0.2 95.7 4.1 0.2 <0.1
Mid 79.4 77.7 17.5 19.2 2.6 2.8 0.4 0.3 93.2 6.5 0.2 <0.1
Superior 67.3 62.0 27.1 30.6 4.4 6.4 1.2 1.1 90.8 8.7 0.5 <0.1
Total 77.8 75.0 18.6 20.8 3.0 3.7 0.6 0.5 93.4 6.3 0.3 <0.1
Figure 4. Examples of local differences in fractionation between epicardium and endocardium.
Four fractionated potentials are shown recorded at the epicardium or endocardium with the nine electro-
grams on the direct opposite side (direct opposite and its 8 surrounding electrograms). In the lower right 
example the second deflection of 4mV at the epicardium is totally absent at the endocardium.
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A total of 1580 electrograms contained potentials with fractionated deflections having a 
fractionation interval ≥15 ms. In 271 of those 1580 cases, deflections remained undetected 
on the other side, based on the annotation criteria, and 53 of those 271 deflections were 
also visually completely absent. In 41 of 271 cases, the same number of deflections were 
present on both sides but with epi-endocardial time-differences between the correspond-
ing deflections of 4-85 ms (median 13 ms). In the remaining 177 of 271 cases, a (small) 
deflection was visually observed that did not meet the criteria for a deflection. Examples 
of epi-endocardial differences in fractionation (Figure 4) demonstrate that deflections up 
to a maximum of 4 mV on one side could be absent at that location on the other side.
Endo-epicardial asynchrony during sinus rhythm
Right atrial EEA >14 ms, as previously defined for AF3, occurred at the inferior RA in 12% 
of the patients, at the mid-RA in 19% and at the superior RA in 57%. EEA increased from 
the inferior to the superior RA (P=0.001). One patient had by far the most EEA of the study 
group (44.4% at the mid-RA) with an endocardial delay of >50 ms. EEA during SR is mainly 
determined by one side being delayed. The degree and incidence of EEA are provided in 
Supplemental Figure 3.
Fractionation attributable to delayed activation or endo-epicardial 
asynchrony
For the far majority (95%) of fractionated deflections, a corresponding local AT was pres-
ent in the surrounding tissue of the same or opposite layer (Table 2). In 4%, a local AT was 
only observed in the opposite plane, which corresponds to sites with EEA (Figure 5A). In 
9%, a corresponding local AT was only observed in the same plane, which corresponded 
to a site with delayed activation that was asymmetrical between the epicardium and 
endocardium (local delayed activation in one plane) (blue outlined potential, Figure 5B). 
In 83% of fractionated deflections, a matching local AT was present in both planes. This 
group contains 3 underlying causes: 1) symmetrical epi-endocardial delayed activation 
(Figure 5C), 2) asymmetrical epi-endocardial delayed activation; after the site with a delay 
in activation (Figure 5B), 3) short fractionation intervals (Figure 5C). Most can be attributed 
Table 2. Classification of fractionated deflections corresponding with local activation times
 Doubles Triples Complex (>3) Total
N (%)N % FI (ms) N % FI (ms) N % FI (ms)
Same plane 144 7 28 (14-58) 73 11 22 (10-27) 24 15 13 (11-47) 241 (9)
Opposite plane 69 3 27 (11-60) 26 4 26 (16-37) 8 5 38 (22-38) 103 (4)
Both planes 1682 85 12 (8-24) 553 82 12 (8-23) 99 63 14 (9-39) 2334 (83)
None 91 5 32 (17-60) 22 3 30 (18-56) 27 17 35 (21-35) 140 (5)
FI = fractionation interval.
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to short fractionation intervals as the median fractionated interval for these deflections 
was only 12 ms (Table 2). For the remaining 5% of fractionated deflections, no matching 
local AT was found. Some of those had corresponding local ATs distanced >4 mm of the 
fractionated site (Figure 5B), and more than half (61%) were deflections on electrodes 
that did not have a complete second ring to search for corresponding ATs (relative border 
electrodes). Figure 5D shows an example of a fractionated deflection likely reflecting 
intramural inhomogeneity in conduction; it only appears in center electrodes without any 
corresponding local AT. Potentials with >3 deflections most often had deflections without 
any corresponding local AT compared to doubles and singles (17% vs 3% and 5%).
Figure 5. Fractionated potentials attributable to various patterns of conduction disorders.
Panels A-D demonstrate examples where fractionated potentials correspond to remote myocardial activa-
tion in the same plane (outlined in blue), in the opposite plane (outlined in red) or in both planes (out-
lined in green) or do not correspond with any remote activation (outlined in orange). A: Endo-epicardial 
asynchrony causes fractionated deflections (blue marked deflections) at the epicardium, matching local 
activation times (AT, red marked deflections) are only present in the opposite plane. B: At sites with asym-
metrical delayed activation (DA), fractionated deflections in front of an area of DA correspond to local ATs 
in the same plane, however at the delayed site, fractionated deflections correspond to ATs in both planes. 
In some cases, even sites >4 mm of the DA site show corresponding fractionated potentials. C: Fractionated 
deflections at sites with symmetrical DA at both sides, local ATs are present in both planes. Deflections with 
short fractionation intervals (FI) similar to normal conduction velocity will also mostly have matching local 
ATs at both sides. D: The third deflection of the upper complex fractionated potential does not correspond 




Electrogram morphology is often used for the identification of structural or electrical 
remodeled areas with arrhythmogenic properties. In most settings, electroanatomical 
mapping is performed via endovascular catheters at the endocardial side. In recent per-
spective, it has become clear that asynchrony within the atrial wall can have an important 
role in the mechanism of atrial arrhythmias.3,8 Our study has shown that EEA >50 ms can 
already be present during SR and that unipolar electrogram fractionation can represent 
the presence of EEA. However, electrical activity within or on the opposite side of the 
atrial wall can also occasionally be missed when electrograms are recorded only from one 
side of the wall. At the superior RA, the highest amount of delayed activation and EEA 
was observed and resulted, because of their interdependence, in the highest amount of 
fractionated electrograms and the lowest voltages.
Right atrial anatomy
Variations between epi- and endocardial unipolar voltage can be explained from the 
anatomical structure of the RA wall. The surface of the endocardial RA appendage, unlike 
the smooth epicardial side, is very irregular due to the pectinate muscles of varying diam-
eters and the thick terminal crest. The mass of cardiac bundles is positively correlated to 
unipolar electrogram voltage and anatomical studies have shown that pectinate muscles 
can vary from <1 to 7 mm.9,10 The different sizes and arrangement of the bundles also 
cause a variation in the level of contact with the electrodes on the flat array. Our high-
resolution epicardial mapping study demonstrated recently that epicardial breakthrough 
waves during SR were most frequently observed at the superior RA.11 EEA indeed occurred 
most often in this area which also correlated to the highest amount of delayed activation 
and fractionation. The superior RA contains the sinus node within its fibrous case and the 
thickest part of the anisotropic terminal crest, which may underlie the proneness of this 
area to delays in activation, EEA and breakthrough waves.9,12 The structural variability of 
the RA therefore influences epi-endocardial synchronicity and electrogram morphology. 
Electrical activity that remains undetected on one side may relate to thicker or more ir-
regular parts of the RA.
The value of unipolar electrograms
Unipolar electrograms have the benefit over bipolar electrograms that their morphology 
carries additional information about the progression of the wavefront and remote activa-
tions. The ratio between the positive and negative component of a unipolar electrogram 
characterizes the start or end of a wavefront and possibly the curvature of the wavefront 
and conduction velocity.13 Epicardial electrograms recorded during AF demonstrated 
an S-predominance which could not be strongly correlated to wavefront curvature or 
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anisotropy.4 A tilted transmural stance of the wavefront resulting in an epicardial lead with 
constant epicardial to endocardial activation was proposed as theoretical explanation 
for S-predominance during AF which would present with more R-predominance at the 
endocardium. In this study, both epicardial and endocardial electrograms showed an S-
predominance and endocardial electrograms did not have higher RS ratios than epicardial 
electrograms. Therefore, S-predominance during SR cannot be explained by epicardial 
to endocardial activation or vice versa. Previous studies demonstrated that endocardial 
unipolar electrogram voltage is more useful for detecting areas of scar at the epicardium 
than bipolar electrogram voltage because of their range of view.14 We established that the 
view of unipolar electrograms can signify the presence of EEA and can reveal areas with 
intramural inhomogeneous conduction. Detecting EEA from the endocardium alone re-
quires the atrial “farfield” potentials on unipolar electrograms that will be filtered out with 
standard bipolar recordings. Furthermore, the limitations of registering all atrial activity 
from throughout the atrial wall demonstrated by our high-density contact mapping ap-
proach will only increase with noncontact mapping systems. Therefore, current mapping 
approaches may be insufficient to detect transmural atrial activity.
Epi-endocardial electrograms during atrial arrhythmias
The incidence of local differences in epicardial and endocardial electrogram morphol-
ogy and of electrogram fractionation due to EEA is relatively low during SR. According 
to the observations of Schuessler et al., epi-endocardial differences in activation were 
least prominent during SR and high-rate pacing, but were significantly increased with 
premature stimulation.2 In a goat model of AF, the amount of EEA increased with AF per-
sistence, which was also associated with more inhomogeneous conduction patterns and a 
shortening of fibrillation cycle length.15 Our previous study in humans also demonstrated 
more EEA at the RA wall during AF with incidences between 0.9 and 55.9%.3 EEA occurs 
more frequently in atrial arrhythmias because of the increase of inhomogeneous con-
duction and (functional) conduction disorders. Therefore, fractionation due to EEA and 
local differences in epi-endocardial electrogram fractionation are expected to increase 
during atrial arrhythmias. The RA appendage, which has the thickest wall of the whole 
atria, is especially susceptible to local differences in electrogram morphology and EEA. 
Nevertheless, breakthrough waves also occur frequently at the left atrium, indicating the 
presence of EEA, and with wavefronts decreasing in size during AF, electrogram amplitude 
will decrease causing local differences in fractionation more likely to occur in any area.11,16 
When fractionated electrograms are ablated only from the endocardial side, epicardial 
fractionated sites could be overlooked. However, more importantly, these fractionated 
sites have different pathophysiological origins, including EEA, and ablating all fraction-




Intraoperative simultaneous endo-epicardial mapping in living humans can only be 
safely performed at the RA; therefore, we could not evaluate the relation of epicardial 
and endocardial electrograms at the structurally less complicated left atrium. However, 
epicardial breakthroughs also are often present at the left atrium, indicating the occur-
rence of EEA at the left atrium during SR as well.11 The finite area of the mapping array and 
relatively low incidence of (complex) fractionation during SR limited the classification of 
fractionated deflections to those situated in the center of the array. The relatively small 
number of fractionated deflections classified to no corresponding local AT is probably still 
an overestimation.
CONCLUSIONS
In SR, EEA of the RA free wall occurs at >50 ms difference between epicardium and en-
docardium, which has never been described before. Electrograms on both sides demon-
strate an S-predominance and the RS ratio cannot be used to identify the leading layer 
during SR. Fractionated potentials are not always identical on a high-resolution scale and 
can have local mismatches; however, these mismatches occur in a minority of cases. If 
a potential is fractionated during SR, most additional deflections can be explained by 
conduction disorders in the same plane and in a small percentage they represent EEA. The 
incidence of EEA and EEA-based fractionation is relatively low during SR, as was expected. 
However, during atrial arrhythmias the presence of (functional) conduction disorders and 
EEA will increase; therefore, epi-endocardial differences in electrogram morphology and 
EEA-based fractionation will likely increase as well. Particularly interesting, especially for 
clinical practice, is the observation that the morphology of unipolar electrograms can 
potentially be a tool to identify areas of EEA when electrograms are recorded on only one 
side of the wall.
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SUPPLEMENTAL MATERIAL CHAPTER 12: DATA ANALySIS
Patient data inclusion
First activation was required to occur at the top or right atrial side of the mapping area of 
the superior or middle right atrial recording site, otherwise the rhythm was labelled as an 
ectopic atrial rhythm and the patient was not included for analysis. Patients required two 
included recording sites (see below) in order to qualify for study inclusion.
Electrogram exclusion criteria
Electrograms with injury potentials (that can appear due to firm contact with local tissue) were 
excluded for RS ratio analysis only or excluded for all analyses based on the following criteria:
RS ratio exclusion criteria:   elevation of the baseline after the local potential ≥1/3 and < to-
tal amplitude of local potential + concordant shift of potential
Total exclusion criteria:  elevation of the baseline after the local potential ≥1 mV and ≥ 
total amplitude of local potential
Examples are provided in Supplemental Figure 1.
Recording sites with 25% of missing or total excluded electrograms were excluded from 
further data analysis which included either a total number of missing/excluded electro-
grams ≥64 or a total of 32 electrodes from which the exact opposite electrode was missing/
excluded. Excluded recording sites of patients are shown in Supplemental Table 2.
Signal marking
Deflections and peaks were marked by the criteria stated in the manuscript using MATLAB 
R2016a (The MathWorks Inc., Natick, MA). The signal-to-noise ratio was determined by 
the amplitude of the deflection in relation to the amplitude of the noise (Supplemental 
Figure 2, top). The peak-prominence of a new peak was used to evaluate the peak-to-noise 
ratio which defined a new deflection (Supplemental Figure 2, bottom). Noise levels were 
determined for each electrode separately. All signal markings were checked manually and 
markings of artifacts were corrected based on a consensus of two investigators.
Analysis of local epi-endocardial differences
Local epi-endocardial differences are analyzed by comparing each potential to the exact 
opposite potential and its 8 surrounding potentials; 9 potentials in total (=opposite square) 
and determined by the minimal difference of these 9 comparisons. If the opposite square 
consisted of 6 or less potentials the electrode was considered a border electrode and was 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Epi Endo Epi Endo Epi Endo Epi Endo
1 inferior 1047 32 20 9.9 12.5 -0.24 -0.19 17 25 0 0 0
mid 1171 8 12 7.5 9.5 -0.22 -0.32 16 25 0 0 0
superior 563 24 36 7.6 7.4 0.19 0.07 35 37 0 0 0
2 inferior 1024 8 12 10.7 12.1 -0.41 -0.43 10 11 0 0 0
mid 1008 72 36 6.3 6.6 -0.60 -0.61 56 55 6.2 4.6 1.6
superior excluded
3 inferior 998 58 46 5.9 6.6 -0.20 -0.30 49 44 0.2 0 0.2
mid excluded
superior 1002 50 58 3.3 3.1 0.10 0.14 55 57 0 0 0
4 inferior 1088 2 8 9.5 11.3 -0.28 -0.24 19 12 0 0 0
mid 1043 34 66 3.9 3.1 -0.80 -0.67 27 49 1.7 1.3 0.5
superior 840 54 130 4.6 2.8 -0.68 -0.74 34 62 0.5 0.1 0.4
5 inferior 669 0 0 9.1 5.2 -0.47 -0.39 1 0 0 0 0
mid 672 0 0 8.4 7.1 -0.31 -0.28 12 7 0 0 0
superior 707 38 50 4.1 1.9 -0.65 -0.97 24 45 10.0 9.2 0.8
6 inferior 717 0 0 10.4 11.4 -0.21 -0.23 0 2 0 0 0
mid 696 0 4 8.5 7.9 -0.32 -0.41 3 7 0 0 0
superior 682 0 24 6.1 5.5 -0.76 -0.96 26 29 0.4 0 0.4
7 inferior 1577 8 2 8.9 7.8 -0.18 -0.20 14 11 0 0 0
mid 1472 2 6 9.1 7.9 -0.17 -0.28 12 12 0 0 0
superior excluded
8 inferior 729 0 0 9.1 7.5 -0.23 -0.17 5 4 0 0 0
mid 718 8 24 8.9 6.3 -0.26 -0.34 14 19 0 0 0
superior 705 18 44 7.1 5.9 -0.39 -0.41 23 24 0 0 0
9 inferior 793 22 44 5.9 3.6 -0.14 -0.28 39 49 0 0 0
mid 793 12 38 6.0 3.9 -0.23 -0.33 39 43 0 0 0
superior 895 66 68 4.0 3.4 -0.65 -0.87 51 49 2.6 0.3 2.3
10 inferior 895 4 6 11.5 7.6 -0.46 -0.43 12 4 0 0 0
mid 1004 8 28 7.5 4.4 -0.73 -0.56 19 21 0 0 0
superior 1005 22 60 4.3 4.1 -0.99 -0.83 36 72 1.5 0.5 1.1
11 inferior 954 0 0 9.7 9.6 -0.24 -0.20 4 5 0 0 0
mid 1005 6 6 8.7 6.5 -0.26 -0.24 15 12 0 0 0
superior 970 26 18 6.1 4.8 -0.26 -0.19 33 34 0.8 0 0.8
12 inferior 983 0 0 9.4 14.3 -0.49 -0.44 6 3 0 0 0
mid 990 38 60 5.1 4.6 -0.63 -0.69 49 49 10.3 10.3 0
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Epi Endo Epi Endo Epi Endo Epi Endo
superior 975 54 146 3.0 1.9 -0.77 -0.90 49 89 23.1 2.0 21.2
13 inferior 1014 0 22 5.1 6.0 -0.22 -0.18 22 28 0 0 0
mid 962 14 24 5.7 5.8 0.05 -0.05 17 19 0 0 0
superior 1005 16 12 4.6 4.6 -0.11 -0.09 32 23 0 0 0
14 inferior 677 36 34 5.7 3.3 0.44 0.44 30 25 2.8 0.0 2.8
mid 820 24 16 3.7 3.2 -0.52 -0.57 26 11 0 0 0
superior 689 62 72 1.9 1.9 -0.68 -0.84 35 16 6.6 0.4 6.3
15 inferior 849 0 0 16.9 16.9 0.19 0.25 2 5 0 0 0
mid 720 0 0 17.8 14.5 -0.16 -0.22 3 9 0 0 0
superior 571 0 0 16.3 13.4 -0.06 -0.17 3 9 0 0 0
16 inferior 1155 0 6 9.7 9.1 -0.25 -0.25 4 17 0 0 0
mid 1135 0 0 11.2 6.0 -0.21 -0.18 4 4 0 0 0
superior 1130 0 16 9.0 4.5 -0.41 -0.51 4 17 0 0 0
17 inferior 966 6 14 8.0 3.7 -0.39 -0.43 9 9 0 0 0
mid 1053 50 34 3.6 2.3 -0.51 -0.49 29 31 0 0 0
superior excluded
18 inferior 732 0 4 7.2 4.9 -0.36 -0.31 7 2 0 0 0
mid 869 0 2 9.1 5.5 -0.32 -0.36 0 2 0 0 0
superior excluded
19 inferior 1088 48 20 3.5 3.2 0.36 0.42 42 45 0 0 0
mid 1067 14 12 8.1 6.8 0.10 0.23 12 10 0 0 0
superior 974 24 50 8.0 6.9 -0.05 0.08 31 29 0 0 0
20 inferior 702 4 4 6.1 5.5 -0.11 -0.19 6 13 0 0 0
mid 703 6 6 5.9 6.3 -0.44 -0.44 12 24 0 0 0
superior 704 14 30 4.7 6.0 -0.66 -0.60 25 33 1.1 1.1 0
21 inferior 834 2 14 5.7 4.1 -0.24 -0.40 11 36 1.5 0 1.5
mid 784 8 48 2.8 0.9 -0.65 -0.46 26 60 44.4 0 44.4
superior 776 48 34 4.7 5.3 -0.32 -0.44 58 36 0 0 0
22 inferior 678 0 0 9.2 7.0 -0.12 -0.20 4 4 0 0 0
mid 698 4 20 8.1 5.5 -0.47 -0.54 22 19 0 0 0
superior 675 56 100 7.3 4.4 -0.69 -0.96 38 43 1.1 0.9 0.2
23 inferior 954 12 2 18.0 18.0 -0.07 -0.12 9 13 0 0 0
mid 972 22 3 14.9 12.8 -0.26 -0.31 20 10 0 0 0
superior 952 30 6 9.8 8.4 -0.35 -0.42 28 17 0 0 0
24 inferior 787 2 14 11.2 8.4 -0.22 -0.21 12 24 0 0 0
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Epi Endo Epi Endo Epi Endo Epi Endo
mid 773 38 38 8.3 7.8 -0.11 -0.29 30 25 0 0 0
superior excluded
25 inferior 728 72 32 3.7 2.8 -0.53 -0.60 45 37 0 0 0
mid 770 60 22 4.7 4.4 -0.43 -0.25 23 5 7.2 7.2 0.0
superior 750 50 34 5.2 3.8 -0.77 -0.56 39 40 16.1 15.1 1.0
26 inferior 802 20 24 11.5 10.7 -0.11 -0.16 19 18 0 0 0
mid 800 26 32 9.5 6.8 -0.23 -0.22 28 31 0 0 0
superior 794 14 48 7.7 6.2 -0.29 -0.40 28 38 0.6 0 0.6
SRCL = sinus rhythm cycle length; DA = delayed activation; EEA = endo-epicardial asynchrony.
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Supplemental Figure 1. Examples of potentials excluded from analysis.
The baseline after the potential in the middle is elevated > 1/3 of the total potential amplitude with a con-
cordant shift of the potential to a positive dominance, this potential is excluded from RS analysis. The bot-
tom potential is excluded from all analyses as the elevation of the baseline after the potential is larger than 
the total potential amplitude.
Supplemental Figure 2. Signal-to noise and peak-to-noise ratio.
Top: the ratio between the amplitude of the deflection and amplitude of the noise defined the signal-to-
noise ratio. Bottom: the ratio between the peak prominence and the amplitude of the noise determined the 
detection of a new peak and the presence of a new deflection.
Chapter 12
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Supplemental Figure 3. Asynchrony in epi-endocardial activation.
Percentage of asynchrony (>14ms) with epicardial vs. endocardial delay per location for all patients with 





A Tale of Two Sides






Cardiac mapping has profoundly impacted diagnosis and treatments of focal and macro-
re-entrant tachyarrhythmias. When the resolution of atrial mapping was increased, it 
revealed more specific patterns of activation during atrial fibrillation (AF) such as break-
through waves. These breakthrough waves arose from circumscriptive areas from where 
they expand to a variable degree into the surrounding tissue. These breakthrough waves 
during AF were described as nonrepetitive events occurring scattered throughout both 
atria without any fixed pattern of activation.1-3 Coupling intervals of breakthrough fibrilla-
tion waves were often longer than the dominant AF cycle lengths, so they were not a “driv-
ing source”. Unlike the unipolar QS morphology at the origin of focal atrial tachycardia, 
most unipolar electrograms recorded from the initiation sites had a rS morphology. All 
these features suggested the presence of transmural propagating waves approaching the 
surface area from below.
As transmural conduction of fibrillation waves can only occur in the presence of endo-
epicardial asynchrony, the hypothesis of asynchronous activation during AF was con-
ceived. We subsequently provided the first direct proof of endo-epicardial asynchrony of 
the atrial wall during AF in humans by performing intraoperative simultaneous mapping 
of the endocardial and epicardial layer of the right atrial free wall. This study revealed not 
only the presence of endo-epicardial asynchrony, but also that breakthrough waves occur 
at both the endocardial and epicardial side.3, 4
The existence of asynchrony in activation between the epicardial and endocardial layer 
has been known for many years5; however, its importance in atrial arrhythmia pathophysi-
ology has just recently started to be recognized. Simultaneous endo-epicardial mapping 
demonstrated that endo-epicardial asynchrony can be present up to 50% of the time 
during atrial fibrillation. For the majority of observed breakthrough waves, waves had 
passed by on the opposite side only a few moments before indicating that asynchronous 
fibrillation waves conducted through the atrial wall resulting in breakthrough waves.2 
The structural architecture of the atria is likely a key player in these phenomena. The first 
study of asynchrony performed by Schuessler et al. already associated endo-epicardial 
asynchrony with regions composed of pectinate muscles and cardiac fibers with different 
alignments.5 Sites of breakthrough will presumably correspond to sites where intramural 
fibers connect the two layers. Although observations of asynchrony are limited to the right 
atrial wall for now, the variability in fiber orientation at the left atrial wall provides a suit-
able substrate for left atrial endo-epicardial asynchrony as well.6
Evidence that the concept of waves conducting from one side to the other is not only 
limited to atrial fibrillation has now been provided by Pathik et al.7 Their elegant study 
demonstrated in a sample of 26 patients by using high-resolution endovascular mapping 
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that breakthrough waves occur at the right atrium during macro-re-entrant tachyarrhyth-
mias as well. Breakthrough waves were present in about half of the cases, mostly at the 
posterior right atrium, situated near sites of slow or blocked conduction. Breakthrough 
sites were in a couple of cases verifiably embedded in the arrhythmia circuit and could 
even be critical in maintaining the circuit. In the latter case, the breakthrough site sig-
nified a shift of the circuit pathway after ablation to an alternative route consisting of a 
preserved pathway on the opposite side of the atrial wall and transmural conduction after 
the ablation line. The breakthrough sites near areas of conduction block demonstrate that 
barriers for conduction are not always transmural. Conduction can be preserved at the 
other side of the wall causing conduction to continue on only one side which results in 
asynchrony and consequently endo-epicardial breakthrough waves. These interesting 
findings underline the fact that the electrophysiology of the atria is not 2-dimensional 
and we should start seeing the atrial wall as a 3-dimensional structure where new waves 
can originate from cardiac fibers coursing on the other side of the wall. Although they 
are, unfortunately, not able to directly confirm an epicardial source for the breakthrough 
waves in this study due to technical limitations, supporting evidence was well provided by 
demonstrating unipolar rS electrogram morphology at breakthrough sites and stability of 
breakthrough sites during pacing.
The fact that asynchronous patterns of activation within the atrial wall can have such a 
key role in multiple arrhythmia pathophysiologies emphasizes the relevance of evaluating 
cardiac electrophysiology from more than one perspective. The two sides of the cardiac 
wall can clearly exhibit discrepancies in barriers for conduction, creating differences in 
timing and possibly patterns of activation between both sides. Disturbances in conduction 
on one side can greatly effect patterns of conduction on the other side and each can rep-
resent a continuous source for new breakthrough waves on the opposite side. Therefore, 
new techniques in order to accomplish mapping in all 3 dimensions of the atrial wall in 
clinical practice should be further explored. The interplay between the endo- and epicar-
dial side can be critical in arrhythmia pathophysiology and to fully understand their hold 
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Endo- and Epicardium at the Right 
Atrium










Background: The predisposition of atrial extrasystoles (AES) to trigger arrhythmia may 
also arise from intramural conduction disorders causing endo-epicardial asynchrony 
(EEA). This study aimed to determine whether spontaneous AES disturb endo-epicardial 
conduction.
Methods: Simultaneous endo-epicardial mapping of the right atrium was performed in 
patients during cardiac surgery with two 128-electrode arrays. Sixty spontaneous AES 
were observed in 23 patients and were analyzed for incidence of conduction delay, con-
duction block and amount of EEA compared to the previous sinus rhythm beat.
Results: Both conduction delay and block occurred more often in AES compared to sinus 
rhythm. The difference in lines of conduction block between the epicardium and endo-
cardium increased in AES causing a greater imbalance of conduction disorders between 
the layers. The incidence of EEA with differences ≥10 ms increased significantly in AES. 
AES caused delays between the epicardium and endocardium up to 130 ms and EEA to 
increase for up to half (47%) of the mapping area.
Conclusion: Conduction disturbances between the epicardial and endocardial layer giv-
ing rise to EEA increase during AES. Asynchronous activation of the atrial layers increases 
during AES which may be a mechanism for triggering cardiac tachyarrhythmias under the 
right conditions but EEA cannot be recognized by current mapping tools.
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INTRODUCTION
Atrial extrasystoles (AES) are a common finding in the general population and usually the 
occurrence of AES is benign. However, frequent AES have been associated with increased 
risk of developing atrial fibrillation and paroxysmal episodes of atrial fibrillation are in 
more than 90% of the cases preceded by an AES.1,2 The majority of AES triggering atrial 
fibrillation originate from the left atrium, most frequently the pulmonary veins.3 Recently, 
high-resolution epicardial mapping demonstrated that atrial conduction disorders in-
crease during spontaneous AES, which are caused by anisotropy due to their ectopic origin 
and/or refractoriness of myocardium due to their prematurity.4 Slowing of conduction can 
in turn facilitate re-entry and initiate arrhythmia such as atrial fibrillation.
Conduction disorders are not limited to the 2-dimensions of the superficial layers of the 
atrial wall. During both atrial fibrillation and sinus rhythm conduction between epicardial 
and endocardial myocardium can be dissociated causing asynchronous activation of the 
epicardial and endocardial atrial wall.5,6 Endo-epicardial asynchrony (EEA) and the ensu-
ing breakthrough waves caused by endo-to-epicardial conduction or vice versa have been 
proposed as a possible mechanism sustaining atrial fibrillation.5 Based on these previ-
ous findings, we hypothesized that during AES endo-epicardial conduction will become 
more disturbed than during SR and that EEA could be a potential mechanism triggering 
arrhythmia. Therefore, we investigated the difference of EEA in sinus rhythm beats and 




Patients participating in the Epic End study (NTR5370), an endo-epicardial mapping study 
in adult patients undergoing open-heart surgery, were included. This study was approved 
by the local ethics committee (MEC 2015-373) and all patients gave informed consent prior 
to inclusion. Twenty-three patients demonstrating AES during mapping were included of 
whom 17 (74%) underwent surgery for coronary artery disease and 11 (48%) had valvular 
heart disease. Nine patients (39%) had a history of atrial fibrillation. Clinical characteristics 




Endo-epicardial mapping is performed during surgery prior to start of cardiopulmonary 
bypass and has been previously described in detail.7 Two arrays containing 128 electrodes 
(16×8) with 2 mm interelectrode spacing were each fixed on a steel spatula and the spatu-
las were bound together at the end to preserve precise opposite alignment of the two ar-
rays. After arterial cannulation, one array is introduced in the right atrium for endocardial 
mapping via the incision for venous cannulation. The second array remains on the outside 
to record from the epicardium. Simultaneous epicardial and endocardial unipolar electro-
gram recordings of the right atrial free wall were obtained for 5–10 s during sinus rhythm 
from three locations at the right free atrial wall (Figure 1A). In one case, endo-epicardial 
mapping was performed at the left atrial appendage before excision.
Table 1. Clinical characteristics
Total patients, N 23
Age, years 64 ±9
Male/ Female 18/5
Median number of AES (min-max) 2 (1-7)
Current heart disease, N (%)
Coronary artery disease 17 (74)
Aortic valve disease 4 (17)
Mitral valve disease 7 (30)
Tricuspid valve disease 1 (4)
Patent foramen ovale 1 (4)
Left ventricular dysfunction 4 (17)*
Left atrial enlargement 7 (30)
Medical history, N (%)
Hypertension 13 (57)
Hypercholesterolemia 10 (43)
Diabetes mellitus 8 (35)
Atrial Fibrillation 9 (39)
Paroxysmal 7 (30)
Persistent 2 (9)
Anti-arrhythmical medication, N (%)
Class 1 0 (0)
Class 2 17 (74)
Class 3 1 (4)
Class 4 3 (13)
Digoxin 3 (13)
*3 mild and 1 moderate dysfunction. AES = atrial extra systole.
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Data analysis
Electrogram analysis was performed in MATLAB R2016a (The MathWorks Inc, Natick, MA, 
USA). Electrograms with injury potentials (baseline elevation after the atrial potential 
larger than the amplitude of the atrial potential) were excluded from analysis.6 Recording 
sites with ≥25% missing or excluded electrograms were not included in this study. Local 
activation times were marked at the steepest negative slope with a minimal slope of 0.05 
mV/ms and a signal-to-noise ratio >2.6 Local endo-epicardial time differences were deter-
mined for each electrode and consisted of the shortest activation time difference between 
the electrode and the 9 electrodes on the opposite side (exact opposite electrode and 
its 8 surrounding electrodes; Figure 1C). Border electrodes (<7 opposite local activation 
times present) were excluded from analysis. Previously, we defined EEA as activation 
time difference between epicardium and endocardium of ≥15 ms.5 As atrial wall thickness 
is very diverse within the atria, we not only analyzed EEA of ≥15 ms (large EEA) but also 
moderate EEA between 10–15 ms. EEA in AES is expressed as a percentage of the total 
electrodes during the AES demonstrating EEA (equaling the area of the array with EEA). 
Conduction disorders in the superficial epicardial and endocardial planes were defined as 
the incidence of 1) conduction block with interelectrode difference >11 ms and 2) conduc-
tion delay with interelectrode difference of 7–11 ms. Conduction disorders are expressed 
in mm, translating to the total length of all interelectrode lines of conduction delay and 
block in the activation maps.
Atrial extrasystoles
AES were defined as beats during sinus rhythm with either a shortening in cycle length 
≥25% to the previous sinus-beat and/or an aberrant activation pattern compared to 
sinus-beats.4 Prematurity compared to the sinus-beat (the prematurity index) could not 
be determined for 1) AES that were the first or second beat of the recording, or 2) AES 
following another AES, or 3) in case of AES in bigeminy. AES were labelled for their degree 
of aberrancy from sinus rhythm, for example, shift in direction of the main wavefront 
trajectory (wave covering the largest area of the mapping area) (Figure 1B, 1D). Based 
on our previous study4 that demonstrated increased conduction disorders for wavefront 
shifts of 90°, breakthrough and complex patterns during AES, the following categories for 
aberrancy of AES were defined: 1) no aberrancy (only premature AES) or mild to moderate 
shift of the main wavefront trajectory in AES (0–45° or 135°–180° shift), 2) severe shift of the 
main wavefront trajectory in AES (90° shift), breakthrough or complex pattern of activation 
of AES (and sinus rhythm) and 3) breakthrough or complex pattern of activation in sinus 
rhythm only. When degree of aberrancy differed between epicardium and endocardium, 
the severest degree of aberrancy of the two determined the aberrancy category.
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Figure 1. Endo-epicardial mapping and data analysis.
A: Endo-epicardial mapping was performed with two 128-electrode arrays, one placed on the epicardium 
and one on the endocardium. Recording locations included 1) the superior right atrium (RA), 2) the mid-RA 
and 3) the inferior RA. B: Endo-epicardial activation maps of a sinus rhythm (SR) beat and an atrial extra-
systole (AES) show the aberrant activation pattern of the AES, at the epicardium there is mild aberrancy 
(180° shift of the main wavefront trajectory), at the endocardium there is a complex pattern of activation 
during sinus rhythm without a main trajectory. Conduction block (∆ > 11 ms) or delay (7–11 ms) between 
two electrodes represents a line of 2 mm. The total length of all lines represents the amount of conduction 
block and delay. Epi- and endocardial electrograms demonstrate the AES is premature as well, with a 57% 
shortening of the cycle length. V, ventricular activation. C: Endo-epicardial asynchrony (EEA) is determined 
by the minimal local activation time difference between the nine opposite electrodes and the index elec-
trode (center). Electrodes at the border of the array only have ≤ 6 opposite electrodes and are excluded. At 
the epicardium the minimal difference is 0 ms (blue), in this example, at the endocardium the minimal dif-
ference is -1 ms (red). The maximal difference of two opposite electrodes is shown in the EEA map. Positive 
values represent an epicardial delay in activation and negatives values an endocardial delay in activation. 
D: Degree of aberrancy is categorized based on the rotational shift of the main trajectory of the AES wave-
front; mild 180°, moderate 45°/135°, severe 90°.
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Statistical analysis
Normally distributed data are presented as mean ± SD and skewed data are presented 
as median (interquartile range). AES mapping data consists of clustered measurements 
(multiple AES recorded within a patient). Therefore, the associations of sinus rhythm and 
AES with conduction delay, conduction block and EEA were evaluated using Generalized 
Estimated Equations. The skewed distributions of conduction delay, conduction block 
and EEA could not be transformed to a normal distribution and thus, were converted 
to a binary distribution by setting cutoff values that represented a possible shift in oc-
currence between AES and sinus rhythm as observed in the histograms. The number of 
positive cases required at least 25% of the data; otherwise, the cutoff value was set at the 
top quartile. All cutoff values are presented after the P-value. A binary logistic model was 
used to assess the effect of AES on conduction delay, conduction block and EEA. Correla-
tion structure was chosen based on the goodness of fit in the quasi-likelihood function. 
In all cases an independent correlation structure was chosen. Statistical analyses were 
performed with IBM SPSS Statistics version 21 (IBM corp., Armonk, NY, USA).
RESULTS
Atrial extrasystole characteristics
Twenty-three patients demonstrated 60 AES, per patient a median AES of 2 (min–max: 
1–7), and most were recorded at the inferior right atrial free wall (31 at the inferior right 
atrium vs 12 at the middle and 16 at the superior right atrium and 1 at the left atrium). Ten 
AES were only aberrant and 9 AES were only premature, the remainder was both aberrant 
and premature or aberrant with unknown prematurity. The prematurity index could not be 
determined for 29 AES of the 50 (possibly) premature AES, the remaining 21 premature AES 
had a prematurity of 45% ± 10%. All premature and/or aberrant AES had a mean interval 
after the previous beat of 560 ± 135 ms (min–max: 340–920 ms). Twenty-five AES (42%) had 
no to moderate aberrancy, 29 AES (48%) had severe/ complex aberrancy and 6 AES (10%) 
had a complex pattern of activation on one or both sides during SR only. The majority of 
AES (37/60) were the second to seventh AES recorded in the same patient. Most of these 
AES likely originated from the same location within the atria as a previous AES in that same 
patient, because 26 AES had the same degree of aberrancy as one of those previous AES.
Conduction delay and block
During sinus rhythm, the endocardium contained more extensive conduction disorders 
than the epicardium as total length of conduction block lines was longer at the endocardi-
um (P=0.015, ≥20 mm). Total length of lines with conduction delay was similar for both the 
epicardium and endocardium. AES increased the total length of these lines of conduction 
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block and delay (Table 2). Conduction block increased during AES from 8 (0–48) mm to 
20 (6–41) mm (P=0.020, ≥10 mm). Comparable to conduction block, conduction delay in-
creased as well during AES from 24 (12.5-36) mm to 38 (18.5–50) mm (P=0.014, ≥30 mm). At 
the epicardium, conduction delay increased from 11 (4–19.5) mm to 16 (8–27.5) mm in AES 
(P=0.030, CD ≥10 mm) whereas conduction block did not change (P=0.639, >16 mm). Total 
length of conduction block (P=0.113, ≥10 mm) rather than conduction delay (P=0.276, ≥24 
mm) tended to increase in AES at the endocardium. The difference between the epicardial 
and endocardial layer in the total length of conduction disorders was also analyzed. The 
endo-epicardial difference in total length of conduction block increased from 2 (0–8) mm 
in SR to 10 (2–18) mm during AES (P=0.037, ∆≥14 mm). Endo-epicardial difference of total 
conduction delay did not change during AES (P=0.102, ∆≥14 mm).
Endo-epicardial asynchrony
During AES, an increase of EEA occurred almost twice as much as a decrease of EEA. An 
increase in EEA ≥15 ms occurred in 17 AES (28%) presenting in 8 patients, which included 
the AES recorded at the left atrium (Figure 2). These AES resulted in EEA with a median 
delay of 20 ms per AES and 23 ms per patient (min–max: 16–81 ms). The largest endo-
epicardial time delay observed at a site during an AES was 130 ms. In 9 AES (15%) recorded 
from 8 patients EEA decreased compared to sinus rhythm. These AES had EEA during sinus 
rhythm with a median delay of 16 ms per AES and patient (min–max: 15–26 ms). In the 
remaining 34 AES (57%), EEA did not change.
Table 2. Conduction disorders during sinus rhythm vs atrial extrasystole
Sinus rhythm Atrial extrasystole P-value
Overall
CB (mm) 8 (0–48) 20 (6–41) 0.020
CD (mm) 24 (12.5–36) 38 (18.5–50) 0.014
Epicardium
CB (mm) 2 (0–16) 4 (0–15.5) 0.639
CD (mm) 11 (4–19.5) 16 (8–27.5) 0.030
Endocardium
CB (mm) 4 (0–26) 14 (5–23.5) 0.113
CD (mm) 12 (6–22) 16 (8–26) 0.276
Endo- vs. epicardium
∆CB (mm) 2 (0–8) 10 (2–17.5) 0.037
∆CD (mm) 6 (2–11.5) 7 (4–14) 0.102
Endo-epicardial asynchrony
EEA ≥ 10 ms (%) 0 (0–2.3) 0.7 (0–6.0) 0.023
EEA ≥ 15 ms (%) 0 (0–0.6) 0 (0–3.0) 0.053
CB = conduction block; CD = conduction delay; EEA = endo-epicardial asynchrony.
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Besides EEA of ≥15 ms, also endo-epicardial time differences between 10-15 ms were ana-
lyzed. Figure 3A shows the number of sinus-beats and AES demonstrating areas of large 
EEA (≥15 ms) and moderate and large EEA combined (≥10 ms). Incidences for both EEA 
groups increased during AES for EEA areas >5%. The changes in EEA during each AES for 
every individual patient are presented in Figure 3B. The top panel includes large EEA (≥15 
ms) only and the middle panel includes both moderate and large EEA (≥10 ms). The in-
crease of large EEA during AES almost reached a significant result (P=0.053, EEA area >5%).
The most extensive increase of EEA area observed during AES involved 47% of the mapped 
area. When both moderate and large EEA were included, almost half of all AES (47%) dem-
onstrated an increase in EEA during AES. Incidence of EEA ≥10 ms increased during AES 
(P=0.023, EEA area >5%).
There was no clear preference for either epicardium or endocardium to lag during AES. 
However in AES with the most increase of EEA (>20% of the array), the endocardial side 
was delayed relative to the epicardium (Figure 4). The same side was often delayed in case 
of EEA during multiple AES within one patient. One of the patients demonstrated a change 
from endocardial to epicardial delay in two consecutive AES (Figure 5). The first AES of this 
Figure 2. Examples of an increase of endo-epicardial asynchrony (EEA) during atrial extrasystoles at the 
right (RA) and left atrium (LA).
Color-coded activation maps of epicardial and endocardial local activation times and asynchrony maps are 
presented for sinus rhythm (SR, top) and atrial extra systole (AES, middle). Grey and black lines represent 
interelectrode conduction delay and block. Bottom: Electrogram examples from the location where EEA 
increases during the AES (asterisks).
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Figure 3. Change in endo-epicardial asynchrony (EEA) during atrial extra systoles (AES).
A: Frequency histograms of EEA between 10–15 ms and ≥15 ms during sinus rhythm (SR) and AES. Areas of 
EEA covering >5% of electrodes increase during AES. For EEA ≥10 ms, binary logistic analysis using Gener-
alized Estimated Equations demonstrated a significant association between >5% EEA and AES (P=0.023). 
B: Difference in EEA of AES compared to SR for EEA ≥10 ms and EEA ≥15 ms. Positive values represent an 
increase of EEA in AES, negative values represent a decrease of EEA in AES. Multiple AES in one patient are 
clustered and a change from an open (white) to a filled (dark) marker represents a different patient.
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patient also had the longest increase in EEA of all AES of all patients; the endocardium was 
delayed by up to 130 ms compared to the epicardium during AES. There was no effect of a 
history of atrial fibrillation on the degree of EEA during sinus rhythm or AES.
Impact of prematurity and aberrancy
There was no correlation observed between prematurity and EEA increase. AES with the 
largest increases in EEA had severe or complex aberrancy (Supplemental Figure 1). Median 
∆EEA for AES with the mildest aberrancy was 0 (0–0)%, for AES with severe and complex 
aberrancy 0 (0–2.8)% and for AES with complex sinus rhythm activation pattern 0.7 
(-1.9–+3.6)%. No difference was observed for ∆EEA in AES between aberrancy categories.
Figure 4. Epicardial vs. endocardial delay in atrial extrasystoles.
Scatterplot presenting the amount of decrease or increase of endocardial and epicardial delays ≥15 ms per 
atrial extrasystole (AES) compared to sinus rhythm. Multiple AES in one patient are clustered and a change 
from an open to a filled marker represents a different patient. For example, in the 8th patient the first AES 
has a 47% increase in endocardial delays and an 0.5% decrease in epicardial delays. The second AES in this 





The main finding of this study is that spontaneous AES demonstrate more EEA than 
sinus-beats. Maximal increase in EEA-delay observed with AES was 130 ms and maximal 
EEA-area increase was 47%. A possible cause for increased EEA during AES was an increase 
in the imbalance of epicardial versus endocardial conduction disorders. Both conduction 
delay and block increased during AES; conduction delay increased mainly at the epicar-
dium whereas conduction block likely increases mainly at the endocardium.
Conduction disorders in atrial extrasystoles
The increase of high-resolution conduction disorders in AES especially for aberrant AES 
was previously reported.4 The current study demonstrated that these conduction disor-
ders also become more unequally distributed between the epicardium and endocardium 
Figure 5. Presentation of severe endocardial delays during atrial extra systoles (AES). 
Delays reach up to 130 ms at the lower part and the upper part is refractory. However, with the second im-
mediately following AES the delay shifts to the epicardium (epi) with delays up to 50 ms at the upper part. 
Electrogram examples demonstrate the severe delays at the endocardium (endo) for the first AES and at the 
epicardium for the second AES. Asterisks refer to the site of the electrograms in the corresponding maps. 
SR, sinus rhythm.
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in AES which may be one of the causes of increased EEA in AES. If conduction is delayed 
unevenly at epicardial and endocardial layers, this creates or enhances a substrate for 
asynchronous endo-epicardial activation. Studies have shown that conduction in AES 
mainly slows in the transverse direction, perpendicular to the myocardial fibers, thereby 
increasing the anisotropic behavior of the tissue.8–10 This was underlined by our previous 
finding that aberrancy had an important role in aggravating conduction disorders during 
AES.4 The severity of transverse conduction disorders in diseased myocardium was related 
to the fibrosis architecture. Myocardium with clustered fibrotic areas demonstrated more 
AES induced conduction disorders than those with diffuse fibrosis.8,9 Distribution between 
sub-epicardial and sub-endocardial atrial fibrosis has not been described so far, however, 
is possibly very heterogeneously in nature. Nonetheless, the right atrial anatomy may 
favor endocardial conduction delays due to naturally limited transverse connections of 
the pectinate bundles making them vulnerable for conduction disorder in case of trans-
versely traveling waves. In this study, there was no clear dominance of endocardial delay. 
Although, the AES with the largest increases in areas of EEA did have endocardial delay.
Arrhythmogenic potential of AES and effect of EEA
AES interrupt the stable rhythm originating from the sinus node by exciting the atria pre-
maturely and/or from a site distant to the sinus node. As a result, at the time of the AES, 
recovery of myocardial cells can still be heterogeneously distributed in case of a premature 
AES. In the case of a different activation site during AES, the direction of activation changes 
leading to different conduction velocities due to anisotropy. Both of these concepts are 
able to result in re-entry in which an electrical pathway sustains itself, like a dog chasing its 
tail, causing a tachyarrhythmia.11,12 The two prerequisites for re-entry are 1) unidirectional 
block and 2) a cycle length longer than the longest refractory (recovery) period. When uni-
directional block occurs from the epicardium to the endocardium or vice versa, this will, 
in the best case, result in EEA only or it could result in an intramural re-entry circuit. This 
study demonstrated that either unidirectional or bidirectional conduction block between 
the layers occurs only during AES in patients.
Schuessler et al. have investigated endo-epicardial conduction at the right atrial append-
age of dogs during sinus rhythm, pacing, extra-stimuli and induced tachyarrhythmias.13 
EEA increased with premature stimulation close to the refractory period and increased 
most with aberrant premature stimulation. Maximal recorded difference in excitation 
between epicardium and endocardium during premature stimulation was 30 ms. They 
then induced tachyarrhythmias in the presence of high-dose acetylcholine with a single 
extra-stimulus and demonstrated an intramural re-entry pattern during tachyarrhythmia 
with a very short cycle length of approximately 60 ms and EEA up to 31 ms. In our study, 
we recorded a much larger endo-epicardial excitation difference of 130 ms in a spontane-
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ous AES in a patient with aortic valve disease. Functional right atrial refractoriness has 
been measured at around 270 ± 30 ms during electrophysiological studies in patients 
with or without a history of atrial fibrillation at cycle lengths of 600 ms.14 In human right 
atrial bundles perfused with pinacidil, intramural re-entry patterns with cycle lengths of 
57 to 210 ms and maximal EEA of about half the re-entry cycle length (22–105 ms) were 
observed.15 During atrial fibrillation, EEA >50 ms was demonstrated at the right atrium in 
patients with atrial fibrillation cycle lengths between 140–246 ms and at the left atrium 
in a goat-model of atrial fibrillation with cycle lengths around 120–140 ms.5,16 In both 
studies, the majority of the frequent focal waves were most likely caused by transmural 
conduction as a result of EEA. These findings suggest that EEA of 130 ms could create an 
intramural pathway of long enough delay for atrial tissue to recover from refractoriness, 
thereby promoting re-entry. Besides re-entry around an unexcitable core, EEA could also 
result in spiral wave re-entry: if conduction between the layers is slowed down to an extent 
that the intramural wavefront curve starts to spiral.
Multifactorial conditions for AES to trigger tachyarrhythmias
Multiple conditions can either contribute or counteract tachyarrhythmias initiation under 
different circumstances. One important factor is the refractory period, as it determines 
excitability of myocardial cells. Prematurity of AES close to the refractory period favors 
conduction disorders and inhomogeneous conduction due to uncompleted repolariza-
tion. However, the refractory period of myocardial cells is not a fixed time period and 
may vary under the influence of different factors. For example, the refractory period is 
rate-dependent and between atrial sites and within myocardial bundles differences in 
refractory duration also exist.12 Furthermore, conduction velocity depends on anatomical 
factors such as anisotropy and source-to-sink principles. Anisotropy is that impulses travel 
slower along the transverse direction of myocardial bundles than the longitudinal direc-
tion. The source-to-sink principle is that conduction slows down when a small bundle has 
to excite a relatively large myocardial area.17 Therefore, the direction of the wavefront in 
the heterogeneous atrial architecture determines conduction velocity.
Next to the previously mentioned conditions for re-entry, a third one is required: the ex-
istence of a pathway for re-entry. If there are no connecting myocardial bundles between 
epicardium and endocardium at the site of EEA, there is no pathway for intramural re-entry. 
Finally, the atrial architecture can be disrupted in all three dimensions by underlying heart 
diseases or aging causing fibrosis or the conduction properties of myocardial cells change 
due to tachyarrhythmia induced electrical remodeling.8,9,18 Atrial structural and electri-
cal remodeling thereby influences conduction velocity and continuity. All these factors 
combined determine atrial sensitivity for an AES to initiate a tachyarrhythmia. Although in 
our study the AES did not initiate tachyarrhythmias, the increase of epi-endocardial con-
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duction disorders observed in AES add to arrhythmogenic tissue properties that underlie 
arrhythmias.
Clinical impact
This study demonstrated that EEA aggravates during AES, which thereby increases the 
arrhythmogenic properties of AES. Importance of EEA therefore seems not confined to 
atrial fibrillation alone. EEA has also been suggested as a mechanism during atrial flutter.19 
Clinicians need to be aware that current mapping technologies in patients are limited to 
diagnosing conduction disturbances on only one side of the atrial wall. There is a whole 
black box of atrial activation on the other side, especially during arrhythmia and arrhyth-
mia prone conditions such as AES.
Study limitations
No atrial tachyarrhythmia was initiated by the AES in this study, as is the case for most 
AES, and most patients also did not have a history of atrial arrhythmias. Multiple factors 
contribute to tachyarrhythmia initiation. Due to the limited size of our study group and 
frequent occurrence of multiple AES in a short recording time period, this study could not 
substantially determine the effect of prematurity or aberrancy on increase of EEA during 
AES. Endo-epicardial mapping with performance of pacing protocols including premature 
stimulation could elucidate the contribution of AES characteristics on EEA occurrence. 
Furthermore, endo-epicardial mapping during cardiac surgery is mostly restricted to the 
right atrium; therefore, left atrial data is limited.
CONCLUSIONS
Atrial ectopic activation interrupting sinus rhythm provokes more conduction disorders 
between the epicardium and endocardium which creates or aggravates EEA. An imbalance 
in the degree of conduction disorders at the epicardium versus the endocardium could 
attribute to the occurrence of EEA in AES. Asynchrony between the layers in AES reached 
up to 130 ms which could be enough to initiate an intramural re-entry pathway under the 
right conditions. Current mapping tools in patients are not equipped to recognize arrhyth-
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SUPPLEMENTAL MATERIAL CHAPTER 15
Supplemental Figure 1. Endo-epicardial asynchrony difference for AES compared to SR per aberrancy cat-
egory.
Aberrancy categories include AES with no, mild or moderate aberrancy vs AES with severe or complex ac-
tivation patterns during AES vs AES with complex activation patterns during SR only. Largest increases in 
EEA occurred in AES with severe/ complex activation patterns. A complex pattern during only SR decreased 











Controversy in mechanisms underlying atrial fibrillation
For most atrial tachyarrhythmias the mechanism, i.e., pathological electrical pathway is 
known and therefore ablative procedures for these tachyarrhythmias are very effective. 
On the other hand, the mechanism underlying atrial fibrillation (AF) remains uncertain 
and controversy exists between researchers studying AF. What is known is that paroxys-
mal AF is in most cases triggered by electrical activity from the pulmonary veins.1 Many 
theories have been proposed for persistence of AF and the two main positions taken over 
the last years were researchers supporting the concept of rotors or focal activity driving AF 
vs researchers supporting the multiple wavelet theory.2-5 Evidence for both sides has been 
published and this raises the question: why do results between AF studies differ so sig-
nificantly?2-4, 6, 7 In 2014, both positions were argued in a crosstalk and the important argu-
ment was made that the mapping resolution and signal processing technologies are fun-
damentally different.8-11 Mapping, i.e., the representation of electrical activity pathways is 
based on, first, recording of local electrical activity on electrograms, and then determining 
the local activation time of each signal recorded on the electrogram. Mapping outcomes 
are determined by recording modus, quality of electrograms, density and surface area of 
electrogram recordings. The next paragraphs will discuss which previous mapping studies 
and mapping approaches have been performed and which mechanism they supported, 
which resolution is required for AF mapping, the effect of recording modus, and will argue 
the added complexity in AF mapping caused by endo-epicardial asynchrony.
Mapping studies of atrial fibrillation
Studies that have mapped AF activation patterns in patients with persistent AF to find the 
underlying mechanism, and have used direct contact mapping with different resolution 
or recording mode have been summarized in Table 1. In the last column the dominant 
supporting theory is shown, meaning which pattern of activation is seen in most patients/ 
most of the recording time. Table 2 specifies also the other activation patterns that were 
observed in these studies. Rotors have been mostly detected during mapping with a very 
low resolution (0.6-1/cm2) and in these studies rotors were present in >88% of patients.5, 12-14 
There was one high-resolution mapping that showed (mostly) transient rotors during only 
12% of the recording time with a median of 3 rotations. In one case, a relatively stable 
rotor (presence >95% of the time) was seen.7 The studies with the highest resolution of 19 
and 21-24/cm2 mainly supported the multiple wavelets theory because drivers were not or 
only sparsely observed.2-4, 7 Earlier studies with a low to medium resolution (0.8-8.5/cm2) 
often attributed their findings to micro- or macro-re-entry, however, often it was based on 
a theoretical explanation of either a focal pattern of activation or regular repetitive activa-








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































exclude the multiple wavelets theory only based on transient regular repetitive activities 
or activation patterns at certain atrial parts. This theory does not imply that all waves have 
to be random at all time, based on local functional or anatomical features, predilection for 
certain activation patterns may exist.
Moreover, the definition used for a rotor in human mapping studies is very debatable. On a 
basic level, the difference between normal re-entry and a rotor is the electrically active core 
(phase singularity) of a rotor in comparison to the electrically inactive center of re-entry 
around an obstacle.19 However, human mapping studies define rotors only as rotational 
activity around a center which was, in the beginning, required to remain sustained for >50 
or >1000 cycles, but later also >10 cycles or >2-3 cycles was defined as a rotor.4, 5, 7, 12, 14, 20 
Core electrical activity of rotational activation patterns in these studies cannot be deter-
mined due to the low resolution. Currently, due to technological limitations, endocardial 
mapping is of low resolution and high-resolution mapping with multi-electrode arrays can 
only be performed epicardially. Therefore, it is unknown if there is an association between 
the atrial side of mapping (endocardium vs epicardium) and the fact that rotors are mainly 
found in endocardial mapping studies. One advantage of low-resolution mapping is that 
a large area can be mapped simultaneously providing a total overview of the atrial activa-
tion pattern.
Chapters 4 and 5 introduced a new epicardial mapping approach covering both atria and 
Bachmann’s bundle with a resolution higher than in the studies of Table 1. At 9 atrial areas, 
192 electrograms were recorded simultaneously with a density of 30/cm2 (total surface 58 
cm2) in order to identify small conduction disturbances and to create a detailed map of 
activation patterns during sinus rhythm, pacing and AF. This technique can also be applied 
during minimally invasive surgery, although for complete left atrial mapping additional 
incision sites would then be required. Also, in Chapter 9 another new mapping technique 
was introduced of simultaneous epicardial and endocardial high-resolution mapping that 
provided a new possible mechanism expanding on the multiple wavelets theory.
The resolution required for atrial fibrillation
To determine the required resolution for mapping of AF, it is necessary to have an under-
standing of the resolution of AF itself. Sizes of waves in human AF have been described in 
two previous studies that performed high-resolution mapping. Lee et al. defined narrow 
AF wavelets as waves between 5-15 mm and observed a mean wave size of 20.9±15 mm 
and median wave size of 15 mm (interquartile range: 15-35 mm).4 AF waves in the figures 
of studies by Allessie et al. and De Groot et al.2, 3 were as narrow as a single electrode row 
translating to a wave diameter of ±2.5 mm. In patients with longstanding persistent AF 




patients without AF in whom AF was induced.2 The focal waves observed in Chapter 9, 
were defined to have a minimal size of 4 electrodes. Smallest focal waves with sizes of 4, 
5 and 6 electrodes comprised, respectively, 5.3%, 4.9% and 4.2% of all focal waves. Sizes 
of focal waves therefore range in 15% between 16-24 mm2. Mapping approaches with a 
low resolution will not be able to detect these small AF wavelets because it would require 
a minimum resolution of unipolar electrodes or bipolar electrode pairs of 7 per cm2 to 
be able to register these AF waves on one electrode alone. From the 11 mapping studies 
presented in Table 1, 4 studies meet these requirements. When comparing the resolution 
of high-resolution electrode arrays to the resolution of the basket catheter used in the 
studies of Narayan et al5, 13, 14 and Honarbakhsh et al12, the resolution of the latter is 30 
to 50 times lower (0.6 or 1 electrode/cm2 vs 30 electrodes/cm2). A high-resolution during 
mapping of AF will decrease the chance of under-detection of AF waves and of incorrect 
interpretation of atrial activation patterns.
Why are current mapping technologies sufficient for most atrial arrhythmias, but not AF? 
The required resolution of mapping depends on the level of complexity of the arrhythmia. 
For example, in Figure 1 two pictures with the same low resolution are shown. The top 
picture is simple and even with a very low resolution you will be able to determine its 
Figure 1. Low-resolution pictures.
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content. However, the bottom picture is much more complex and the low resolution 
here can easily result in a false interpretation of the actual picture (the high-resolution 
versions are shown in Figure 2). Similar with regular tachyarrhythmias and AF; regular 
tachyarrhythmias are mostly easy to identify even with a low resolution, however, the 
chaotic patterns of activation and small wavelets during AF require a high resolution. The 
challenge with current high-resolution mapping is that due to the relatively small size of 
the arrays, atrial areas need to be mapped sequentially. This can be explained as having 
to take several small pictures of one large picture in order to cover the entire object (black 
square in Figure 2). You will still be able to correctly deduce the object, but if the situation 
changes between pictures, for example a few balls are taken away or moved, this may not 
be noticed. Although studies have shown that patterns of activation remain stable in areas 
during 10 minutes of AF7, a more panoramic high-resolution view will help to identify and 
understand the mechanisms underlying AF even better.
Endo-epicardial asynchrony: a new mechanism during atrial fibrillation
Focal waves observed in the study of De Groot et al. in 2010 led to the concept of asyn-
chrony between epicardial and endocardial activation being the origin of focal waves.3 
The evidence for this theory was provided in the study presented in Chapter 9. This was 
the first study to perform simultaneous epicardial and endocardial mapping in living hu-
man subjects to investigate differences in electrical activation. Because mapping on both 
sides simultaneously is technically very challenging, it can only be consistently performed 
at the right atrial free wall. The right atrial appendage is the only location where an inci-
sion in the atrium is standardly made during cardiac surgery before induced cardiac arrest. 
Endo-epicardial asynchrony (EEA) occurred in patients at 0.9-55.9% of the sites during 
10 seconds of AF. EEA was especially observed in patients with longstanding persistent 
AF; all patients with longstanding AF demonstrated EEA in over 20% of the sites. Focal 
waves were preceded by a wave of activation on the opposite side in 65% which means 
that the majority of focal waves could be attributed to transmural electrical conduction. 
These findings constitute an important new mechanism during AF. The electrical dissocia-
tion between the layers provides an opportunity for waves to travel from one side to the 
other and create new (focal) waves by conducting through the atrial wall. The possibilities 
for waves to encounter excitable tissue thereby increase substantially. Focal activation 
observed in previous studies may actually represent transmural conduction of AF waves.
Significance of EEA is not limited to AF alone, EEA also increases in atrial extrasystoles 
which can act as triggers for AF (Chapter 15) and EEA has also been significant in some 
cases of atrial flutter.21 The presence and likely important role of EEA during arrhythmia 
further complicates mapping of AF. Current technologies can only record electrograms 




on the other side. This presents a great challenge as the incidence of EEA is high and there 
are no simple technical solutions to record the entire atria on both sides simultaneously. 
However, in Chapter 12 the morphology of epicardial and endocardial electrograms was 
compared during sinus rhythm. A possible solution was provided by the discovery that 
EEA can be reflected on the electrogram by fractionation. Analyzing fractionation of the 
electrogram could be the key to indirectly detect EEA. This possibility was explored further 
in Chapter 14. Areas at the right atrial free wall demonstrating EEA in patients during sinus 
rhythm, pacing or atrial extrasystoles were analyzed to determine how sensitive fraction-
ation is in identifying EEA. In 86% of patients, EEA was visible on the epicardial or endocar-
dial electrogram at a median of 75% and 72% electrode sites with EEA, respectively. EEA 
was easier to identify on unipolar electrograms than on bipolar electrograms.
Electrograms: unipolar vs bipolar and functionality of fractionation
As explained, bipolar electrograms are the difference between two unipolar electrograms 
and therefore farfield electrical activity is mostly cancelled. The disadvantage of bipolar 
electrograms is that they are affected by wave orientation.22, 23 When the activation direc-
tion is parallel to the two poles or in case of simultaneous activation, timing of the signals 
are similar and electrogram voltage can decrease to very low values making it more dif-
ficult to determine the local activation time. Especially during AF, where AF waves travel in 
chaotic patterns constantly changing direction, bipolar electrograms are likely much more 
often affected than during other atrial tachyarrhythmias. Furthermore, technical proper-
ties such as a larger electrode size and larger electrode spacing increase the amount of 
electrogram fractionation on the bipolar electrogram.24 The foundation for unipolar 
fractionation was elegantly demonstrated a long time ago by Spach and co-workers. On a 
microscopic level it was seen that each component of a fractionated electrogram could be 
traced to activation of a specific muscle bundle.25 Although in Chapter 11 other possible 
factors contributing to fractionation were discussed, the conclusion in Chapter 12 was that 
95% of fractionation on unipolar high-resolution electrograms could be attributed to re-
mote atrial activation. It was also demonstrated that EEA causes fractionation of unipolar 
electrograms. It was then theorized that EEA based electrogram fractionation would be 
largely removed from bipolar electrograms as farfield electrical activity is substracted. In 
actuality, EEA remote electrical activity proved to be local enough to appear on bipolar 
electrograms as well. However, fractionation corresponding to EEA was less distinguish-
able from the noise on bipolar electrograms and more additional fractionation will make 
it more difficult to identify fractionated deflections based on EEA (Chapter 14). These 




In some AF mapping studies of Table 1, a different type of electrogram analysis was 
performed to map AF. In the endocardial electrophysiology studies by Narayan et al. uni-
polar or bipolar electrograms are converted to monophasic action potentials from which 
activation maps are created.5, 14 Recently, the effects of mapping using monophasic action 
potentials (phase mapping) were demonstrated by direct comparison of activation map-
ping from unipolar electrograms to mapping based on phase analysis of unipolar electro-
grams.26 Mapping in this study was performed with a very high resolution of 50 electrodes/
cm2. The specificity of rotor waves by phase mapping was only 10%, and false-positive 
cases were mostly localized at lines of conduction block with waves traveling opposite to 
each other in unipolar activation maps.26
Limitations of high-resolution mapping
Currently, there are still several limitations of high-resolution mapping. First, high-resolu-
tion arrays can only be placed on the epicardium due to their size, thereby certain atrial 
areas such as the septum cannot be mapped. Secondly, the arrays can, due to its epicardial 
application, only be used during cardiac surgery. Endovascular electrophysiological pro-
cedures are much less invasive and therefore available to a larger AF population. Finally, 
to cover the entire atrial surface, mapping is performed sequentially in high-resolution 




mapping, whereas low-resolution mapping studies can map the entire surface simultane-
ously. As mentioned, the entire activation pattern of both atria cannot yet be visualized 
by high-resolution mapping. Both low-resolution and high-resolution mapping have 
certain advantages and disadvantages; however, these differences also lead to differences 
in study outcomes of AF mechanisms. It is plausible that different mechanisms of AF are 
involved in different patients. Because of the complexity of AF, high-resolution mapping is 
necessary in order to find the individual arrhythmogenic substrates and to not make false 
assumptions based on an undetailed map. This way, the optimal treatment course can 
be determined for each AF patient. To this end, technical advancements need to follow in 
order to further unravel mechanisms underlying AF.
CONCLUSIONS AND FUTURE PERSPECTIVES: BACK TO THE 
DRAWING BOARD
Mapping of AF requires a high resolution of electrogram recording sites that is able to 
spot detailed conduction disorders and thereby identify the arrhythmogenic substrate 
in individual patients. Asynchrony in activation between the epicardial and endocardial 
layers is a potential substrate for AF and a new mechanism explaining perpetuation of AF. 
Although current mapping tools are unable to identify EEA, it was discovered here that 
EEA is reflected on the electrogram as fractionation in most patients. To detect EEA on 
the electrogram, unipolar electrograms are superior to bipolar electrograms due to less 
disturbances and a better signal-to-noise ratio of EEA based fractionation. As the frequent 
occurrence of EEA demonstrated, AF is even more complex than previously thought and 
current technologies for AF mapping are insufficient. To actually understand mechanisms 
involved in AF, we need to go back to the drawing board and start to critically review 
mapping techniques that may lead to false interpretation of AF and develop new high-
resolution tools and software.
The most optimal AF mapping tool will require the following features:
1. A high resolution/ electrode density
2. Cover the entire surface of both atria
3. Simultaneous recordings of all electrograms
4. Use unipolar electrograms
5. Be able to detect asynchrony between epicardium and endocardium
6. A high sample rate (to increase accuracy of fractionation)
7. Preferably record from the endocardium
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The technical side of developing a system of high-resolution than can be placed within 
small catheters but still cover the entire atrium will be extremely challenging. It will re-
quire experts in electrical engineering to design and develop such an advanced mapping 
system. Development of feature 5 can be continued based on findings in this thesis. It 
would require software that is able to relate fractionation to activation patterns and 
identify fractionation caused by EEA. Therefore, future studies will need to characterize 
fractionated unipolar deflections which identify EEA and determine features that provide 
the best sensitivity and specificity for EEA.
Finally, to overcome current controversies in AF mechanisms, besides upgrading mapping 
tools, research into AF would greatly benefit from exchanging electrogram data between 
research groups to discover the differences in annotation and analysis of electrograms 
resulting in activation maps. If a consensus is made over how to analyze and interpret 
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Chapter 1 introduces atrial fibrillation which is the most common heart rhythm disorder 
in the world that is associated with life-threatening long-term complications. Treatment 
strategies for atrial fibrillation often fail and atrial fibrillation runs a progressive course in 
a quarter of patients. One important cause is the inability to determine the electrophysi-
ological mechanism in individual patients. This thesis focusses on 1) new techniques to 
identify conduction disorders of the heart with a high resolution, 2) the presence of dif-
ferences in electrical conduction during a normal heart rhythm between different patient 
groups and areas of the atria, 3) the implication and value of complex electrical signals, 
and 4) asynchronous activation of the inner and outer layers of the atrial wall and the role 
it potentially has in the pathophysiology of atrial fibrillation.
In Chapter 2 is explained that currently the only curative treatment for atrial fibrillation is 
electrical isolation of the pulmonary veins. However, a single ablative treatment is often 
not successful and in many cases conduction from the pulmonary veins recovers. New 
ablation techniques are being developed to prevent reconduction such as visualization 
of the treated area during ablation as outlined by the commented article of Chapter 2. 
In some patients, despite optimal isolation of the pulmonary veins, atrial fibrillation still 
recurs. At this time, there is no proven effective subsequent therapy when isolation of the 
pulmonary veins has been achieved. In order to effectively treat these patients, research 
into the underlying mechanism of atrial fibrillation is required.
To take the first step towards an individualized diagnosis and treatment plan for patients 
with atrial fibrillation, a new study was proposed in Chapter 3. There is a diversity of other 
heart diseases among patients with atrial fibrillation. Heart diseases such as coronary 
artery disease, valvular heart disease and congenital heart disease can all contribute to 
the occurrence of atrial fibrillation. Atrial myocardial scarring could occur in different pre-
disposed locations of the atria depending on the underlying heart disease. Therefore, the 
cause and mechanism of atrial fibrillation could originate from different areas in the atria. 
In our research proposal, we use a high-resolution epicardial mapping approach to record 
atrial electrical conduction in patients during standard cardiac operation procedures. 
These patients are divided into 12 subgroups based on their underlying heart disorder 
and if they have a history of atrial fibrillation. Characteristics of electrical conduction and 
morphology of signals will be compared between these groups to find the differences that 
may lead to atrial fibrillation. A postoperative follow-up of five years will demonstrate 
early or late development of atrial fibrillation after surgery.
The mapping technique used for this study is a unique new approach of mapping. In Chap-
ter 4 the execution and experiences with this mapping approach are described in detail. In 
adult patients undergoing open-heart surgery a ribbon-shaped electrode-array is placed 
Chapter 17
270
on the atria during surgery just before cardiopulmonary bypass is started. This electrode 
array consists of 192 electrodes of 0.45 mm diameter and an interelectrode distance of 
2 mm. The flexible array is fixed to a bendable steel spatula for stability. Then the array 
is placed on all accessible areas of the right and left atrium among which Bachmann’s 
bundle. The areas are mapped following a schedule and anatomical landmarks. Unipo-
lar electrograms are recorded from 192 spots at the atrium simultaneously during 5-10 
seconds. When recordings are made of all areas of both atria, there are a minimal of 1728 
unipolar electrograms recorded. Epicardial mapping is performed during sinus rhythm 
and atrial fibrillation. In case a patient is in sinus rhythm, atrial fibrillation is induced by 
high-rate atrial burst pacing using a pacemaker. In case a patient is in atrial fibrillation, 
sinus rhythm is restored by electrical cardioversion after mapping of atrial fibrillation. In 
168 patients, the mapping procedure and preparations took 9±2 minutes and no compli-
cations were observed.
The surgical techniques for patients requiring cardiac surgery are still in development 
and cardiac surgical procedures are increasingly performed with minimally invasive tech-
niques. Minimally invasive cardiac surgery uses small openings between the ribs instead 
of a long incision and a sternotomy. Patients with mitral valve disease are nowadays more 
often operated minimally invasively and are known to have a high incidence of atrial fibril-
lation. In Chapter 5 we present three cases in which we performed our high-resolution 
mapping approach who underwent minimally invasive mitral valve surgery. The electrode 
array fixed on the steel spatula was introduced via a lateral mini-thoracotomy incision of 
4-5 cm in the intercostal space on the right side of the chest. The right atrium and Bach-
mann’s bundle were easily accessible for mapping. The left atrium was more challenging 
to reach and not all areas were able to be reached. The left atrial appendage was accessed 
by sliding the array past Bachmann’s bundle. The posterior left atrium beneath the inferior 
pulmonary veins was reached in one patient. An additional incision on the left chest side 
could possibly offer better access to the left atrium for epicardial mapping during mini-
mally invasive surgery. This study has shown that epicardial high-resolution mapping with 
good quality electrograms can also be performed during minimally invasive cardiac sur-
gery. Epicardial mapping via minimally invasive procedures offers future possibilities for 
patients with atrial fibrillation who do not require cardiac surgery for other heart diseases.
The incidence of atrial fibrillation in patients with mitral valve disease is between 25-50% 
and much more frequent than in patients with aortic valve disease. Atrial fibrillation in-
cidence in patients with aortic valve disease is around 12%. The stretch of the left atrium 
is larger in mitral valve insufficiency than in patients with an aortic valve insufficiency or 
stenosis. Likely, this causes more damage of atrial tissue which leads to atrial fibrillation. 




of conduction delay and block during sinus rhythm than patients with aortic valve disease 
and if there were predilection areas for conduction disorders. The extent of conduction 
disorders on the right and left atrium and Bachmann’s bundle was studied in 85 patients 
with aorta valve stenosis or insufficiency and 54 patients with mitral valve insufficiency. 
We used our high-resolution mapping approach to quantify conduction disorders. Both 
groups demonstrated various degrees of conduction disorders throughout the atria. Most 
conduction disorders were observed at the superior right atrium, the area of the sinus 
node. Patients with mitral valve disease more often presented with conduction disorders 
at the lateral left atrium and left atrial appendage. The 38 patients with a history of atrial 
fibrillation, however, had more conduction disorders at Bachmann’s bundle.
Conduction disorders at Bachmann’s bundle during sinus rhythm are further explored in 
Chapter 7. In 304 patients, of which 193 with coronary artery disease and 11 with valvular 
heart disease, activation patterns were analyzed and the length of lines with conduction 
disorders were quantified. No differences were observed in conducting disorders at Bach-
mann’s bundle between patients with coronary artery disease and valvular heart disease. 
Patients in whom Bachmann’s bundle was (also) activated from the center of the bundle 
more often had a history of atrial fibrillation. In addition, the absence of both central 
activation and long lines ≥12 mm with interrupted electrical conduction was highly sensi-
tive for the absence of atrial fibrillation. Therefore, conduction disorders and activation 
patterns at Bachmann’s bundle were not associated with the underlying heart disease but 
with atrial fibrillation.
The pulmonary vein area is also known as a potential arrhythmogenic area for atrial fibril-
lation. Scarring of the posterior wall of the left atrium where the pulmonary veins exit is 
associated with recurrence of atrial fibrillation after isolation of the pulmonary veins. The 
conduction disorders in this area during sinus rhythm and the relation to persistent atrial 
fibrillation were analyzed in Chapter 8. High-resolution epicardial mapping of the poste-
rior left wall was performed in 268 patients with coronary artery disease or valvular heart 
disease. The 49 patients with a history of atrial fibrillation had more uninterrupted lines 
and long lines >6 mm of conduction disorders between the pulmonary veins. The extent 
and distribution of conduction disorders did not differ between patients with paroxysmal 
or persistent atrial fibrillation. Although conduction disorders are more frequently pres-
ent during sinus rhythm in patients with atrial fibrillation, the relation to atrial fibrillation, 
whether they are a symptom or a contributor, remains unclear.
Spontaneous electrical impulses originating from the pulmonary veins are known as the 
most important cause for triggering paroxysmal atrial fibrillation. However, the underlying 
mechanism for persistent atrial fibrillation remains unclear. A new discovery in Chapter 9 
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is a potential mechanism for persistence of atrial fibrillation. It was demonstrated in 14 pa-
tients that the atrial wall is asynchronously activated during atrial fibrillation. Electrograms 
were recorded on both the epicardial (outer) and endocardial (inner) side during surgery 
for this study. One of two identical electrode-arrays was introduced in the right atrium 
and placed on the endocardial wall via the incision made for cardiopulmonary bypass. 
All patients had atrial fibrillation during recording, either spontaneous or induced with 
a pacemaker. The activation times between 128 opposite electrograms were compared. 
Endo-epicardial asynchrony of the right atrial wall varied between 0.9-55.9% during atrial 
fibrillation. Patients with longstanding persistent atrial fibrillation all had asynchrony of 
>20%. Focal waves, waves originating in the middle of the mapping area, were observed 
frequently on both sides. Those focal waves were in 65% preceded by a wave passing by 
on the other side. The majority of focal waves could thus be attributed to transmural con-
duction of a wave traveling on the other side. Asynchronous activation of the epicardial 
and endocardial atrial layers give opportunity for waves to travel from one side to the 
other and creating new breakthrough waves causing atrial fibrillation to persist.
In Chapter 10 a case is presented demonstrating the dynamic of focal waves during 
atrial fibrillation. Simultaneous endo-epicardial mapping was performed in a 63-year-old 
patient with mitral valve and tricuspid valve insufficiency and longstanding persistent 
atrial fibrillation. Focal waves appeared equally frequent on both the epicardial and en-
docardial side, respectively 59 and 53 times, during 10 seconds of atrial fibrillation. Most 
focal waves appeared on a random location without a fixed pattern or timing between 
the focal waves. This observation decreases the likelihood of focal waves being caused 
by a rotor or ectopic focus. This random behavior of focal waves better suits the theory of 
endo-epicardial asynchrony and transmural conduction of atrial fibrillation waves being 
the source for focal waves as described in chapter 9.
One of the additional treatments developed for persistent atrial fibrillation after isolation 
of the pulmonary veins is ablation of complex fractionated atrial electrograms (CFAEs). 
These electrograms consist of signals with multiple deflections that could represent areas 
with conduction disorders. However, there are also other pathophysiological causes for 
these electrograms and definitions used for CFAE differ between studies. Chapter 11 de-
scribes a literary search, firstly, to provide an overview of the pathophysiological causes of 
electrogram fractionation. Both pathological and non-pathological causes of fractionation 
of electrograms have been identified. Secondly, a systemic literature search was performed 
to the definitions for CFAE that have been used over the years. Large differences existed 
between studies: 11 visual definitions for CFAE, 3 automatic detection programs for CFAE 




a pathological origin, a clear method to identify pathological fractionation needs to be 
developed before CFAE locations are (unnecessarily) targeted during ablation.
The morphologic properties of electrograms such as fractionation are thus being used to 
identify areas to target during ablation. However, in chapter 9 the asynchronicity between 
the epicardial and endocardial atrial side was described signifying that differences in 
epicardial and endocardial electrograms occur regularly. The morphology of epicardial 
and endocardial electrograms were compared during sinus rhythm in Chapter 12. Fur-
thermore, asynchronous activation of the atrial wall as cause for fractionation was ana-
lyzed. Most fractionation during sinus rhythm was similar between both sides, incidentally 
signals up to 4 mV were absent at the opposite electrogram. The large majority (95%) of 
additional deflections (fractionation) observed on unipolar electrograms could be attrib-
uted to remote electrical activation. Asynchronous activation was the cause in 4% of those 
additional deflections. Although differences in epicardial and endocardial fractionation 
occur only incidentally during sinus rhythm, they will likely increase during atrial fibrilla-
tion due to increase of asynchrony and smaller waves. An important finding in this study 
is that endo-epicardial asynchrony can reflect on the electrogram on the opposite side.
In Chapter 13, the consequences of endo-epicardial asynchrony during atrial fibrillation 
are described and a study is reviewed that demonstrated that asynchrony can also be 
important in the persistence of an atrial flutter. The significance of endo-epicardial asyn-
chrony in the pathophysiology of heart rhythm disorders requires further investigation, 
however, there is a major limitation. During most electrophysiological procedures electro-
grams can only be recorded from one side of the atrial wall. Fortunately, it was discovered 
in chapter 12 that the morphology of unipolar electrograms contain information about the 
state of the neighboring tissue and with that the presence of asynchrony. This is a possible 
method to indirectly measure asynchrony when only recording from one side.
However, bipolar electrograms are mostly used in current clinical practice. If bipolar 
electrograms are equally suitable for identifying asynchrony via fractionation is studied 
in Chapter 14. Unipolar electrograms of areas with endo-epicardial asynchrony were con-
verted to bipolar electrograms in two directions of the array (x and y). Two investigators 
independently labelled all fractionation on the unipolar and bipolar electrograms. Pres-
ence of fractionation corresponding to atrial activation on the opposite side (asynchrony) 
was identified. Fractionation corresponding to asynchrony was equally present on both 
unipolar as bipolar electrograms. Nineteen of 22 patients demonstrated fractionation 
based on asynchrony. However, this fractionation was easier to distinguish from the noise 
on unipolar electrograms than on bipolar electrograms in the y-direction. In addition, 
more additional fractionation was observed on bipolar electrograms in the x-direction 
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than on unipolar electrograms which makes it harder to identify fractionation caused by 
asynchrony. Unipolar electrograms are therefore more suited to detect endo-epicardial 
asynchrony based on fractionation.
Endo-epicardial asynchrony does not only have a possible role in persistent atrial fibrilla-
tion, but also in triggering atrial fibrillation which is investigated in Chapter 15. Most atrial 
fibrillation episodes are preceded by an atrial extrasystole. These arise spontaneously in 
the atria, mostly the pulmonary veins, and result in increased conduction disorders due 
to their prematurity or different atrial origin. Sixty atrial extrasystoles from 23 patients 
were examined for differences in degree of endo-epicardial asynchrony compared to sinus 
rhythm. Endo-epicardial asynchrony increased in atrial extra systoles. One of the possible 
causes is increased inequality in the total amount of conduction disorders in the epicardial 
vs endocardial plane. Maximal time difference between the epicardial and endocardial 
layers during an atrial extrasystole was 130 ms. Under the right circumstances, this extent 









De achtergrond van het ziektebeeld atriumfibrilleren (boezemfibrilleren) wordt ingeleid 
in Hoofdstuk 1. Hier wordt toegelicht dat atriumfibrilleren de meest voorkomende 
hartritmestoornis is die ook ernstige complicaties op de lange termijn kan hebben. De 
behandelmogelijkheden falen regelmatig en de ziekte heeft in een kwart van de patiënten 
een progressief beloop. Een belangrijke oorzaak is dat het mechanisme van atriumfibril-
leren nog niet goed vastgesteld kan worden bij de individuele patiënt. Dit proefschrift 
richt zich op 1) nieuwe technieken om geleidingsstoornissen van het hart vast te kunnen 
stellen met een hoge resolutie, 2) aanwezigheid van verschillen in elektrische geleiding 
tijdens het normale hartritme tussen patiëntgroepen en gebieden van de hartboezems, 3) 
de betekenis en waarde van complexe elektrische signalen en 4) asynchrone activatie van 
de binnenste en buitenste laag van de boezemwand en de rol die dit mogelijk heeft in de 
pathofysiologie van atriumfibrilleren.
In Hoofdstuk 2 wordt beschreven dat op dit moment de enige mogelijkheid voor het cura-
tief behandelen van atriumfibrilleren bestaat uit het elektrisch isoleren van de pulmonaal 
venen door middel van ablatie. Vaak is één behandeling echter niet genoeg en komt het 
regelmatig voor dat de geleiding vanaf de pulmonaal venen zich hersteld. Er worden nog 
steeds nieuwe ablatie technieken voor de pulmonaal venen ontwikkeld zoals het visuali-
seren van het behandelde gebied tijdens de ablatie om te voorkomen dat de geleiding zich 
hersteld. Echter bij een deel van de patiënten komt atriumfibrilleren toch terug ondanks 
dat de pulmonaal venen goed zijn geïsoleerd. Op dit moment bestaat voor deze patiënten 
nog geen bewezen effectieve vervolg behandeling na pulmonaal venen isolatie. Hiervoor 
moet eerst worden onderzocht wat het onderliggende mechanisme van atriumfibrilleren 
is bij deze patiënten.
Om de eerste stap te zetten voor de individualisering van de diagnose en behandeling voor 
patiënten met atriumfibrilleren, wordt in Hoofdstuk 3 een nieuw onderzoeksvoorstel 
gedaan. Patiënten met atriumfibrilleren kunnen een diversiteit van andere onderliggende 
hartziekten hebben. Hartziekten zoals kransslagaderlijden, hartklepafwijkingen en aan-
geboren hartaandoeningen kunnen allen bijdragen aan het ontstaan van boezemfibril-
leren. De schade aan het hartweefsel zou bij deze verschillende hartaandoeningen op 
andere (voorkeurs)plaatsen in de boezems kunnen optreden. Hierdoor kan de oorzaak 
en mechanisme van atriumfibrilleren op andere plekken in de boezems liggen. In dit 
onderzoeksvoorstel wordt gebruik gemaakt van een hoge resolutie epicardiale mapping 
methode om bij patiënten die een hartoperatie ondergaan de elektrische geleiding van de 
boezems te meten tijdens de operatie. Deze patiënten worden in 12 groepen verdeeld op 
basis van hun onderliggende hartziekte(n) en of zij in hun voorgeschiedenis atriumfibril-
leren hebben gehad. Deze groepen worden met elkaar vergeleken om zo te zien waar de 
verschillen zitten in de elektrische geleiding en de morfologie van de elektrische signalen 
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die mogelijk in verband kunnen worden gebracht met het ontstaan van atriumfibrilleren. 
Na de operatie worden de patiënten 5 jaar opgevolgd om te zien of zij vroeg of laat na de 
operatie atriumfibrilleren ontwikkelen.
De epicardiale mapping techniek die voor deze studie wordt toegepast is een unieke, 
nieuwe methode van mapping. In Hoofdstuk 4 wordt de uitvoering en onze ervaringen 
met het gebruik van deze techniek in detail beschreven. Bij volwassen patiënten die een 
openhartoperatie ondergaan wordt tijdens de operatie, net voordat zij aan de hartlong-
machine gaan, een lint-elektrode op de boezems gelegd. Deze lint-elektrode bestaat uit 
een array van totaal 192 elektrodes van 0.45 mm groot met een afstand van 2 mm tussen 
de elektrodes. De flexibele lint-elektrode wordt gebonden op een stalen buigzame spatel 
voor stevigheid. Vervolgens wordt de elektrode op alle bereikbare plekken van de linker- 
en rechterboezem gelegd, waaronder ook de bundel van Bachmann. Dit wordt gedaan 
volgens een vast schema met anatomische oriëntatiepunten. Gedurende 5 tot 10 seconden 
worden op 192-plaatsen gelijktijdig unipolaire elektrische signalen (elektrogrammen) van 
de boezem gemeten. Als de elektrode op alle plaatsen van beide boezems is gelegd, zijn er 
op minimaal 1728 plekken unipolaire elektrogrammen met boezemsignalen opgenomen. 
Epicardiale mapping wordt tijdens sinusritme en atriumfibrilleren uitgevoerd. Indien no-
dig wordt met behulp van een pacemaker die met hoge frequentie de boezems stimuleert 
atriumfibrilleren geïnduceerd tijdens de operatie. Patiënten die atriumfibrilleren hebben 
bij aanvang van de operatie worden elektrisch gecardioverteerd naar sinusritme na map-
ping van atriumfibrilleren. In de 168 patiënten waarbij deze techniek is uitgevoerd in dit 
hoofdstuk duurde de gehele epicardiale mapping procedure inclusief voorbereidingen 
9±2 minuten en waren er geen complicaties.
De chirurgische technieken voor hartpatiënten zijn volop in ontwikkeling en steeds meer 
operaties worden niet meer via een ‘openhart’ procedure uitgevoerd maar via minimaal 
invasieve technieken. Hierbij wordt, zoals bij een kijkoperatie, gebruik gemaakt van kleine 
openingen in de borstkas om de operatie uit te voeren in plaats van het openzagen van 
het borstbeen. Een patiëntengroep waarbij veel atriumfibrilleren voorkomt die steeds 
vaker minimaal invasief worden geopereerd zijn patiënten met mitraliskleplijden. Dat ook 
tijdens deze operaties onze epicardiale mapping techniek kan worden toegepast wordt 
gedemonstreerd bij 3 patiënten in Hoofdstuk 5. De elektrode gebonden op de spatel 
wordt ingebracht via de laterale mini-thoracotomie snede van 4-5 cm tussen de ribben 
aan de rechterzijde van de borstkas. De rechterboezem en de bundel van Bachmann zijn 
vanuit hier goed bereikbaar, maar de linkerboezem was niet geheel bereikbaar. Het lin-
kerhartoor was wel bereikbaar door de elektrode voorbij de bundel van Bachmann door 
te schuiven. De achterwand van de linkerboezem onder de pulmonaal venen was in één 




uitkomst bieden voor het bereiken van de linkerboezem in de toekomst. De studie heeft 
laten zien dat ook bij minimaal invasieve operaties epicardiale mapping met een hoge 
resolutie en hoge signaalkwaliteit haalbaar is. Daarnaast is epicardiale hoge resolutie 
mapping via minimaal invasieve methoden ook in de toekomst toegankelijker voor de vele 
patiënten met atriumfibrilleren die geen openhartoperatie hoeven ondergaan.
De incidentie van atriumfibrilleren bij patiënten met mitraliskleplijden ligt tussen de 
25-50%. Dit is ruim hoger dan bij patiënten met aortakleplijden, de andere meest voor-
komende hartklepafwijking. Bij aortaklepafwijkingen komt atriumfibrilleren voor bij on-
geveer 12% van de patiënten. De rek op de linkerboezem is bij een lekkende mitralisklep 
groter dan bij patiënten met een lekkende of vernauwde aortaklep. Hierdoor ontstaat 
waarschijnlijk meer schade in het hartspierweefsel van de boezems wat kan leiden tot 
atriumfibrilleren. In Hoofdstuk 6 werd onderzocht of patiënten met mitraliskleplijden 
meer vertraging van de elektrische geleiding hebben tijdens sinusritme dan patiënten 
met aortakleplijden en of er voorkeurslocaties waren voor geleidingsstoornissen. In 
85 patiënten met aortaklepstenose of –insufficiëntie en 54 patiënten met mitralisklep 
insufficiëntie werd de mate van geleidingsstoornissen op de hele oppervlakte van beide 
boezems onderzocht. Hierbij werd opnieuw gebruik gemaakt van de epicardiale map-
ping techniek met een hoge resolutie welke kleine geleidingsstoornissen kan opsporen. 
Tijdens sinusritme waren er in beide groepen in verschillende mate geleidingsstoornissen 
aanwezig verspreid over de hele boezems. De meeste geleidingsstoornissen zaten in het 
bovenste deel van de rechterboezem, in het gebied van de sinusknoop. Patiënten met 
mitraliskleplijden hadden vaker geleidingsstoornissen aan de zijkant van de linkerboezem 
waaronder het linker hartoor. Bij de 38 patiënten uit beide groepen met een voorgeschie-
denis van atriumfibrilleren werden juist vaker geleidingsstoornissen gezien op de bundel 
van Bachmann.
In Hoofdstuk 7 is de geleiding op de bundel van Bachmann tijdens sinusritme verder ge-
analyseerd bij patiënten met kransslagaderlijden en/of hartklepafwijkingen en het verband 
op de aanwezigheid van atriumfibrilleren. Bij 304 patiënten waarvan 193 met ischemische 
hartziekte en 111 met hartklepafwijkingen werd gekeken naar het activatiepatroon van 
de bundel van Bachmann en de lengte en aantal lijnen die de elektrische geleiding ver-
stoorden. Geleidingsstoornissen op de bundel van Bachmann kwamen bij patiënten met 
kransslagaderlijden en hartklepafwijkingen evenveel voor. Patiënten waarbij de bundel 
van Bachmann (ook) vanuit het midden van de bundel werd geactiveerd hadden vaker 
een voorgeschiedenis van atriumfibrilleren. In dit onderzoek bleek dat de afwezigheid 
van activatie vanuit het midden en een lange lijn ≥12 mm met onderbroken geleiding erg 
voorspellend (90%) was voor de afwezigheid van atriumfibrilleren. Geleidingstoornissen 
Chapter 18
282
en het activatiepatroon op de bundel van Bachmann zijn dus niet geassocieerd met de 
onderliggende hartziekte maar wel met aanwezigheid van atriumfibrilleren.
Naast de bundel van Bachmann staat ook het pulmonaal venen gebied als een potentieel 
belangrijk gebied voor atriumfibrilleren. Verlittekening van de achterwand van de linker-
boezem waar de pulmonaalvenen uitmonden is geassocieerd met een hogere recidief 
kans van atriumfibrilleren na ablatie van de pulmonaalvenen zelf. In Hoofdstuk 8 hebben 
we de geleidingsstoornissen in dit gebied onderzocht en de relatie tot persistentie van het 
atriumfibrilleren. Hiervoor is er tijdens sinusritme hoge resolutie mapping verricht van de 
achterwand tussen de pulmonaal venen bij 268 patiënten met kransslagaderlijden en/of 
hartklepafwijkingen. Van deze patiënten waren er 49 bekend met atriumfibrilleren. Deze 
patiënten met atriumfibrilleren hadden meer aaneengesloten lijnen van geleidingsstoor-
nissen en meer lange lijnen >6 mm van gestoorde geleiding tussen de pulmonaalvenen. 
Er werd geen verschil gezien in de mate of verdeling van geleidingsstoornissen tussen 
patiënten met paroxismaal of persistent atriumfibrilleren. Hoewel er dus duidelijk meer 
geleidingsstoornissen aanwezig zijn tijdens sinusritme bij patiënten met atriumfibrilleren, 
is het nog onduidelijk wat het verband is met atriumfibrilleren. Het kan slechts een uiting 
zijn van de ziekte of een mede-veroorzaker.
De spontane elektrische impulsen die ontstaan in de pulmonaalvenen staan al enkele ja-
ren bekend als de belangrijkste oorzaak achter het opstarten van paroxismaal atriumfibril-
leren. Maar het elektrische mechanisme die het persisteren van atriumfibrilleren veroor-
zaakt is nog niet precies bekend. In Hoofdstuk 9 wordt een nieuwe bevinding beschreven 
die een mogelijke verklaring hiervoor biedt. Bij 14 patiënten is aangetoond dat tijdens 
(geïnduceerd) atriumfibrilleren de boezemwand asynchroon wordt geactiveerd. Om dit 
te kunnen doen zijn tijdens de operatie elektrische signalen van de rechterboezem aan 
de epicardiale (buiten-) zijde en de endocardiale (binnen-) zijde tegelijkertijd gemeten. 
Eén van twee identieke elektrode-arrays werd tegen de binnenzijde van de rechterboezem 
gelegd via een snede in het rechterhartoor die werd gemaakt voor het aansluiten van de 
hartlongmachine. De activatietijden tussen de 128 paar tegenoverliggende epicardiale en 
endocardiale elektrogrammen werden met elkaar vergeleken. De mate van endo-epicardi-
ale asynchrone activatie van de rechterboezem tijdens atriumfibrilleren varieerde tussen 
de 0.9-55.9%. Patiënten met langdurig persisterend atriumfibrilleren hadden allen >20% 
asynchrone activatie. Er werden ook frequent focale golven gezien aan beide kanten; 
golven die middenin het mapping-gebied ontstaan. In 65% van de gevallen werd gezien 
dat een focale golf aan de ene zijde vooraf werd gegaan door een golf die voorbij kwam 
aan de andere zijde. Focale golven konden dus in de meerderheid worden verklaard door 
transmurale geleiding van een golf van de ene naar de andere zijde. De asynchrone activa-




van de ene naar de andere zijde te geleiden en daar nieuwe golven te creëren, waardoor 
atriumfibrilleren kan blijven doorgaan.
In Hoofdstuk 10 wordt een casus gepresenteerd waarbij de dynamiek van focale golven 
tijdens atriumfibrilleren wordt gedemonstreerd. Er was endo-epicardiale mapping ver-
richt in een 63-jarige patiënte met mitralis- en tricuspidalisinsufficiëntie en langdurig per-
sisterend atriumfibrilleren. Focale golven verschenen even vaak aan zowel de epicardiale 
als endocardiale zijde, respectievelijk 59 en 53 keer, gedurende 10 seconden atriumfibril-
leren. Daarbij verschenen de meeste op een willekeurige locatie zonder vast patroon of 
vaste tijdsduur tussen de focale golven. Deze bevinding maakt het minder waarschijnlijk 
dat focale golven worden veroorzaakt door een mechanisme zoals een rotor of een ecto-
pisch focus. Het willekeurig verschijnen van deze golven past beter bij het mechanisme 
van endo-epicardiale asynchronie en transmurale geleiding van atriumfibrillatie-golven 
zoals beschreven in hoofdstuk 9.
Eén van de behandelingen die is toegepast als aanvulling op pulmonaalvenen isolatie ter 
voorkomen van recidieven van atriumfibrilleren, is het ableren van complex gefractio-
neerde atriale elektrogrammen (CFAEs). Deze elektrogrammen bestaan uit signalen met 
meerdere deflecties die kunnen wijzen op gebieden met geleidingsstoornissen. Alleen zijn 
er ook andere pathofysiologische oorzaken voor deze elektrogrammen en de definities 
gebruikt voor CFAE verschillen tussen studies. Er is daarom in Hoofdstuk 11 een litera-
tuurstudie gedaan waarin eerst een overzicht is geven van de oorzaken van elektrogram 
fractionatie. Er wordt beschreven dat er zowel pathologische als niet-pathologische 
oorzaken zijn voor fractionatie van elektrogrammen. Daarnaast is er op een systematische 
wijze gezocht naar de definities voor CFAE die de afgelopen jaren zijn gebruikt. Er werden 
grote verschillen onder studies gevonden voor het bepalen van fractionatie: 11 visuele 
definities voor CFAE, 3 verschillende automatische detectie programma’s voor CFAE en 
7 verschillende parameters om CFAE te omschrijven. Voordat er (onnodig) op plaatsen 
van CFAE een ablatie behandeling wordt toepassen, moet eerst duidelijk worden hoe we 
pathologische fractionatie kunnen identificeren.
De morfologische eigenschappen van elektrogrammen zoals fractionatie (CFAE) worden 
dus gebruikt voor het identificeren van gebieden om te ableren. Echter in hoofdstuk 9 is 
gezien dat de activatie van het epicardiale en endocardiale zijde van de boezem niet altijd 
synchroon plaatsvindt. Er zijn dus verschillen tussen meten van electrogrammen aan de 
binnenzijde en buitenzijde van het hart. In Hoofdstuk 12 is de epicardiale en endocardiale 
morfologie van atriale signalen op 16.954 unipolaire elektrogrammen van 26 patiënten 
met elkaar vergeleken tijdens sinusritme. Ook is er onderzocht of asynchrone activatie van 
de boezemwand fractionatie kan veroorzaken. Voor het grootste deel kwam fractionatie 
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aan beide zijde overeen tijdens sinusritme, in incidentele gevallen waren er signalen tot 
4 mV die niet werden gezien op dezelfde plek aan de andere zijde. De grote meerderheid 
(95%) van de extra deflecties (fractionatie) gezien op unipolaire elektrogrammen kon 
worden toegeschreven aan elektrische activatie in de omgeving. Hiervan bestond 4% uit 
asynchrone activatie aan de tegenoverliggende zijde. Hoewel verschillen in fractionatie 
tussen de epicardiale en endocardiale zijde dus maar weinig voorkomen tijdens sinus-
ritme, zullen deze waarschijnlijk toenemen tijdens atriumfibrilleren door de toename van 
asynchronie en kleinere golven. Een belangrijke bevinding in deze studie is dat asynchro-
nie weerspiegeld kan zijn op het electrogram aan de andere zijde.
De gevolgen die endo-epicardiale asynchronie kan hebben tijdens atriumfibrilleren 
wordt verder toegelicht in Hoofdstuk 13. Er wordt ook een studie besproken waarin 
is aangetoond dat asynchronie ook een rol kan hebben bij het onderhouden van een 
andere hartritmestoornis; een atriumflutter. Het is daarom van belang de betekenis van 
endo-epicardiale asynchronie in de pathofysiologie van hartritmestoornissen verder te 
onderzoeken. Maar is er ook een grote hindernis: tijdens de meeste elektrofysiologische 
onderzoeken kan er maar aan één kant van het hart worden gemeten. In hoofdstuk 12 
is echter gezien dat de morfologie van unipolaire elektrogrammen informatie bevat over 
wat er gebeurd in de omgeving en daarbij de aanwezigheid van asynchronie. Dit is een 
mogelijke methode om asynchronie indirect te meten wanneer er maar aan één zijde 
signalen worden gemeten.
In de klinische praktijk wordt er daarentegen voornamelijk gebruik gemaakt van bipolaire 
elektrogrammen. Of bipolaire elektrogrammen even geschikt zijn voor het aantonen van 
asynchronie door middel van fractionatie als unipolaire elektrogrammen is onderzocht in 
Hoofdstuk 14. Unipolaire elektrogrammen van gebieden met endo-epicardiale asynchro-
nie werden omgezet naar bipolaire elektrogrammen in twee verschillende richtingen (x 
en y). Twee onderzoekers markeerde onafhankelijk van elkaar handmatig alle fractionatie 
op de unipolaire en bipolaire elektrogrammen. Vervolgens werd gezocht naar fractiona-
tie die overeenkwam met het moment van activatie aan de andere zijde (asynchronie). 
Fractionatie overeenkomend met asynchronie kwam even vaak voor op unipolaire als 
bipolaire elektrogrammen. Bij 19 van de 20 patiënten was fractionatie gebaseerd op 
asynchronie aanwezig. Alleen was deze fractionatie op bipolaire elektrogrammen in de 
y-richting aan de endocardiale zijde minder goed te onderscheiden van de ruis dan op 
unipolaire elektrogrammen. Daarnaast was er meer extra fractionatie aanwezig op bipo-
laire elektrogrammen in de x-richting dan op unipolaire elektrogrammen, waardoor het 
onderscheiden van fractionatie door asynchronie lastiger wordt. Unipolaire elektrogram-





Naast een rol bij het persisteren van atriumfibrilleren is endo-epicardiale asynchronie ook 
een mogelijk mechanisme voor het opstarten van atriumfibrilleren, dit wordt onderzocht 
in Hoofdstuk 15. De meeste episodes van atriumfibrilleren worden voorafgegaan door 
een atriale extra slag. Deze ontstaan spontaan in de boezems, meestal in de pulmonaal 
venen, en zorgen voor meer geleidingsstoornissen doordat ze vroeger komen of vanuit 
een andere plek dan bij sinusritme. In deze studie werden in 23 patiënten 60 atriale extra 
slagen onderzocht op de mate van endo-epicardiale asynchronie in vergelijking tot sinus-
ritme. Tijdens atriale extra slagen was er meer endo-epicardiale asynchronie aanwezig 
was dan tijdens sinusritme slagen. Eén van de mogelijke oorzaken hiervoor was dat er een 
grotere ongelijkheid was in het aantal geleidingsstoornissen in het endocardiale vlak ten 
opzichte van het epicardiale vlak tijdens atriale extra slagen. Het maximale tijdsverschil 
tussen de epicardiale en endocardiale laag dat werd geobserveerd tijdens een atriale 
extra slag was 130 ms. Onder de juiste omstandigheden zou deze mate van asynchronie 








ENDO–EPICARDIAL DISSOCIATION IN CONDUCTION
Lisette van der Does, Charles Kik, Maurits Allessie, Natasja de Groot
Cardiovascular Flashlight. Eur Heart J. 2016;38:1775.
The online video* shows 40 successive, simultaneous epicardial (left) and endocar-
dial (right) wavemaps of the right atrial free wall constructed during 5 s (40 times slowed 
down) of longstanding persistent atrial fibrillation (LSPAF) obtained from a 70-year-old 
female patient who underwent cardiac surgery for severe tricuspid and mitral valve insuf-
ficiency. Mapping was performed with a high-resolution endo–epicardial clamp consisting 
of two identical rectangular electrode arrays of 8 × 16 electrodes (interelectrode distance 
2 mm) precisely positioned opposite to each other. Wavemaps are generated by previ-
ously described computer algorithms and show areas activated by individual fibrillation 
waves; the territories of the waves are demarcated by colors according to their sequence 
of appearance. Fibrillation waves do not only enter the mapping area from the border of 
the electrode array, but they also emerge frequently in the middle. Significant differences 
in endocardial and epicardial activation time are present throughout the entire recording 
period. In map 14, for example, activation time differences in the lower part of the map-
ping area vary between 41 and 71 ms. In addition, the direction of activation can also be 
different between the endocardial and epicardial layer. In Figure 1, the middle part of the 
epicardial mapping area is activated by a wave front propagating from the right to the left, 
whereas the same area on the endocardial surface was earlier activated by a fibrillation 
wave traversing from the bottom to the top of the mapping array. Hence, this video clearly 











AFCL Atrial Fibrillation Cycle Length
AV Aortic Valve
BB Bachmann’s Bundle




CFAE Complex Fractionated Atrial Electrograms
CHD Congenital Heart Disease






ICF Informed Consent Form
ICS InterCaval Superior
IHD Ischemic Heart Disease
IQR Inter Quartile Range
LA Left Atrium
LAA Left Atrial Appendage
LLA Lateral Left Atrium
LVF Left Ventricular Function
MV Mitral Valve
PLA Posterior Left Atrium
PV Pulmonary Veins
PVI Pulmonary Vein Isolation
PVL Left Pulmonary Veins
PVR Right Pulmonary Veins
RA Right Atrium
RAA Right Atrial Appendage
RAI Right Appendage Inferior





VCI Vena Cava Inferior
VCS Vena Cava Superior






1. Atrial Ectopy Increases Asynchronous Activation of the Endo- and Epicardium at the 
Right Atrium.
 van der Does LJME, Kharbanda RK, Teuwen CP, Knops P, Kik C, Bogers AJJC, de Groot 
NMS. J Clin Med. 2020;18:E558.
2. The Effects of Valvular Heart Disease on Atrial Conduction during Sinus Rhythm
 van der Does LJME, Lanters EAH, Teuwen CP, Mouws EJMP, Yaksh A, Knops P, Kik C, 
Bogers AJJC, de Groot NMS. J Cardiovasc Transl Res. 2020;13:632-639.
3. Unipolar atrial electrogram morphology from an epicardial and endocardial perspec-
tive.
 van der Does LJME, Knops P, Teuwen CP, Serban C, Starreveld R, Lanters EAH, Mouws 
EMJP, Kik C, Bogers AJJC, de Groot NMS. Heart Rhythm. 2018;15:879-887.
4. Epicardial atrial mapping during minimally invasive cardiothoracic surgery.
 van der Does LJME, Oei FBS, Knops P, Bogers AJJC, de Groot NMS. Interact Cardiovasc 
Thorac Surg. 2019;28:108-111.
5. Endo-epicardial breakthrough: A tale of 2 sides.
 van der Does LJME, de Groot NM. Heart Rhythm. 2017;14:1208-1209.
6. Inhomogeneity and complexity in defining fractionated electrograms.
 van der Does LJME, de Groot NM. Heart Rhythm. 2017;14:616-624.
7. Endo-epicardial dissociation in conduction.
 van der Does LJME, Kik C, Allessie MA, de Groot NMS. Eur Heart J. 2016;38:1775.
8. Direct Proof of Endo-Epicardial Asynchrony of the Atrial Wall During Atrial Fibrillation 
in Humans.
 de Groot NMS*, van der Does LJME*, Yaksh A, Lanters EAH, Teuwen CP, Knops P, van 




9. QUest for the Arrhythmogenic Substrate of Atrial fibRillation in patients undergoing 
cardiac surgery (QUASAR study): rationale and design.
 van der Does LJME, Yaksh A, Kik C, Oei F, van de Woestijne P, Knops P, Lanters 
EAH, Teuwen CP, Bogers AJJC, Allessie MA, de groot NMS. J Cardiovasc Transl Res. 
2016;9:194-201.
10. Dynamics of Endo- and Epicardial Focal Fibrillation Waves at the Right Atrium in a 
Patient with Advanced Atrial Remodelling.
 van der Does LJME, Kik C, Bogers AJJC, Allessie MA, de groot NMS. Can J Cardiol. 
2016;32:1260.e19-1260.e21
11. A Novel Intra-Operative, High-Resolution Atrial Mapping Approach.
 Yaksh A*, van der Does LJME*, Kik C, Knops P, Oei F, van de Woestijne PC, Bogers AJJC, 
Allessie MA, de groot NMS. J Interventional Card Electrophysiol. 2015;44:221-225.
12. A Genetic Predisposition for Lethal Arrhythmias: No Need for Preventive Treatment?
 van der Does LJME, Burghouwt DE, de Groot NMS. Am J Med Sci. 2015;350:340-341.
13. What’s to come after isolation of the pulmonary veins?
 van der Does LJME, de Groot NM. Neth Heart J. 2015;23:94-5.
14. Anatomical hotspots of fractionated electrograms in the left and right atrium: do they 
exist?
 Starreveld R, van der Does LJME, de Groot NMS. Europace. 2019;21:60-72.
15. Pharmacological Therapy of Tachyarrhythmias During Pregnancy. 
 Yaksh A, van der Does LJME, Lanters EAH, de Groot NMS. Arrhythm Electrophysiol Rev. 
2016;5:41-44.
16. Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal 
atrial fibrillation (Riverleft study): study protocol for randomized controlled trial.
 Ramdjan TT, van der Does LJME, Knops P, Res JC, de Groot NMS. Trials. 2014;15:445.
17. A Rare Case of the Digenic Inheritance of Long QT Syndrome Type 2 and Type 6.




18. Impact of the Arrhythmogenic Potential of Long Lines of Conduction Slowing at the 
Pulmonary Vein Area.
 Mouws EMJP, van der Does LJME, Kik C, Lanters EAH, Teuwen CP, Knops P, Bogers 
AJJC, de Groot NMS. Heart Rhythm. 2019;16:511-519.
19. Sinus Rhythm Conduction Properties Across Bachmann’s Bundle: Impact of Underly-
ing Heart Disease and Atrial Fibrillation.
 Teuwen CP, van der Does LJME, Kik C, Mouws EMJP, Lanters EAH, Knops P, Taverne Y, 
Bogers AJJC, de Groot NMS. J Clin Med. 2020;16;9:E1875.
20. Simultaneous Endo-Epicardial Mapping of the Human Right Atrium: Unraveling Atrial 
Excitation.
 Kharbanda RK, Knops P, van der Does LJME, Kik C, Taverne YJHJ, Roos-Serote MC, 
Heida A, Oei FBS, Bogers AJJC, de Groot NMS. J Am Heart Assoc. 2020;9:e017069.
21. Atrial Programmed Electrical Stimulation Techniques on Unipolar Electrogram Mor-
phology.
 Knops P, Schram-Serban C, van der Does LJME, Croes M, Houben R, de Groot NMS. J 
Cardiovasc Electrophysiol. 2020;31:943-951.
22. Novel Insights in the Activation Patterns at the Pulmonary Vein Area.
 Mouws EMJP, Kik C, van der Does LJME, Lanters EAH, Teuwen CP, Knops P, Bogers 
AJJC, de Groot NMS. Circulation: Arrhythmia and Electrophysiology. 2018;11:e006720
23. Impact of Ischemic and Valvular Heart Disease on Atrial Excitation: A High-Resolution 
Epicardial Mapping Study.
 Mouws EMJP, Lanters EAH, Teuwen CP, van der Does LJME, Kik C, Knops P, Yaksh A, 
Bekkers JA, Bogers AJJC, de Groot NMS. J Am Heart Assoc. 2018;7: e008331.
24. Spatial Distribution of Conduction Disorders during Sinus Rhythm.
 Lanters EAH, Yaksh A, Teuwen CP, van der Does LJME, Kik C, Knops P, van Marion DMS, 
Brundel BJJM, Bogers AJJC, Allessie MA, de Groot NMS. Int J Cardiol. 2017;249:220-225.
25. Intraoperative Inducibility of Atrial Fibrillation Does Not Predict Early Postoperative 
Atrial Fibrillation.
 Lanters EAH, Teuwen CP, Yaksh A, Kik C, van der Does LJME, Mouws EMJP, Knops 




26. Epicardial Breakthrough Waves during Sinus Rhythm: Depiction of the Arrhythmogenic 
Substrate?
 Mouws EMJP, Lanter EAH, Teuwen CP, van der Does LJME, Kik C, Knops P, Bekkers JA, 
Bogers AJJC, de Groot NMS. Circ Arrhythm Electrophysiol. 2017;10:e005145.
27. Quantification of the Arrhythmogenic Effects of Spontaneous Atrial Extrasystole Using 
High-Resolution Epicardial Mapping.
 Teuwen CP, Kik C, van der Does LJME, Lanters EAH, Knops P, Mouws EMJP, Bogers 
AJJC, de Groot NMS. Circ Arrhythm Electrophysiol. 2018;11:e005745.
28. Relevance of Conduction Disorders in Bachmann’s Bundle During Sinus Rhythm in 
Humans.
 Teuwen CP, Yaksh A, Lanter EAH, Kik C, van der Does LJME, Knops P, Taverne YJ, van 
de Woestijne PC, Oei FB, Bekkers JA, Bogers AJJC, Allessie MA, de Groot NMS. Circ Ar-
rhythm Electrophysiol. 2016;9:e003972.
29. Impact of Supraventricular Tachyarrhythmia in Patients With Inherited Cardiac Ar-
rhythmia.
 Ragab AAY, Houck CA, van der Does LJME, Lanters EAH, Muskens AJQM, de Groot NMS. 
Am J Cardiol. 2017;120:1985-1989.
30. Prediction of ventricular tachyarrhythmia in Brugada syndrome by right ventricular 
outflow tract conduction delay signs.
 Ragab AAY, Houck CA, van der Does LJME, Lanters EAH, Muskens AJQM, de Groot NMS. 
J Cardiovasc Electrophysiol. 2018;29:998-1003.
31. Usefulness of the R-Wave Sign as a Predictor for Ventricular Tachyarrhythmia in Pa-
tients With Brugada Syndrome.
 Ragab AAY, Houck CA, van der Does LJME, Lanters EAH, Burghouwt DE, Muskens 
AJQM, de Groot NMS. Am J Cardiol. 2017;120:428-434.
32. Effects of visual processing and congenital nystagmus on visually guided ocular motor 
behavior.
 Pel JJ, van der Does LJME, Boot FH, de Faber T, van der Steen-Kant S, Willemsen S, van 




33. Orienting Responses to Various Visual Stimuli in Children With Visual Processing Im-
pairments or Infantile Nystagmus Syndrome.
 Pel JJ, Kooiker MJ, van der Does LJME, Boot FH, de Faber T, van der Steen-Kant S, van 
der Steen H. Journal of child neurology. 2014;29:1632-1637.
Book chapters
1. Cardiac Mapping, 5th edition. M Shenasa, G Hindricks, DJ Callans, JM Miller, ME Jo-
sephson. Hoboken (New Yersey). Wiley-Blackwell. 2019.
 Chapter 26 Atrial Fibrillation from a Unipolar, High-resolution Perspective.
 NMS de Groot, MA Allessie, LJME van der Does, AJJC Bogers.
Submitted
1. Detection of Endo-Epicardial Asynchrony in the Atrial Wall using One-Sided Unipolar 
and Bipolar Electrograms.







Summary of PhD training and teaching activities
Name PhD student: Lisette (JME) van der Does
Erasmus MC Department: Cardiology
Research School: Cardiovascular Research School (COEUR)
PhD period: 2014-2020
Title thesis: Mapping of Atrial Fibrillation: Back to the Drawing Board
Promotors: Prof. dr. N.M.S. de Groot





- Research Integrity 2015 0.3
- Basiscursus Regelgeving en Organisatie voor Klinisch Onderzoekers 2016 1.5
In-depth courses (e.g. Research school, Medical Training)
- Research master Neuroscience 2008-2010 120
- Summer school Neuroscience 2008 1.5
Presentations
- AAV wetenschapsmiddag, oral 2015 0.5
- American Heart Association, poster 2015 0.3
- AF symposium, poster 2016 0.3
- NVVC Unlimited, oral 2016 0.5
- ECAS, oral 2016 0.5
- Hearth Rhythm, oral 2016 0.5
- Cardiostim, poster 2017 0.3
(Inter)national conferences
- NVVC Spoed Congress 2014 0.3
- NVVC Cardiologie in Beweging 2015 0.3
- American Heart Association 2015 1.5
- AF Symposium 2016 0.9
- NVVC Unlimited 2016 0.3
- ECAS 2016 0.9
- Heart Rhythm 2016 1.5
- ECAS 2017 0.9
- Cardiostim 2017 1.0




- Elektrocardiografie, CVOI 2012 0.3
- Pacemaker cursus 2014 0.6
- COEUR seminar: imaging of cardiac arrhythmias 2014 0.2
- COEUR seminar: role of biomarkers in pathophysiology of AF 2015 0.4
- COEUR PhD course Arrhythmia Research 2016 1.5
- SVT Workshop Biotronik 2016 0.6
- Cardiac Arrhythmias: from biology & technology to electrophysiology 2019 0.2
Didactic skills
- BKO Teaching the Teacher I 2015 0.6
- BKO workshop Omgaan met Groepen 2015 0.2
- BKO workshop Individuele Begeleiding 2015 0.2
Other
- Advanced Life Support 2017 1.0





- Continuing Nursing Education 2016 0.5
Supervising practicals and excursions
- VO patient met hartritmestoornissen 2015 0.1
- VO Interpretatie van het ECG 2015 0.1
- ICK 2015 0.2
Supervising Master’s theses
- Medical students 2014-2015 1.0
TOTAL 140.4
Did you see and uncover AF?

Financial support for the publication of this thesis was generously provided by:
Erasmus Medisch Centrum
Afdeling Cardiologie, Erasmus Medisch Centrum
Stichting BeroepsOpleiding Huisartsen
Mapping of Atrial Fibrillation:
Back to the Drawing Board
Lisette van der Does
